<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML 3.2//EN">
<HTML>
<HEAD>
<TITLE>
HL7 Version 2.8 Chapter 4
</TITLE>
<link rel="stylesheet" href="formate.css" type="Text/css">
<link rel="shortcut icon" href="../hl7.ico">
<META name="generator" contents="HL7-v2.x-XML-Extractor">
<META name="author" contents="FO">
</HEAD>
<BODY>
<Table width="100%" border="0">
<TR>
<TD align=right>
<font size=+5><p>4. Order Entry</font>
</TD>
</TR>
<TR>
<TD BGCOLOR=black>
<br>
</TD>
</TR>
</Table><p>
<H1>Contents</H1>
<ul>
<li><a href="hl7.html">Contents</a></li>
<li><a href="ch01.html">Chapter 01: Introduction</a></li>
<li><a href="ch02.html">Chapter 02: Control</a></li>
<li><a href="ch02a.html">Chapter 02a: Control (continued)</a></li>
<li><a href="ch02b.html">Chapter 02b: Control (continued)</a></li>
<li><a href="ch02c.html">Chapter 02c: Control (continued)</a></li>
<li><a href="ch03.html">Chapter 03: Patient Administration</a></li>
<li><a href="ch04.html">Chapter 04: Order Entry</a></li>
<li><a href="ch04a.html">Chapter 04a: Order Entry</a></li>
<li><a href="ch05.html">Chapter 05: Query</a></li>
<li><a href="ch06.html">Chapter 06: Financial Management</a></li>
<li><a href="ch07.html">Chapter 07: Observation Reporting</a></li>
<li><a href="ch08.html">Chapter 08: Master Files</a></li>
<li><a href="ch09.html">Chapter 09: Medical Records/Information Management  (Document Management)</a></li>
<li><a href="ch10.html">Chapter 10: Scheduling</a></li>
<li><a href="ch11.html">Chapter 11: Patient Referral</a></li>
<li><a href="ch12.html">Chapter 12: Patient Care</a></li>
<li><a href="ch13.html">Chapter 13: Clinical Laboratory Automation</a></li>
<li><a href="ch14.html">Chapter 14: Application Management</a></li>
<li><a href="ch15.html">Chapter 15: Personnel Management</a></li>
<li><a href="ch16.html">Chapter 16: Claims and Reimbursement</a></li>
<li><a href="ch17.html">Chapter 17: Materials Management</a></li>
</ul>
<hr>
<UL>
<li><a href="ch04a.html#Heading1">4 A. Order Entry: Pharmacy/Treatment, Vaccination</a></li>
<UL>
<li><a href="ch04a.html#Heading2">4.A CHAPTER 4A CONTENTS</a></li>
<li><a href="ch04a.html#Heading3">4.A PURPOSE</a></li>
<UL>
<li><a href="ch04a.html#Heading4">4.A.1 Preface (organization of this chapter)</a></li>
</UL>
<li><a href="ch04a.html#Heading5">4.A PHARMACY/TREATMENT TRIGGER EVENTS & MESSAGES</a></li>
<UL>
<li><a href="ch04a.html#Heading6">4.A.1 Usage notes for pharmacy/treatment messages</a></li>
<li><a href="ch04a.html#Heading7">4.A.2 IV solution groups</a></li>
<li><a href="ch04a.html#Heading8">4.A.3 OMP - Pharmacy/Treatment Order Message (Event O09) </a></li>
<li><a href="ch04a.html#Heading9">4.A.4 ORP - Pharmacy/Treatment Order Acknowledgment (Event O10)</a></li>
<li><a href="ch04a.html#Heading10">4.A.5 RDE - Pharmacy/Treatment Encoded Order Message (Event O11)</a></li>
<li><a href="ch04a.html#Heading11">4.A.6 RRE - Pharmacy/Treatment Encoded Order Acknowledgment (Event O12)</a></li>
<li><a href="ch04a.html#Heading12">4.A.7 RDS - Pharmacy/Treatment Dispense Message (Event O13)</a></li>
<li><a href="ch04a.html#Heading13">4.A.8 RRD - Pharmacy/Treatment Dispense Acknowledgement Message (Event O14) </a></li>
<li><a href="ch04a.html#Heading14">4.A.9 RGV - Pharmacy/Treatment Give Message (Event O15) </a></li>
<li><a href="ch04a.html#Heading15">4.A.10 RRG - Pharmacy/Treatment Give Acknowledgment Message (Event O16) </a></li>
<li><a href="ch04a.html#Heading16">4.A.11 RAS - Pharmacy/Treatment Administration Message (Event O17) </a></li>
<li><a href="ch04a.html#Heading17">4.A.12 RRA - Pharmacy/Treatment Administration Acknowledgment Message (Event O18) </a></li>
<li><a href="ch04a.html#Heading18">4.A.13 RDE - Pharmacy/Treatment Refill Authorization Request Message (Event O25)</a></li>
<li><a href="ch04a.html#Heading19">4.A.14 RRE - Pharmacy/Treatment Refill Authorization Request Acknowledgment (Event O26)</a></li>
<li><a href="ch04a.html#Heading20">4.A.15 ROR - Pharmacy/Treatment Order Response</a></li>
<li><a href="ch04a.html#Heading21">4.A.16 RAR - Pharmacy/Treatment Administration Information</a></li>
<li><a href="ch04a.html#Heading22">4.A.17 RDR - Pharmacy/Treatment Dispense Information</a></li>
<li><a href="ch04a.html#Heading23">4.A.18 RER - Pharmacy/Treatment Encoded Order</a></li>
<li><a href="ch04a.html#Heading24">4.A.19 RGR - Pharmacy/Treatment Dose Information</a></li>
<li><a href="ch04a.html#Heading25">4.A.20 Pharmacy Query/Response Message Pair </a></li>
<UL>
<li><a href="ch04a.html#Heading27">4.A.20.1 Example</a></li>
</UL>
</UL>
<li><a href="ch04a.html#Heading28">4.A PHARMACY/TREATMENT SEGMENTS</a></li>
<UL>
<li><a href="ch04a.html#Heading29">4.A.1 RXO - Pharmacy/Treatment Order Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading30">4.A.1.0 RXO field definitions</a></li>
<li><a href="ch04a.html#Heading31">4.A.1.1 RXO-1   Requested Give Code   (CWE)   00292</a></li>
<li><a href="ch04a.html#Heading32">4.A.1.2 RXO-2   Requested Give Amount - Minimum   (NM)   00293</a></li>
<li><a href="ch04a.html#Heading33">4.A.1.3 RXO-3   Requested Give Amount - Maximum   (NM)   00294</a></li>
<li><a href="ch04a.html#Heading34">4.A.1.4 RXO-4   Requested Give Units   (CWE)   00295</a></li>
<li><a href="ch04a.html#Heading35">4.A.1.5 RXO-5   Requested Dosage Form   (CWE)   00296</a></li>
<li><a href="ch04a.html#Heading36">4.A.1.6 RXO-6   Provider's Pharmacy/Treatment Instructions   (CWE)   00297</a></li>
<li><a href="ch04a.html#Heading37">4.A.1.7 RXO-7   Provider's Administration Instructions   (CWE)   00298</a></li>
<li><a href="ch04a.html#Heading38">4.A.1.8 RXO-8   Deliver-to Location</a></li>
<li><a href="ch04a.html#Heading39">4.A.1.9 RXO-9   Allow Substitutions   (ID)   00300</a></li>
<li><a href="ch04a.html#Heading40">4.A.1.10 RXO-10   Requested Dispense Code   (CWE)   00301</a></li>
<li><a href="ch04a.html#Heading41">4.A.1.11 RXO-11   Requested Dispense Amount   (NM)   00302</a></li>
<li><a href="ch04a.html#Heading42">4.A.1.12 RXO-12   Requested Dispense Units   (CWE)   00303</a></li>
<li><a href="ch04a.html#Heading43">4.A.1.13 RXO-13   Number of Refills   (NM)   00304</a></li>
<li><a href="ch04a.html#Heading44">4.A.1.14 RXO-14   Ordering Provider's DEA Number   (XCN)   00305</a></li>
<li><a href="ch04a.html#Heading45">4.A.1.15 RXO-15   Pharmacist/Treatment Supplier's Verifier ID   (XCN)   00306</a></li>
<li><a href="ch04a.html#Heading46">4.A.1.16 RXO-16   Needs Human Review   (ID)   00307</a></li>
<li><a href="ch04a.html#Heading47">4.A.1.17 RXO-17   Requested Give Per (Time Unit)   (ST)   00308</a></li>
<li><a href="ch04a.html#Heading48">4.A.1.18 RXO-18   Requested Give Strength   (NM)   01121</a></li>
<li><a href="ch04a.html#Heading49">4.A.1.19 RXO-19   Requested Give Strength Units   (CWE)   01122</a></li>
<li><a href="ch04a.html#Heading50">4.A.1.20 RXO-20   Indication   (CWE)   01123</a></li>
<li><a href="ch04a.html#Heading51">4.A.1.21 RXO-21   Requested Give Rate Amount   (ST)   01218</a></li>
<li><a href="ch04a.html#Heading52">4.A.1.22 RXO-22   Requested Give Rate Units   (CWE)   01219</a></li>
<li><a href="ch04a.html#Heading53">4.A.1.23 RXO-23   Total Daily Dose   (CQ)   00329</a></li>
<li><a href="ch04a.html#Heading54">4.A.1.24 RXO-24   Supplementary Code   (CWE)   01476</a></li>
<li><a href="ch04a.html#Heading55">4.A.1.25 RXO-25   Requested Drug Strength Volume   (NM)   01666</a></li>
<li><a href="ch04a.html#Heading56">4.A.1.26 RXO-26   Requested Drug Strength Volume Units   (CWE)   01667</a></li>
<li><a href="ch04a.html#Heading57">4.A.1.27 RXO-27   Pharmacy Order Type   (ID)   01668</a></li>
<li><a href="ch04a.html#Heading58">4.A.1.28 RXO-28   Dispensing Interval   (NM)   01669</a></li>
<li><a href="ch04a.html#Heading59">4.A.1.29 RXO-29   Medication Instance Identifier   (EI)   02149</a></li>
<li><a href="ch04a.html#Heading60">4.A.1.30 RXO-30   Segment Instance Identifier   (EI)   02150</a></li>
<li><a href="ch04a.html#Heading61">4.A.1.31 RXO-31   Mood Code   (CNE)   02151</a></li>
<li><a href="ch04a.html#Heading62">4.A.1.32 RXO-32   Dispensing Pharmacy   (CWE)   01681</a></li>
<li><a href="ch04a.html#Heading63">4.A.1.33 RXO-33   Dispensing Pharmacy Address   (XAD)   01682</a></li>
<li><a href="ch04a.html#Heading64">4.A.1.34 RXO-34   Deliver-to Patient Location   (PL)   01683</a></li>
<li><a href="ch04a.html#Heading65">4.A.1.35 RXO-35   Deliver-to Address   (XAD)   01684</a></li>
<li><a href="ch04a.html#Heading66">4.A.1.36 RXO-36   Pharmacy Phone Number   (XTN)   02309</a></li>
</UL>
<li><a href="ch04a.html#Heading67">4.A.2 RXR - Pharmacy/Treatment Route Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading68">4.A.2.0 RXR field definitions</a></li>
<li><a href="ch04a.html#Heading69">4.A.2.1 RXR-1   Route   (CWE)   00309</a></li>
<li><a href="ch04a.html#Heading70">4.A.2.2 RXR-2   Administration Site   (CWE)   00310</a></li>
<li><a href="ch04a.html#Heading71">4.A.2.3 RXR-3   Administration Device   (CWE)   00311</a></li>
<li><a href="ch04a.html#Heading72">4.A.2.4 RXR-4   Administration Method   (CWE)   00312</a></li>
<li><a href="ch04a.html#Heading73">4.A.2.5 RXR-5   Routing Instruction   (CWE)   01315</a></li>
<li><a href="ch04a.html#Heading74">4.A.2.6 RXR-6   Administration Site Modifier   (CWE)   01670</a></li>
</UL>
<li><a href="ch04a.html#Heading75">4.A.3 RXC - Pharmacy/Treatment Component Order Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading76">4.A.3.0 RXC field definitions</a></li>
<li><a href="ch04a.html#Heading77">4.A.3.1 RXC-1   RX Component Type   (ID)   00313</a></li>
<li><a href="ch04a.html#Heading78">4.A.3.2 RXC-2   Component Code   (CWE)   00314</a></li>
<li><a href="ch04a.html#Heading79">4.A.3.3 RXC-3   Component Amount   (NM)   00315</a></li>
<li><a href="ch04a.html#Heading80">4.A.3.4 RXC-4   Component Units   (CWE)   00316</a></li>
<li><a href="ch04a.html#Heading81">4.A.3.5 RXC-5   Component Strength   (NM)   01124</a></li>
<li><a href="ch04a.html#Heading82">4.A.3.6 RXC-6   Component Strength Units   (CWE)   01125</a></li>
<li><a href="ch04a.html#Heading83">4.A.3.7 RXC-7   Supplementary Code   (CWE)   01476</a></li>
<li><a href="ch04a.html#Heading84">4.A.3.8 RXC-8   Component Drug Strength Volume   (NM)   01671</a></li>
<li><a href="ch04a.html#Heading85">4.A.3.9 RXC-9   Component Drug Strength Volume Units   (CWE)   01672</a></li>
<li><a href="ch04a.html#Heading86">4.A.3.10 RXC-10   Dispense Amount   (NM)   03314</a></li>
<li><a href="ch04a.html#Heading87">4.A.3.11 RXC-11   Dispense Units   (CWE)   03315</a></li>
</UL>
<li><a href="ch04a.html#Heading88">4.A.4 RXE - Pharmacy/Treatment Encoded Order Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading89">4.A.4.0 RXE field definitions</a></li>
<li><a href="ch04a.html#Heading90">4.A.4.1 RXE-1   Quantity/Timing</a></li>
<li><a href="ch04a.html#Heading91">4.A.4.2 RXE-2   Give Code   (CWE)   00317</a></li>
<li><a href="ch04a.html#Heading92">4.A.4.3 RXE-3   Give Amount - Minimum   (NM)   00318</a></li>
<li><a href="ch04a.html#Heading93">4.A.4.4 RXE-4   Give Amount - Maximum   (NM)   00319</a></li>
<li><a href="ch04a.html#Heading94">4.A.4.5 RXE-5   Give Units   (CWE)   00320</a></li>
<li><a href="ch04a.html#Heading95">4.A.4.6 RXE-6   Give Dosage Form   (CWE)   00321</a></li>
<li><a href="ch04a.html#Heading96">4.A.4.7 RXE-7   Provider's Administration Instructions   (CWE)   00298</a></li>
<li><a href="ch04a.html#Heading97">4.A.4.8 RXE-8   Deliver-to Location</a></li>
<li><a href="ch04a.html#Heading98">4.A.4.9 RXE-9   Substitution Status   (ID)   00322</a></li>
<li><a href="ch04a.html#Heading99">4.A.4.10 RXE-10   Dispense Amount   (NM)   00323</a></li>
<li><a href="ch04a.html#Heading100">4.A.4.11 RXE-11   Dispense Units   (CWE)   00324</a></li>
<li><a href="ch04a.html#Heading101">4.A.4.12 RXE-12   Number of Refills   (NM)   00304</a></li>
<li><a href="ch04a.html#Heading102">4.A.4.13 RXE-13   Ordering Provider's DEA Number   (XCN)   00305</a></li>
<li><a href="ch04a.html#Heading103">4.A.4.14 RXE-14   Pharmacist/Treatment Supplier's Verifier ID   (XCN)   00306</a></li>
<li><a href="ch04a.html#Heading104">4.A.4.15 RXE-15   Prescription Number   (ST)   00325</a></li>
<li><a href="ch04a.html#Heading105">4.A.4.16 RXE-16   Number of Refills Remaining   (NM)   00326</a></li>
<li><a href="ch04a.html#Heading106">4.A.4.17 RXE-17   Number of Refills/Doses Dispensed   (NM)   00327</a></li>
<li><a href="ch04a.html#Heading107">4.A.4.18 RXE-18   D/T of Most Recent Refill or Dose Dispensed   (DTM)   00328</a></li>
<li><a href="ch04a.html#Heading108">4.A.4.19 RXE-19   Total Daily Dose   (CQ)   00329</a></li>
<li><a href="ch04a.html#Heading109">4.A.4.20 RXE-20   Needs Human Review   (ID)   00307</a></li>
<li><a href="ch04a.html#Heading110">4.A.4.21 RXE-21   Special Dispensing Instructions   (CWE)   00330</a></li>
<li><a href="ch04a.html#Heading111">4.A.4.22 RXE-22   Give Per (Time Unit)    (ST)   00331</a></li>
<li><a href="ch04a.html#Heading112">4.A.4.23 RXE-23   Give Rate Amount   (ST)   00332</a></li>
<li><a href="ch04a.html#Heading113">4.A.4.24 RXE-24   Give Rate Units   (CWE)   00333</a></li>
<li><a href="ch04a.html#Heading114">4.A.4.25 RXE-25   Give Strength   (NM)   01126</a></li>
<li><a href="ch04a.html#Heading115">4.A.4.26 RXE-26   Give Strength Units   (CWE)   01127</a></li>
<li><a href="ch04a.html#Heading116">4.A.4.27 RXE-27   Give Indication   (CWE)   01128</a></li>
<li><a href="ch04a.html#Heading117">4.A.4.28 RXE-28   Dispense Package Size   (NM)   01220</a></li>
<li><a href="ch04a.html#Heading118">4.A.4.29 RXE-29   Dispense Package Size Unit   (CWE)   01221</a></li>
<li><a href="ch04a.html#Heading119">4.A.4.30 RXE-30   Dispense Package Method   (ID)   01222</a></li>
<li><a href="ch04a.html#Heading120">4.A.4.31 RXE-31   Supplementary Code   (CWE)   01476</a></li>
<li><a href="ch04a.html#Heading121">4.A.4.32 RXE-32   Original Order Date/Time   (DTM)   01673</a></li>
<li><a href="ch04a.html#Heading122">4.A.4.33 RXE-33   Give Drug Strength Volume   (NM)   01674</a></li>
<li><a href="ch04a.html#Heading123">4.A.4.34 RXE-34   Give Drug Strength Volume Units   (CWE)   01675</a></li>
<li><a href="ch04a.html#Heading124">4.A.4.35 RXE-35   Controlled Substance Schedule   (CWE)   01676</a></li>
<li><a href="ch04a.html#Heading125">4.A.4.36 RXE-36   Formulary Status   (ID)   01677</a></li>
<li><a href="ch04a.html#Heading126">4.A.4.37 RXE-37   Pharmaceutical Substance Alternative   (CWE)   01678</a></li>
<li><a href="ch04a.html#Heading127">4.A.4.38 RXE-38   Pharmacy of Most Recent Fill   (CWE)   01679</a></li>
<li><a href="ch04a.html#Heading128">4.A.4.39 RXE-39   Initial Dispense Amount   (NM)   01680</a></li>
<li><a href="ch04a.html#Heading129">4.A.4.40 RXE-40   Dispensing Pharmacy   (CWE)   01681</a></li>
<li><a href="ch04a.html#Heading130">4.A.4.41 RXE-41   Dispensing Pharmacy Address   (XAD)   01682</a></li>
<li><a href="ch04a.html#Heading131">4.A.4.42 RXE-42   Deliver-To Patient Location   (PL)   01683</a></li>
<li><a href="ch04a.html#Heading132">4.A.4.43 RXE-43   Deliver-to Address   (XAD)   01684</a></li>
<li><a href="ch04a.html#Heading133">4.A.4.44 RXE-44   Pharmacy Order Type   (ID)   01685</a></li>
<li><a href="ch04a.html#Heading134">4.A.4.45 RXE-45   Pharmacy Phone Number   (XTN)   02310</a></li>
</UL>
<li><a href="ch04a.html#Heading135">4.A.5 RXD - Pharmacy/Treatment Dispense Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading136">4.A.5.0 RXD field definitions</a></li>
<li><a href="ch04a.html#Heading137">4.A.5.1 RXD-1   Dispense Sub-ID counter   (NM)   00334</a></li>
<li><a href="ch04a.html#Heading138">4.A.5.2 RXD-2   Dispense/Give Code   (CWE)   00335</a></li>
<li><a href="ch04a.html#Heading139">4.A.5.3 RXD-3   Date/Time Dispensed   (DTM)   00336</a></li>
<li><a href="ch04a.html#Heading140">4.A.5.4 RXD-4   Actual Dispense Amount   (NM)   00337</a></li>
<li><a href="ch04a.html#Heading141">4.A.5.5 RXD-5   Actual Dispense Units   (CWE)   00338</a></li>
<li><a href="ch04a.html#Heading142">4.A.5.6 RXD-6   Actual Dosage Form   (CWE)   00339</a></li>
<li><a href="ch04a.html#Heading143">4.A.5.7 RXD-7   Prescription Number   (ST)   00325</a></li>
<li><a href="ch04a.html#Heading144">4.A.5.8 RXD-8   Number of Refills Remaining   (NM)   00326</a></li>
<li><a href="ch04a.html#Heading145">4.A.5.9 RXD-9   Dispense Notes   (ST)   00340</a></li>
<li><a href="ch04a.html#Heading146">4.A.5.10 RXD-10   Dispensing Provider   (XCN)   00341</a></li>
<li><a href="ch04a.html#Heading147">4.A.5.11 RXD-11   Substitution Status   (ID)   00322</a></li>
<li><a href="ch04a.html#Heading148">4.A.5.12 RXD-12   Total Daily Dose   (CQ)   00329</a></li>
<li><a href="ch04a.html#Heading149">4.A.5.13 RXD-13   Dispense-to Location</a></li>
<li><a href="ch04a.html#Heading150">4.A.5.14 RXD-14   Needs Human Review   (ID)   00307</a></li>
<li><a href="ch04a.html#Heading151">4.A.5.15 RXD-15   Special Dispensing Instructions   (CWE)   00330</a></li>
<li><a href="ch04a.html#Heading152">4.A.5.16 RXD-16   Actual Strength   (NM)   01132</a></li>
<li><a href="ch04a.html#Heading153">4.A.5.17 RXD-17   Actual Strength Unit   (CWE)   01133</a></li>
<li><a href="ch04a.html#Heading154">4.A.5.18 RXD-18   Substance Lot Number   (ST)   01129</a></li>
<li><a href="ch04a.html#Heading155">4.A.5.19 RXD-19   Substance Expiration Date   (DTM)   01130</a></li>
<li><a href="ch04a.html#Heading156">4.A.5.20 RXD-20   Substance Manufacturer Name   (CWE)   01131</a></li>
<li><a href="ch04a.html#Heading157">4.A.5.21 RXD-21   Indication   (CWE)   01123</a></li>
<li><a href="ch04a.html#Heading158">4.A.5.22 RXD-22   Dispense Package Size   (NM)   01220</a></li>
<li><a href="ch04a.html#Heading159">4.A.5.23 RXD-23   Dispense Package Size Unit   (CWE)   01221</a></li>
<li><a href="ch04a.html#Heading160">4.A.5.24 RXD-24   Dispense Package Method   (ID)   01222</a></li>
<li><a href="ch04a.html#Heading161">4.A.5.25 RXD-25   Supplementary code   (CWE)   01476</a></li>
<li><a href="ch04a.html#Heading162">4.A.5.26 RXD-26   Initiating Location   (CWE)   01477 </a></li>
<li><a href="ch04a.html#Heading163">4.A.5.27 RXD-27   Packaging/Assembly Location   (CWE)   01478</a></li>
<li><a href="ch04a.html#Heading164">4.A.5.28 RXD-28   Actual Drug Strength Volume   (NM)   01686</a></li>
<li><a href="ch04a.html#Heading165">4.A.5.29 RXD-29   Actual Drug Strength Volume Units   (CWE)   01687</a></li>
<li><a href="ch04a.html#Heading166">4.A.5.30 RXD-30   Dispense to Pharmacy   (CWE)   01688</a></li>
<li><a href="ch04a.html#Heading167">4.A.5.31 RXD-31   Dispense to Pharmacy Address   (XAD)   01689</a></li>
<li><a href="ch04a.html#Heading168">4.A.5.32 RXD-32   Pharmacy Order Type   (ID)   01690</a></li>
<li><a href="ch04a.html#Heading169">4.A.5.33 RXD-33   Dispense Type   (CWE)   01691</a></li>
<li><a href="ch04a.html#Heading170">4.A.5.34 RXD-34   Pharmacy Phone Number   (XTN)   02311</a></li>
<li><a href="ch04a.html#Heading171">4.A.5.35 RXD-35   Dispense Tag Identifier   (EI)   03392</a></li>
</UL>
<li><a href="ch04a.html#Heading172">4.A.6 RXG - Pharmacy/Treatment Give Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading173">4.A.6.0 RXG fields definitions</a></li>
<li><a href="ch04a.html#Heading174">4.A.6.1 RXG-1   Give Sub-ID Counter   (NM)   00342</a></li>
<li><a href="ch04a.html#Heading175">4.A.6.2 RXG-2   Dispense Sub-ID Counter   (NM)   00334</a></li>
<li><a href="ch04a.html#Heading176">4.A.6.3 RXG-3   Quantity/Timing</a></li>
<li><a href="ch04a.html#Heading177">4.A.6.4 RXG-4   Give Code   (CWE)   00317</a></li>
<li><a href="ch04a.html#Heading178">4.A.6.5 RXG-5   Give Amount - Minimum   (NM)   00318</a></li>
<li><a href="ch04a.html#Heading179">4.A.6.6 RXG-6   Give Amount - Maximum   (NM)   00319</a></li>
<li><a href="ch04a.html#Heading180">4.A.6.7 RXG-7   Give Units   (CWE)   00320</a></li>
<li><a href="ch04a.html#Heading181">4.A.6.8 RXG-8   Give Dosage Form   (CWE)   00321</a></li>
<li><a href="ch04a.html#Heading182">4.A.6.9 RXG-9   Administration Notes   (CWE)   00351</a></li>
<li><a href="ch04a.html#Heading183">4.A.6.10 RXG-10   Substitution Status   (ID)   00322</a></li>
<li><a href="ch04a.html#Heading184">4.A.6.11 RXG-11   Dispense-to Location</a></li>
<li><a href="ch04a.html#Heading185">4.A.6.12 RXG-12   Needs Human Review   (ID)   00307</a></li>
<li><a href="ch04a.html#Heading186">4.A.6.13 RXG-13   Special Administration Instructions   (CWE)   00343</a></li>
<li><a href="ch04a.html#Heading187">4.A.6.14 RXG-14   Give Per (Time Unit)   (ST)   00331</a></li>
<li><a href="ch04a.html#Heading188">4.A.6.15 RXG-15   Give Rate Amount   (ST)   00332</a></li>
<li><a href="ch04a.html#Heading189">4.A.6.16 RXG-16   Give Rate Units   (CWE)   00333</a></li>
<li><a href="ch04a.html#Heading190">4.A.6.17 RXG-17   Give Strength   (NM)   01126</a></li>
<li><a href="ch04a.html#Heading191">4.A.6.18 RXG-18   Give Strength Units   (CWE)   01127</a></li>
<li><a href="ch04a.html#Heading192">4.A.6.19 RXG-19   Substance Lot Number   (ST)   01129</a></li>
<li><a href="ch04a.html#Heading193">4.A.6.20 RXG-20   Substance Expiration Date   (DTM)   01130</a></li>
<li><a href="ch04a.html#Heading194">4.A.6.21 RXG-21   Substance Manufacturer Name   (CWE)   01131</a></li>
<li><a href="ch04a.html#Heading195">4.A.6.22 RXG-22   Indication   (CWE)   01123</a></li>
<li><a href="ch04a.html#Heading196">4.A.6.23 RXG-23   Give Drug Strength Volume   (NM)   01692</a></li>
<li><a href="ch04a.html#Heading197">4.A.6.24 RXG-24   Give Drug Strength Volume Units   (CWE)   01693</a></li>
<li><a href="ch04a.html#Heading198">4.A.6.25 RXG-25   Give Barcode Identifier   (CWE)   01694</a></li>
<li><a href="ch04a.html#Heading199">4.A.6.26 RXG-26   Pharmacy Order Type   (ID)   01695</a></li>
<li><a href="ch04a.html#Heading200">4.A.6.27 RXG-27   Dispense to Pharmacy   (CWE)   01688</a></li>
<li><a href="ch04a.html#Heading201">4.A.6.28 RXG-28   Dispense to Pharmacy Address   (XAD)   01689</a></li>
<li><a href="ch04a.html#Heading202">4.A.6.29 RXG-29   Deliver-to Patient Location   (PL)   01683</a></li>
<li><a href="ch04a.html#Heading203">4.A.6.30 RXG-30   Deliver-to Address   (XAD)   01684</a></li>
<li><a href="ch04a.html#Heading204">4.A.6.31 RXG-31   Give Tag Identifier   (EI)   03393</a></li>
<li><a href="ch04a.html#Heading205">4.A.6.32 RXG-32   Dispense Amount   (NM)   03316</a></li>
<li><a href="ch04a.html#Heading206">4.A.6.33 RXG-33   Dispense Units   (CWE)   03317</a></li>
</UL>
<li><a href="ch04a.html#Heading207">4.A.7 RXA - Pharmacy/Treatment Administration Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading208">4.A.7.0 RXA field definitions</a></li>
<li><a href="ch04a.html#Heading209">4.A.7.1 RXA-1   Give Sub-ID Counter   (NM)   00342</a></li>
<li><a href="ch04a.html#Heading210">4.A.7.2 RXA-2   Administration Sub-ID Counter   (NM)   00344</a></li>
<li><a href="ch04a.html#Heading211">4.A.7.3 RXA-3   Date/Time Start of Administration   (DTM)   00345</a></li>
<li><a href="ch04a.html#Heading212">4.A.7.4 RXA-4   Date/Time End of Administration   (DTM)   00346</a></li>
<li><a href="ch04a.html#Heading213">4.A.7.5 RXA-5   Administered Code   (CWE)   00347</a></li>
<li><a href="ch04a.html#Heading214">4.A.7.6 RXA-6   Administered Amount   (NM)   00348</a></li>
<li><a href="ch04a.html#Heading215">4.A.7.7 RXA-7   Administered units   (CWE)   00349</a></li>
<li><a href="ch04a.html#Heading216">4.A.7.8 RXA-8   Administered Dosage Form   (CWE)   00350</a></li>
<li><a href="ch04a.html#Heading217">4.A.7.9 RXA-9   Administration Notes   (CWE)   00351</a></li>
<li><a href="ch04a.html#Heading218">4.A.7.10 RXA-10   Administering Provider   (XCN)   00352</a></li>
<li><a href="ch04a.html#Heading219">4.A.7.11 RXA-11   Administered-at Location</a></li>
<li><a href="ch04a.html#Heading220">4.A.7.12 RXA-12   Administered Per (Time Unit)   (ST)   00354</a></li>
<li><a href="ch04a.html#Heading221">4.A.7.13 RXA-13   Administered Strength   (NM)   01134</a></li>
<li><a href="ch04a.html#Heading222">4.A.7.14 RXA-14   Administered Strength Units   (CWE)   01135</a></li>
<li><a href="ch04a.html#Heading223">4.A.7.15 RXA-15   Substance Lot Number   (ST)   01129</a></li>
<li><a href="ch04a.html#Heading224">4.A.7.16 RXA-16   Substance Expiration Date   (DTM)   01130</a></li>
<li><a href="ch04a.html#Heading225">4.A.7.17 RXA-17   Substance Manufacturer Name   (CWE)   01131</a></li>
<li><a href="ch04a.html#Heading226">4.A.7.18 RXA-18   Substance/Treatment Refusal Reason   (CWE)   01136</a></li>
<li><a href="ch04a.html#Heading227">4.A.7.19 RXA-19   Indication   (CWE)   01123</a></li>
<li><a href="ch04a.html#Heading228">4.A.7.20 RXA-20   Completion Status   (ID)   01223 </a></li>
<li><a href="ch04a.html#Heading229">4.A.7.21 RXA-21   Action Code - RXA   (ID)   01224 </a></li>
<li><a href="ch04a.html#Heading230">4.A.7.22 RXA-22   System Entry Date/Time   (DTM)   01225 </a></li>
<li><a href="ch04a.html#Heading231">4.A.7.23 RXA-23   Administered Drug Strength Volume   (NM)   01696</a></li>
<li><a href="ch04a.html#Heading232">4.A.7.24 RXA-24   Administered Drug Strength Volume Units   (CWE)   01697</a></li>
<li><a href="ch04a.html#Heading233">4.A.7.25 RXA-25   Administered Barcode Identifier   (CWE)   01698</a></li>
<li><a href="ch04a.html#Heading234">4.A.7.26 RXA-26   Pharmacy Order Type   (ID)   01699</a></li>
<li><a href="ch04a.html#Heading235">4.A.7.27 RXA-27   Administered-At   (PL)   02264</a></li>
<li><a href="ch04a.html#Heading236">4.A.7.28 RXA-28   Administered-at Address   (XAD)   02265</a></li>
<li><a href="ch04a.html#Heading237">4.A.7.29 RXA-29   Administration Tag Identifier   (EI)   03396</a></li>
</UL>
<li><a href="ch04a.html#Heading238">4.A.8 RXV - Pharmacy/Treatment Infusion Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading239">4.A.8.0 RXV Field Definitions</a></li>
<li><a href="ch04a.html#Heading240">4.A.8.1 RXV-1   Set ID    (SI)   03318</a></li>
<li><a href="ch04a.html#Heading241">4.A.8.2 RXV-2   Bolus Type    (ID)   03319</a></li>
<li><a href="ch04a.html#Heading242">4.A.8.3 RXV-3   Bolus Dose Amount    (NM)   03320</a></li>
<li><a href="ch04a.html#Heading243">4.A.8.4 RXV-4   Bolus Dose Amount Units    (CWE)   03321</a></li>
<li><a href="ch04a.html#Heading244">4.A.8.5 RXV-5   Bolus Dose Volume    (NM)   03322</a></li>
<li><a href="ch04a.html#Heading245">4.A.8.6 RXV-6   Bolus Dose Volume Units    (CWE)   03323</a></li>
<li><a href="ch04a.html#Heading246">4.A.8.7 RXV-7   PCA Type    (ID)   03324</a></li>
<li><a href="ch04a.html#Heading247">4.A.8.8 RXV-8   PCA Dose Amount    (NM)   03325</a></li>
<li><a href="ch04a.html#Heading248">4.A.8.9 RXV-9   PCA Dose Amount Units    (CWE)   03326</a></li>
<li><a href="ch04a.html#Heading249">4.A.8.10 RXV-10   PCA Dose Amount Volume    (NM)   03327</a></li>
<li><a href="ch04a.html#Heading250">4.A.8.11 RXV-11   PCA Dose Amount Volume Units    (CWE)   03328</a></li>
<li><a href="ch04a.html#Heading251">4.A.8.12 RXV-12   Max Dose Amount    (NM)   03329</a></li>
<li><a href="ch04a.html#Heading252">4.A.8.13 RXV-13   Max Dose Amount Units    (CWE)   03330</a></li>
<li><a href="ch04a.html#Heading253">4.A.8.14 RXV-14   Max Dose Amount Volume    (NM)   03331</a></li>
<li><a href="ch04a.html#Heading254">4.A.8.15 RXV-15   Max Dose Amount Volume Units    (CWE)   03332</a></li>
<li><a href="ch04a.html#Heading255">4.A.8.16 RXV-16   Max Dose per Time    (CQ)   03333</a></li>
<li><a href="ch04a.html#Heading256">4.A.8.17 RXV-17   Lockout Interval    (CQ)   03334</a></li>
<li><a href="ch04a.html#Heading257">4.A.8.18 RXV-18   Syringe Manufacturer    (CWE)   03339</a></li>
<li><a href="ch04a.html#Heading258">4.A.8.19 RXV-19   Syringe Model Number    (CWE)   03385</a></li>
<li><a href="ch04a.html#Heading259">4.A.8.20 RXV-20   Syringe Size    (NM)   03386</a></li>
<li><a href="ch04a.html#Heading260">4.A.8.21 RXV-21   Syringe Size Units    (CWE)   03431</a></li>
<li><a href="ch04a.html#Heading261">4.A.8.22 RXV-22   Action Code    (ID)   00816</a></li>
</UL>
<li><a href="ch04a.html#Heading262">4.A.9 CDO - Cumulative Dosage Segment</a></li>
<UL>
<li><a href="ch04a.html#Heading263">4.A.9.0 CDO fields definitions</a></li>
<li><a href="ch04a.html#Heading264">4.A.9.1 CDO-1   Set ID - CDO   (SI)   03430</a></li>
<li><a href="ch04a.html#Heading265">4.A.9.2 CDO-2   Action Code   (ID)   00816</a></li>
<li><a href="ch04a.html#Heading266">4.A.9.3 CDO-3   Cumulative Dosage Limit   (CQ)   03397</a></li>
<li><a href="ch04a.html#Heading267">4.A.9.4 CDO-4   Cumulative Dosage Limit Time Interval   (CQ)   03398</a></li>
</UL>
</UL>
<li><a href="ch04a.html#Heading268">4.A PHARMACY/TREATMENT MESSAGE EXAMPLES </a></li>
<UL>
<li><a href="ch04a.html#Heading269">4.A.1 Example of various levels of coding in an order</a></li>
<li><a href="ch04a.html#Heading270">4.A.2 RXO segment field examples</a></li>
<UL>
<li><a href="ch04a.html#Heading271">4.A.2.0 RXO segment field examples</a></li>
<li><a href="ch04a.html#Heading272">4.A.2.1 RXO-1 Requested Give code example</a></li>
<li><a href="ch04a.html#Heading273">4.A.2.2 RXO-18 and RXO-19 Requested Strength and Strength Unit examples</a></li>
</UL>
<li><a href="ch04a.html#Heading274">4.A.3 RXD segment field examples</a></li>
<UL>
<li><a href="ch04a.html#Heading275">4.A.3.0 RXD segment field examples</a></li>
<li><a href="ch04a.html#Heading276">4.A.3.1 RXD-4 and RXD-5 Dispense amount and Actual dispense units</a></li>
<li><a href="ch04a.html#Heading277">4.A.3.2 Actual dispense amount, Actual dispense units, Actual strength, Actual strength units</a></li>
<li><a href="ch04a.html#Heading278">4.A.3.3 Valuing the Dispense Package Size Unit </a></li>
</UL>
<li><a href="ch04a.html#Heading279">4.A.4 RDS with FT1 segments example</a></li>
<li><a href="ch04a.html#Heading280">4.A.5 Alternating IV order messages</a></li>
<li><a href="ch04a.html#Heading281">4.A.6 Query examples</a></li>
</UL>
<li><a href="ch04a.html#Heading282">4.A PHARMACY/TREATMENT TRANSACTION FLOW DIAGRAM</a></li>
<UL>
<li><a href="ch04a.html#Heading283">4.A.1 OMP:</a></li>
<li><a href="ch04a.html#Heading284">4.A.2 RDE:</a></li>
<li><a href="ch04a.html#Heading285">4.A.3 RDS:</a></li>
<li><a href="ch04a.html#Heading286">4.A.4 RGV:</a></li>
<li><a href="ch04a.html#Heading287">4.A.5 RAS:</a></li>
</UL>
<li><a href="ch04a.html#Heading288">4.A VACCINE TRIGGER EVENTS & MESSAGE DEFINITIONS </a></li>
<UL>
<li><a href="ch04a.html#Heading289">4.A.1 Vaccine administration data</a></li>
<li><a href="ch04a.html#Heading290">4.A.2 Queries for immunization records (QRF Segments) </a></li>
<li><a href="ch04a.html#Heading291">4.A.3 XQ - Query for Vaccination Record (Event V01)</a></li>
<li><a href="ch04a.html#Heading292">4.A.4 VXX - RESPONSE TO VACCINATION QUERY RETURNING MULTIPLE PID MATCHES (EVENT V02)</a></li>
<li><a href="ch04a.html#Heading293">4.A.5 VXR - Vaccination Record Response (Event V03)</a></li>
<li><a href="ch04a.html#Heading294">4.A.6 VXU - Unsolicited Vaccination Record Update (Event V04)</a></li>
</UL>
<li><a href="ch04a.html#Heading295">4.A VACCINE SEGMENTS</a></li>
<UL>
<li><a href="ch04a.html#Heading296">4.A.1 RXA - segment usage in vaccine messages</a></li>
<UL>
<li><a href="ch04a.html#Heading297">4.A.1.0 RXA field definitions</a></li>
<li><a href="ch04a.html#Heading298">4.A.1.1 Using RXA-5 in vaccine messages</a></li>
<li><a href="ch04a.html#Heading299">4.A.1.2 Using RXA-17 in vaccine messages</a></li>
</UL>
</UL>
<li><a href="ch04a.html#Heading300">4.A VACCINATION MESSAGE EXAMPLES </a></li>
<UL>
<li><a href="ch04a.html#Heading301">4.A.1 VXQ - query for vaccination record</a></li>
<li><a href="ch04a.html#Heading302">4.A.2 VXX - response to vaccination query with multiple PID matches</a></li>
<li><a href="ch04a.html#Heading303">4.A.3 VXR - vaccination record response</a></li>
<li><a href="ch04a.html#Heading304">4.A.4 VXU - unsolicited vaccination record update</a></li>
<li><a href="ch04a.html#Heading305">4.A.5 Query acknowledgment with no records found</a></li>
</UL>
</UL>
</UL>
<p>
<HR>
<a id="Heading1">
<H1 class="css_Überschrift1" >
4 A. Order Entry: Pharmacy/Treatment, Vaccination
</H1>
<p>
</p>
<p>
</p>
<p>
Chapter Chair:
</p>
<TABLECELL>
</TABLECELL>
<p>
Hans Buitendijk Siemens Healthcare
</p>
<TABLECELL>
</TABLECELL>
<p>
</p>
<TABLECELL>
</TABLECELL>
<p>
Chapter Chair:
</p>
<TABLECELL>
</TABLECELL>
<p>
Robert Hausam Hausam Consulting
</p>
<TABLECELL>
</TABLECELL>
<p>
</p>
<TABLECELL>
</TABLECELL>
<p>
Chapter Chair:
</p>
<TABLECELL>
</TABLECELL>
<p>
Ken McCaslin Quest Diagnostics
</p>
<TABLECELL>
</TABLECELL>
<p>
</p>
<TABLECELL>
</TABLECELL>
<p>
Chapter Chair:
</p>
<TABLECELL>
</TABLECELL>
<p>
Lorraine Constable Constable Consulting
</p>
<TABLECELL>
</TABLECELL>
<p>
</p>
<TABLECELL>
</TABLECELL>
<p>
Chapter Chair:
</p>
<TABLECELL>
</TABLECELL>
<p>
Patrick Loyd Gordon Point Informatics Ltd
</p>
<TABLECELL>
</TABLECELL>
<p>
</p>
<TABLECELL>
</TABLECELL>
<p>
Editor
</p>
<TABLECELL>
</TABLECELL>
<p>
Scott M Robertson Kaiser Permanente
</p>
<TABLECELL>
</TABLECELL>
<p>
</p>
<TABLECELL>
</TABLECELL>
<p>
Sponsoring Committee:
</p>
<TABLECELL>
</TABLECELL>
<p>
Orders & Observations
</p>
<TABLECELL>
</TABLECELL>
<p>
</p>
<TABLECELL>
</TABLECELL>
<p>
List Server:
</p>
<TABLECELL>
</TABLECELL>
<p>
ord@lists.hl7.org 
</p>
<TABLECELL>
</TABLECELL>
<p>
</p>
<TABLECELL>
</TABLECELL>
<a id="Heading2">
<H2 class="css_Überschrift2" >
4.A CHAPTER 4A CONTENTS
</H2>
<a id="Heading3">
<H2 class="css_Überschrift2" >
4.A PURPOSE
</H2>
<p>
This extension of chapter 4 was created because as of version 2.6 it had become too large to edit without great difficulty.  Thus, the sections specific to pharmacy and vaccines were excised from that chapter and now comprise the content of this chapter.
</p>
<a id="Heading4">
<H3 class="css_Überschrift3" >
4.A.1 Preface (organization of this chapter)
</H3>
<p>
This chapter is organized into two major sections, Pharmacy, and Vaccine.  Each section contains the trigger events, message definitions, segments and examples for the specific type of order messages. Each section about a type of order is organized into background and overview, message structure, and message segments (that are specific to the order class in question).  Special discussions of the use of fields, segments or messages, and examples are included. Segments are introduced in order of occurrence in a message.  A list of allowable values for a field is included in the body of the text, along with the field definition for easier reference.
</p>
<p>
Section 4A.3 to 4A.6	Covers pharmacy/treatment trigger events & messages, pharmacy/treatment segments, pharmacy/treatment message examples and pharmacy/treatment message flow diagrams.
</p>
<p>
Sections 4A.7 to 4A.6	Covers vaccine trigger events & message definitions, vaccine segments and vaccine message examples.
</p>
<a id="Heading5">
<H2 class="css_Überschrift2" >
4.A PHARMACY/TREATMENT TRIGGER EVENTS & MESSAGES
</H2>
<a id="Heading6">
<H3 class="css_Überschrift3" >
4.A.1 Usage notes for pharmacy/treatment messages
</H3>
<p>
For the RDS (pharmacy/treatment dispense), RGV (pharmacy/treatment give) and RAS (pharmacy/treatment administration) messages, the placer and filler order numbers are those of the parent RDE (pharmacy/treatment encoded order) message.  In these messages, the filler order number does not provide a unique identification of the instance of the pharmacy/treatment action (dispense, give or administer).  To correct this problem, each of the defining segments (RXD, RXG, and RXA) has an appropriately named sub-ID field (dispense sub-ID counter, give sub-ID counter, and administration sub-ID counter).  The combination of the filler order number (including its application ID component) and the appropriate sub-ID counter uniquely identifies the instance of the pharmacy/treatment action(s) present in these messages.
</p>
<p>
Although the default order control code for the RDE, RDS, RGV and RAS messages is "RE," there are cases in which the pharmacy or treatment system and the receiving system must communicate changes in state.  Depending on whether the pharmacy or treatment supplier's relationship to the receiving system is that of placer or filler, the appropriate order control code may be substituted for the default value of RE. The receiving system can also use an appropriate order control code to report status back to the pharmacy or treatment system.
</p>
<p>
For example, suppose that a pharmacy or treatment system is sending RGV messages to a nursing system which will administer the medication and that the pharmacy or treatment system needs to request that several instances of a give order be discontinued.  To implement this request, the RGV message may be sent with a "DC" order control code (discontinue request), and the appropriate RXG segments whose give sub-ID fields identify the instances to be discontinued.  If a notification back to the pharmacy or treatment supplier is needed, the nursing system can initiate an RGV message with a "DR" order control code (discontinue as requested), and containing RXG segments whose give sub-ID fields identify the discontinued instances.
</p>
<a id="Heading7">
<H3 class="css_Überschrift3" >
4.A.2 IV solution groups
</H3>
<p>
An order for a group of IV solutions to be given sequentially can be supported in two similar ways: Parent/Child and Separate Orders.  This HL7 Standard supports both methods of ordering.  The method used at a particular site must be negotiated between the site institution and the various application vendors. See Chapter 2, section 2.A.53 OSD Order Sequence Definition, "Use Case 1 Cyclic placer order groups," for further details.
</p>
<a id="Heading8">
<H3 class="css_Überschrift3" >
4.A.3 OMP - Pharmacy/Treatment Order Message (Event O09) 
</H3>
<a id="BUI">
<p>
OMP^O09^OMP_O09: Pharmacy/treatment Order Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ADDITIONAL_DEMOGRAPHICS begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading330">PD1</a>
</TD><TD>
Additional Demographics
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPD1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Additional Demographics)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ADDITIONAL_DEMOGRAPHICS end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Patient ID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT_VISIT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading120">PV1</a>
</TD><TD>
Patient Visit
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading176">PV2</a>
 ] 
</TD><TD>
Patient Visit - Additional Info
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Patient Visit)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT_VISIT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- INSURANCE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch06.html#Heading210">IN1</a>
</TD><TD>
Insurance
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading267">IN2</a>
 ] 
</TD><TD>
Insurance Additional Information
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading341">IN3</a>
 ] 
</TD><TD>
Insurance Additional Information, Certification
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN3.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- INSURANCE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading151">GT1</a>
 ] 
</TD><TD>
Guarantor
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmGT1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading271">AL1</a>
 } 
 ] 
</TD><TD>
Allergy Information
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmAL1.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading29">RXO</a>
</TD><TD>
Pharmacy/Treatment Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXO.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXO)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXO)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- COMPONENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading75">RXC</a>
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for each RXC)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- COMPONENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading262">CDO</a>
 } 
 ] 
</TD><TD>
Cumulative Dosage Segment
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmCDO.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Observation/Result
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Observation)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for OBX)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch06.html#Heading16">FT1</a>
 } 
 ] 
</TD><TD>
Financial Transaction
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmFT1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch04.html#Heading73">BLG</a>
 ] 
</TD><TD>
Billing Segment
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmBLG.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<a id="Heading9">
<H3 class="css_Überschrift3" >
4.A.4 ORP - Pharmacy/Treatment Order Acknowledgment (Event O10)
</H3>
<a id="BUI">
<p>
ORP^O10^ORP_O10: Description
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch02.html#Heading165">MSA</a>
</TD><TD>
Message Acknowledgment
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading131">ERR</a>
 } 
 ] 
</TD><TD>
Error
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmERR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Response Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- RESPONSE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Patient ID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading29">RXO</a>
</TD><TD>
Pharmacy/Treatment Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXO.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXO)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXO)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- COMPONENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading75">RXC</a>
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for each RXC)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- COMPONENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- RESPONSE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<a id="Heading10">
<H3 class="css_Überschrift3" >
4.A.5 RDE - Pharmacy/Treatment Encoded Order Message (Event O11)
</H3>
<p>
This message communicates the pharmacy or treatment application's encoding of the pharmacy/treatment order ,OMP, message. It may be sent as an unsolicited message to report on either a single order or multiple pharmacy/treatment orders for a patient.
</p>
<p>
The RDE/RRE message pair can also be used to communicate a refill authorization request; however, a specific trigger event has been assigned.  See section 4A.3.13 "RDE - Pharmacy/Treatment Refill Authorization Request Message (Event O25)." As a site-specific variant, the original order segments (RXO, RXRs, associated RXCs, and any NTEs) may be sent optionally (for comparison).
</p>
<a id="BUI">
<p>
RDE^O11^RDE_O11: Pharmacy/Treatment Encoded Order Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading330">PD1</a>
 ] 
</TD><TD>
Additional Demographics
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPD1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Patient)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Patient ID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT_VISIT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading120">PV1</a>
</TD><TD>
Patient Visit
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading176">PV2</a>
 ] 
</TD><TD>
Patient Visit - Additional Info
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Patient Visit)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT_VISIT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- INSURANCE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch06.html#Heading210">IN1</a>
</TD><TD>
Insurance
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><a href="../hl7v28segmIN1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading267">IN2</a>
 ] 
</TD><TD>
Insurance Additional Information
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading341">IN3</a>
 ] 
</TD><TD>
Insurance Additional Information, Certification
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN3.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- INSURANCE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading151">GT1</a>
 ] 
</TD><TD>
Guarantor
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmGT1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading271">AL1</a>
 } 
 ] 
</TD><TD>
Allergy Information
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmAL1.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading29">RXO</a>
</TD><TD>
Pharmacy/Treatment Prescription Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXO.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXO)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXO)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- COMPONENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading75">RXC</a>
</TD><TD>
Pharmacy/Treatment Component (for RXO)
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for each RXC)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- COMPONENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading88">RXE</a>
</TD><TD>
Pharmacy/Treatment Encoded Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXE)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXE)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_ENCODED end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading238">RXV</a>
</TD><TD>
Pharmacy/Treatment Infusion Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXV.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXV)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXV)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component (for RXE)
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading262">CDO</a>
 } 
 ] 
</TD><TD>
Cumulative Dosage Segment
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmCDO.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Results
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Observation)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for OBX)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch06.html#Heading16">FT1</a>
 } 
 ] 
</TD><TD>
Financial Detail
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmFT1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch04.html#Heading73">BLG</a>
 ] 
</TD><TD>
Billing Segment
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmBLG.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading252">CTI</a>
 } 
 ] 
</TD><TD>
Clinical Trial Identification
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmCTI.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<p>
Note: 	The RXCs which follow the RXO may not be fully encoded, but those that follow the RXE must be fully encoded.
</p>
<p>
The NTE segment(s) following the PD1 segment are intended to communicate notes and comments relative to the patient.
</p>
<p>
The NTE segment(s) following the RXO segment are intended to communicate notes and comments relative to the pharmacy/treatment order.
</p>
<p>
The NTE segment(s) following the RXE segment are intended to communicate notes and comments relative to the encoded order.
</p>
<p>
The NTE segment(s) following the RXV segment are intended to communicate notes and comments relative to the encoded order.
</p>
<p>
The NTE segment(s) following the RXC segment are intended to communicate notes and comments relative to the component(s).
</p>
<p>
The NTE segment following the OBX segment is intended to communicate notes and comments relative to the results.
</p>
<a id="Heading11">
<H3 class="css_Überschrift3" >
4.A.6 RRE - Pharmacy/Treatment Encoded Order Acknowledgment (Event O12)
</H3>
<a id="BUI">
<p>
RRE^O12^RRE_O12: Pharmacy/Treatment Encoded Order Acknowledgment Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch02.html#Heading165">MSA</a>
</TD><TD>
Message Acknowledgment
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading131">ERR</a>
 } 
 ] 
</TD><TD>
Error
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmERR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- RESPONSE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for PID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ENCODING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading88">RXE</a>
</TD><TD>
Pharmacy/Treatment Encoded Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXE)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXE)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_ENCODED end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ENCODING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- RESPONSE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<p>
Note: The use of RDE with the trigger of O01 and RRE with the trigger O02 is maintained for backward compatibility as of v 2.4 and is withdrawn as of v 2.7.
</p>
<a id="Heading12">
<H3 class="css_Überschrift3" >
4.A.7 RDS - Pharmacy/Treatment Dispense Message (Event O13)
</H3>
<p>
The RDS message may be created by the pharmacy/treatment application for each instance of dispensing a drug or treatment to fill an existing order or orders.  In the most common case, the RDS messages would be routed to a Nursing application or to some clinical application, which needs the data about drugs dispensed or treatments given.  As a site-specific variant, the original order segments (RXO, RXE and their associated RXR/RXCs) may be sent optionally (for comparison).
</p>
<p>
The ORC must have the filler order number and the order control code RE.  The RXE and associated RXCs may be present if the receiving application needs any of their data.  The RXD carries the dispense data for a given issuance of medication: thus it may describe a single dose, a half-day dose, a daily dose, a refill of a prescription, etc.  The RXD is not a complete record of an order.  Use the RXO and RXE segments if a complete order is needed.  It is a record from the pharmacy or treatment supplier to the Nursing application (or other) with drug/treatment dispense and administration instructions.
</p>
<p>
The FT1 segment is optional and repeating in order to accommodate multiple charge, benefit and pricing situations.  Example use cases demonstrating zero, one and two FT1 segments follow:
</p>
<p>
In the case where the RDS message represents a dispense event that is in process (i.e., has not been received by the patient), the financial transactions associated with the dispense do not yet exist.  Until the financial transactions associated with the dispense event have been completed, no FT1 segment may exist in the message.
</p>
<p>
In the case where the RDS message represents a dispense event that has been received by the patient, and thus all financial transactions have been completed, the RDS message may contain one or more FT1 segments.  Examples of single and multiple FT1 segments follow.
</p>
<p>
Payment for the dispense event completed by a single payor:
</p>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006082911150700||RDS^O13^RDS_O13|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|RE|...&lt;cr&gt;
</p>
<p>
RXD|1|00310-0131-10^LISINOPRIL 10MG TABLET^NDC|200607150830|100|TAB|...&lt;cr&gt;
</p>
<p>
FT1|1|||200607151035||PY|00310-0131-10^LISINOPRIL 10MG TABLET^NDC|||100|125.43&USD|...&lt;cr&gt;
</p>
<p>
Payment for the dispense event involves multiple payment sources:
</p>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006082213000700||RDS^O13^RDS_O13|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|RE|...&lt;cr&gt;
</p>
<p>
RXD|1|00340-0241-10^VERAPAMIL 120MG TABLET^NDC|200607200940|100|TAB|...&lt;cr&gt;
</p>
<p>
FT1|1|||200607211055||CD|00340024110^VERAPAMIL 120MG TABLET ^NDC|||100|55.43&USD|...&lt;cr&gt;   (amount paid by insurance)
</p>
<p>
FT1|2|||200607211055||CP|00340024110^VERAPAMIL 120MG TABLET ^NDC|||100|5.00&USD|...&lt;cr&gt;        (copay paid by patient)
</p>
<p>
Note: The use of RDS with the trigger of O01 and RRD with the trigger O02 is maintained for backward compatibility as of v 2.4 and is withdrawn as of v 2.7.
</p>
<a id="BUI">
<p>
RDS^O13^RDS_O13: Pharmacy/Treatment Dispense Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ADDITIONAL_DEMOGRAPHICS begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading330">PD1</a>
</TD><TD>
Additional Demographics
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPD1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Additional Demographics)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ADDITIONAL_DEMOGRAPHICS end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for PID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading271">AL1</a>
 } 
 ] 
</TD><TD>
Allergy Information
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmAL1.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT_VISIT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading120">PV1</a>
</TD><TD>
Patient Visit
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading176">PV2</a>
 ] 
</TD><TD>
Patient Visit - Additional Info
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Patient Visit)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT_VISIT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading29">RXO</a>
</TD><TD>
Pharmacy /Treatment Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXO.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXO)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL_SUPPLEMENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
</TD><TD>
Notes and Comments (for RXO)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- COMPONENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading75">RXC</a>
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for each RXC)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- COMPONENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL_SUPPLEMENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ENCODING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading88">RXE</a>
</TD><TD>
Pharmacy/Treatment Encoded Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXE)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXE)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_ENCODED end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ENCODING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading135">RXD</a>
</TD><TD>
Pharmacy/Treatment Dispense
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXD.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Treatment Dispense)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXD)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading262">CDO</a>
 } 
 ] 
</TD><TD>
Cumulative Dosage Segment
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmCDO.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Results
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for OBX)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for OBX)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch06.html#Heading16">FT1</a>
 } 
 ] 
</TD><TD>
Financial Transaction segment
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmFT1.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<p>
Note:	The NTE segment(s) following the PD1 segment are intended to communicate notes and comments relative to the patient.
</p>
<p>
The NTE segment(s) following the RXO segment are intended to communicate notes and comments relative to the pharmacy/treatment order.
</p>
<p>
The NTE segment(s) following the RXE segment are intended to communicate notes and comments relative to the encoded order.
</p>
<p>
The NTE segment(s) following the RXD segment are intended to communicate notes and comments relative to the dispense event.
</p>
<p>
The NTE segment(s) following the RXC segment are intended to communicate notes and comments relative to the component(s).
</p>
<p>
The NTE segment following the OBX segment is intended to communicate notes and comments relative to the results.
</p>
<a id="Heading13">
<H3 class="css_Überschrift3" >
4.A.8 RRD - Pharmacy/Treatment Dispense Acknowledgement Message (Event O14) 
</H3>
<a id="BUI">
<p>
RRD^O14^RRD_O14: Pharmacy/Treatment Dispense Acknowledgment Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch02.html#Heading165">MSA</a>
</TD><TD>
Message Acknowledgment
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading131">ERR</a>
 } 
 ] 
</TD><TD>
Error
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmERR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- RESPONSE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Patient ID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- DISPENSE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading135">RXD</a>
</TD><TD>
Pharmacy/Treatment Dispense
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXD.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXD)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- DISPENSE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- RESPONSE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<a id="Heading14">
<H3 class="css_Überschrift3" >
4.A.9 RGV - Pharmacy/Treatment Give Message (Event O15) 
</H3>
<p>
The RDS message's RXD segment carries the dispense data for a given issuance of medication: thus it may describe a single dose, a half-day dose, a daily dose, a refill of a prescription, etc.  It does not contain the given instructions or scheduling information.  When this "give" (i.e., administration) information needs to be transmitted from the pharmacy or treatment application to another application, it is done with the RGV message.
</p>
<p>
The RGV message uses the RXG segment to record drug or treatment administration instructions.  It may carry information about a single scheduled administration on a drug or treatment, or it may carry information about multiple administrations.  If the pharmacy or treatment application (or some other application) needs to create an unambiguous MAR report where each administration is matched to a particular give date/time instruction, it may use the RGV message as described in the following way:
</p>
<p>
For each scheduled administration of the medication, the pharmacy/treatment issues either a single RGV message or a single RGV message with multiple RXG segments, one for each scheduled administration.  The actual administrations (transmitted by one or more RAS messages) are matched against the scheduled ones by recording in each RXA segment the Give Sub-ID of the corresponding RXG segment.  If more than one administration needs to be matched (as in the case of recording a change or rate of an IV solution) the administering application issues additional RXA segment(s) (corresponding to the same RXG segment).  If no matching is needed, the Give Sub-ID of the RXA segments has the value zero (0).
</p>
<p>
The ORC must have the filler order number and the order control code RE.  The RXE and associated RXCs may be present if the receiving application needs any of their data.  The RXG carries the scheduled administration data for either a single "give instruction" (single dose) of medication or for multiple "give instructions."  The RXG is not a complete record of an order.  Use the RXO and RXE segments if a complete order is needed.  It is a record from the pharmacy or treatment application to the Nursing application (or other) with drug/treatment administration instructions.
</p>
<a id="BUI">
<p>
RGV^O15^RGV_O15: Pharmacy/Treatment Give
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for PID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading271">AL1</a>
 } 
 ] 
</TD><TD>
Allergy Information
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmAL1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT_VISIT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading120">PV1</a>
</TD><TD>
Patient Visit
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading176">PV2</a>
 ] 
</TD><TD>
Patient Visit - Additional Info
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Patient Visit)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT_VISIT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading29">RXO</a>
</TD><TD>
Pharmacy /Treatment Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXO.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXO)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL_SUPPLEMENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
</TD><TD>
Notes and Comments (for RXO)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- COMPONENTS begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading75">RXC</a>
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for each RXC)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- COMPONENTS end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL_SUPPLEMENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ENCODING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading88">RXE</a>
</TD><TD>
Pharmacy/Treatment Encoded Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Encoded Order)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXE)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_ENCODED end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ENCODING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- GIVE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading172">RXG</a>
</TD><TD>
Pharmacy/Treatment Give
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXG.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_GIVE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_GIVE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading262">CDO</a>
 } 
 ] 
</TD><TD>
Cumulative Dosage Segment
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmCDO.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Observation/Results
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Observation)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for OBX)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- GIVE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<a id="Heading15">
<H3 class="css_Überschrift3" >
4.A.10 RRG - Pharmacy/Treatment Give Acknowledgment Message (Event O16) 
</H3>
<a id="BUI">
<p>
RRG^O16^RRG_O16: Pharmacy/Treatment Give Acknowledgment Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch02.html#Heading165">MSA</a>
</TD><TD>
Message Acknowledgment
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading131">ERR</a>
 } 
 ] 
</TD><TD>
Error
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmERR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- RESPONSE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for PID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- GIVE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading172">RXG</a>
</TD><TD>
Pharmacy/Treatment Give
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXG.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_GIVE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_GIVE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- GIVE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- RESPONSE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<p>
Note: The use of RGV with the trigger of O01 and RRG with the trigger O02 is maintained for backward compatibility as of v 2.4 and is withdrawn as of v 2.7.
</p>
<a id="Heading16">
<H3 class="css_Überschrift3" >
4.A.11 RAS - Pharmacy/Treatment Administration Message (Event O17) 
</H3>
<p>
The RAS message may be created by the administering application (e.g., nursing application) for each instance of administration for an existing order.  If the administering application wants to report several administrations of medication/treatment for a given order with a single RAS message, each instance is reported by a separate (repeating) RXA segment.  In addition, the administration records for a group of orders may be sent in a single message by creating repeating groups of segments at the ORC level.
</p>
<p>
In the most common case, the RAS messages would be sent from a nursing application to the pharmacy or treatment application (or to the ordering application or another clinical application), which could use the data to generate the medication administration reports.  Multiple RXA segments, each corresponding to a separate administration instance for a given order, may be sent with a single ORC.
</p>
<a id="BUI">
<p>
RAS^O17^RAS_O17: Pharmacy/Treatment Administration
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ADDITIONAL_DEMOGRAPHICS begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading330">PD1</a>
</TD><TD>
Additional Demographics
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPD1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Additional Demographics)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ADDITIONAL_DEMOGRAPHICS end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for PID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading271">AL1</a>
 } 
 ] 
</TD><TD>
Allergy Information
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmAL1.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT_VISIT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading120">PV1</a>
</TD><TD>
Patient Visit
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading176">PV2</a>
 ] 
</TD><TD>
Patient Visit - Additional Info
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Patient Visit)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT_VISIT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading29">RXO</a>
</TD><TD>
Pharmacy /Treatment Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXO.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL_SUPPLEMENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
</TD><TD>
Notes and Comments (for RXO)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- COMPONENTS begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading75">RXC</a>
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for each RXC)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- COMPONENTS end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL_SUPPLEMENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ENCODING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading88">RXE</a>
</TD><TD>
Pharmacy/Treatment Encoded Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Encoded Order)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXE)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_ENCODED end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading262">CDO</a>
 } 
 ] 
</TD><TD>
Cumulative Dosage Segment
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmCDO.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ENCODING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ADMINISTRATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading207">RXA</a>
 } 
</TD><TD>
Pharmacy/Treatment Administration
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Administration)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading67">RXR</a>
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Observation/Result
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Observation)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for OBX)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ADMINISTRATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading252">CTI</a>
 } 
 ] 
</TD><TD>
Clinical Trial Identification
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmCTI.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<a id="Heading17">
<H3 class="css_Überschrift3" >
4.A.12 RRA - Pharmacy/Treatment Administration Acknowledgment Message (Event O18) 
</H3>
<a id="BUI">
<p>
RRA^O18^RRA_O18: Pharmacy/Treatment Administration Acknowledgment Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch02.html#Heading165">MSA</a>
</TD><TD>
Message Acknowledgment
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading131">ERR</a>
 } 
 ] 
</TD><TD>
Error
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmERR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- RESPONSE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for PID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ADMINISTRATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TREATMENT begin
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading207">RXA</a>
</TD><TD>
Pharmacy/Treatment Administration
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Administration)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TREATMENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading67">RXR</a>
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ADMINISTRATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- RESPONSE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<p>
Note: The use of RAS with the trigger of O01 and RRA with the trigger O02 is maintained for backward compatibility as of v2.4 and is withdrawn as of v2.7.
</p>
<a id="Heading18">
<H3 class="css_Überschrift3" >
4.A.13 RDE - Pharmacy/Treatment Refill Authorization Request Message (Event O25)
</H3>
<p>
The RDE/RRE is used to communicate a refill authorization request originating with the pharmacy.  This message replicates the standard RDE message with a different trigger event code to indicate the specific use case of a refill authorization request.
</p>
<a id="BUI">
<p>
RDE^O25^RDE_O11: Pharmacy/Treatment Refill Authorization Request
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading330">PD1</a>
 ] 
</TD><TD>
Additional Demographics
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPD1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Additional Demographics)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Patient ID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT_VISIT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading120">PV1</a>
</TD><TD>
Patient Visit
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading176">PV2</a>
 ] 
</TD><TD>
Patient Visit - Additional Info
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Patient Visit)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT_VISIT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- INSURANCE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch06.html#Heading210">IN1</a>
</TD><TD>
Insurance
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><a href="../hl7v28segmIN1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading267">IN2</a>
 ] 
</TD><TD>
Insurance Additional Information
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading341">IN3</a>
 ] 
</TD><TD>
Insurance Additional Information, Certification
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN3.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- INSURANCE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading151">GT1</a>
 ] 
</TD><TD>
Guarantor
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmGT1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading271">AL1</a>
 } 
 ] 
</TD><TD>
Allergy Information
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmAL1.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Order)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading29">RXO</a>
</TD><TD>
Pharmacy/Treatment Prescription Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXO.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXO)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXO)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- COMPONENTS begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading75">RXC</a>
</TD><TD>
Pharmacy/Treatment Component (for RXO)
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for each RXC)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- COMPONENTS end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading88">RXE</a>
</TD><TD>
Pharmacy/Treatment Encoded Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXE)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXE)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_ENCODED end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading238">RXV</a>
</TD><TD>
Pharmacy/Treatment Infusion Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXV.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXV)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXV)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component (for RXE)
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading262">CDO</a>
 } 
 ] 
</TD><TD>
Cumulative Dosage Segment
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmCDO.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Results
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for OBX)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for OBX)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch06.html#Heading16">FT1</a>
 } 
 ] 
</TD><TD>
Financial Detail
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmFT1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch04.html#Heading73">BLG</a>
 ] 
</TD><TD>
Billing Segment
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmBLG.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading252">CTI</a>
 } 
 ] 
</TD><TD>
Clinical Trial Identification
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmCTI.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<a id="Heading19">
<H3 class="css_Überschrift3" >
4.A.14 RRE - Pharmacy/Treatment Refill Authorization Request Acknowledgment (Event O26)
</H3>
<a id="BUI">
<p>
RRE^O26^RRE_O12: Pharmacy/Treatment Refill Authorization Request Acknowledgment Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch02.html#Heading165">MSA</a>
</TD><TD>
Message Acknowledgment
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading131">ERR</a>
 } 
 ] 
</TD><TD>
Error
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmERR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for Header)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- RESPONSE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for PID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ENCODING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading88">RXE</a>
</TD><TD>
Pharmacy/Treatment Encoded Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXE)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXE)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_ENCODED end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ENCODING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- RESPONSE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<a id="Heading20">
<H3 class="css_Überschrift3" >
4.A.15 ROR - Pharmacy/Treatment Order Response
</H3>
<p>
Attention: This query/response pair was retained for backward compatibility only as of v2.4 and withdrawn as of v2.7.  Please refer to Chapter 5 for detailed coverage of query/response methodology to be employed in Versions 2.4 and later.
</p>
<a id="Heading21">
<H3 class="css_Überschrift3" >
4.A.16 RAR - Pharmacy/Treatment Administration Information
</H3>
<p>
Attention:This query/response pair was retained for backward compatibility only as of v2.4 and withdrawn as of v2.7.  Please refer to Chapter 5 for detailed coverage of query/response methodology to be employed in Versions 2.4 and later.
</p>
<a id="Heading22">
<H3 class="css_Überschrift3" >
4.A.17 RDR - Pharmacy/Treatment Dispense Information
</H3>
<p>
Attention: This query/response pair was retained for backward compatibility only as of v2.4 and withdrawn as of v2.7.  Please refer to Chapter 5 for detailed coverage of query/response methodology to be employed in Versions 2.4 and later.
</p>
<a id="Heading23">
<H3 class="css_Überschrift3" >
4.A.18 RER - Pharmacy/Treatment Encoded Order
</H3>
<p>
Attention: This query/response pair was retained for backward compatibility only as of v2.4 and withdrawn as of v2.7.  Please refer to Chapter 5 for detailed coverage of query/response methodology to be employed in Versions 2.4 and later.
</p>
<a id="Heading24">
<H3 class="css_Überschrift3" >
4.A.19 RGR - Pharmacy/Treatment Dose Information
</H3>
<p>
Attention: This query/response pair was retained for backward compatibility only as of v2.4 and withdrawn as of v2.7.  Please refer to Chapter 5 for detailed coverage of query/response methodology to be employed in Versions 2.4 and later.
</p>
<a id="Heading25">
<H3 class="css_Überschrift3" >
4.A.20 Pharmacy Query/Response Message Pair 
</H3>
<p>
Conformance Statement
</p>
<table border=4>
<tr>
<td>
Query ID
</td>
<td>
Q31
</td>
</tr>
<tr>
<td>
Query Type
</td>
<td>
Query
</td>
</tr>
<tr>
<td>
Query Name
</td>
<td>
Dispense History
</td>
</tr>
<tr>
<td>
Query Trigger
</td>
<td>
QBP^Q31^QBP_Q11
</td>
</tr>
<TR>
<TD>
Both
</TD>
</TR>
<tr>
<td>
Response Trigger
</td>
<td>
RSP^K31^RSP_K31
</td>
</tr>
<tr>
<td>
Query Characteristics
</td>
<td>
May specify patient, medication, a date range, and how the response is to be sorted.
</td>
</tr>
<tr>
<td>
Query Purpose
</td>
<td>
To retrieve patient pharmacy dispense history information from the Server.
</td>
</tr>
<tr>
<td>
Response Characteristics
</td>
<td>
Sorted by Medication Dispensed unless otherwise specified in SortControl.
</td>
</tr>
<tr>
<td>
Query Trigger
</td>
<td>
QBP^Q31^QBP_Q11
</td>
</tr>
</TABLE>    <p>
<p>
</p>
<a id="BUI">
<p>
QBP^Q31^QBP_Q11: Query Grammar:  QBP Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header Segment
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch05.html#Heading74">QPD</a>
</TD><TD>
Query Parameter Definition
</TD><TD>
<br>
</TD><TD>
5
</TD>
<td><a href="../hl7v28segmQPD.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- QBP begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
...
 ] 
</TD><TD>
Optional query by example segments
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><a href="../hl7v28segm....htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- QBP end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch05.html#Heading85">RCP</a>
</TD><TD>
Response Control Parameter
</TD><TD>
<br>
</TD><TD>
5
</TD>
<td><a href="../hl7v28segmRCP.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading127">DSC</a>
 ] 
</TD><TD>
Continuation Pointer
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmDSC.htm">DB</a></td>
</TR>
</TABLE><p>
<a id="BUI">
<p>
RSP^K31^RSP_K31: Response Grammar:  Pharmacy Dispense Message
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch02.html#Heading165">MSA</a>
</TD><TD>
Message Acknowledgement
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading131">ERR</a>
 } 
 ] 
</TD><TD>
Error
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmERR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch05.html#Heading62">QAK</a>
</TD><TD>
Query Acknowledgement
</TD><TD>
<br>
</TD><TD>
5
</TD>
<td><a href="../hl7v28segmQAK.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch05.html#Heading74">QPD</a>
</TD><TD>
Query Parameter Definition
</TD><TD>
<br>
</TD><TD>
5
</TD>
<td><a href="../hl7v28segmQPD.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch05.html#Heading85">RCP</a>
</TD><TD>
Response Control Parameter
</TD><TD>
<br>
</TD><TD>
5
</TD>
<td><a href="../hl7v28segmRCP.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- RESPONSE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ADDITIONAL_DEMOGRAPHICS begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading330">PD1</a>
</TD><TD>
Additional Demographics
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPD1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Additional Demographics)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ADDITIONAL_DEMOGRAPHICS end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for PID)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading271">AL1</a>
 } 
 ] 
</TD><TD>
Allergy Information
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmAL1.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT_VISIT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading120">PV1</a>
</TD><TD>
Patient Visit
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading176">PV2</a>
 ] 
</TD><TD>
Patient Visit - Additional Info
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Patient Visit)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT_VISIT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ORDER_DETAIL begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading29">RXO</a>
</TD><TD>
Pharmacy/Treatment Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXO.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXO)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- COMPONENTS begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading75">RXC</a>
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for each RXC)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- COMPONENTS end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ORDER_DETAIL end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- ENCODING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading88">RXE</a>
</TD><TD>
Pharmacy/Treatment Encoded Order
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXE.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXE)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for RXE)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
{
</TD><TD>
--- TIMING_ENCODED begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- TIMING_ENCODED end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- ENCODING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading135">RXD</a>
</TD><TD>
Pharmacy/Treatment Dispense
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXD.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for RXD)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 { 
<a href="ch04a.html#Heading67">RXR</a>
 } 
</TD><TD>
Pharmacy/Treatment Route
</TD><TD>
<br>
</TD><TD>
A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading75">RXC</a>
 } 
 ] 
</TD><TD>
Pharmacy/Treatment Component
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04a.html#Heading262">CDO</a>
 } 
 ] 
</TD><TD>
Cumulative Dosage Segment
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmCDO.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Results
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for OBX)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes and Comments (for OBX)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}
</TD><TD>
--- RESPONSE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading127">DSC</a>
 ] 
</TD><TD>
Continuation Pointer
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmDSC.htm">DB</a></td>
</TR>
</TABLE><p>
<TABLE width="100%" border=1>
<TR>
<TH>
Field Seq (Query ID=Q31)
</TH><TH>
Name
</TH><TH>
Key/
<p>
Search
</TH><TH>
Sort
</TH><TH>
LEN
</TH><TH>
TYPE
</TH><TH>
Opt
</TH><TH>
Rep
</TH><TH>
Match Op
</TH><TH>
TBL
</TH><TH>
Segment Field Name
</TH><TH>
Service Identifier Code
</TH><TH>
Element Name
</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
MessageQueryName
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
60
</TD><TD>
CWE
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
</TR>
<TR>
<TD>
2
</TD><TD>
QueryTag
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
32
</TD><TD>
ST
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
</TR>
<TR>
<TD>
<br>
</TD><TD>
PatientList
</TD><TD>
S
</TD><TD>
Y
</TD><TD>
20
</TD><TD>
CX
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
PID.3
</TD><TD>
<br>
</TD><TD>
PID-3: Patient  Identifier List
</TD>
</TR>
<TR>
<TD>
<br>
</TD><TD>
MedicationDispensed
</TD><TD>
S
</TD><TD>
Y
</TD><TD>
100
</TD><TD>
CWE
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
=
</TD><TD>
<br>
</TD><TD>
RXD.2
</TD><TD>
<br>
</TD><TD>
RXD-2: Dispense/Give Code
</TD>
</TR>
<TR>
<TD>
<br>
</TD><TD>
DispenseDate.LL
</TD><TD>
S
</TD><TD>
Y
</TD><TD>
24
</TD><TD>
DTM
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
> =
</TD><TD>
<br>
</TD><TD>
RXD.3
</TD><TD>
<br>
</TD><TD>
RXD-3: Date/Time Dispensed
</TD>
</TR>
<TR>
<TD>
<br>
</TD><TD>
DispenseDate.UL
</TD><TD>
S
</TD><TD>
Y
</TD><TD>
24
</TD><TD>
DTM
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
< =
</TD><TD>
<br>
</TD><TD>
RXD.3
</TD><TD>
<br>
</TD><TD>
RXD-3: Date/Time Dispensed
</TD>
</TR>
</TABLE><p>
<TABLE width="100%" border=1>
<TR>
<TH>
Input Parameter (Query ID=Q31)
</TH><TH>
Comp. Name
</TH><TH>
DT
</TH><TH>
Description
</TH>
</TR>
<TR>
<TD>
MessageQueryName
</TD><TD>
<br>
</TD><TD>
CWE
</TD><TD>
Must be valued Q31^Dispense History^HL7nnnn.
</TD>
</TR>
<TR>
<TD>
QueryTag
</TD><TD>
<br>
</TD><TD>
ST
</TD><TD>
Unique to each query message instance.
</TD>
</TR>
<TR>
<TD>
PatientList
</TD><TD>
<br>
</TD><TD>
CX
</TD><TD>
The combination of values for PatientList.ID, and PatientList.AssigningAuthority, are intended to identify a unique entry on the PATIENT_MASTER table. The PatientList.IdentifierTypeCode is useful for further filtering or to supply uniqueness in the event that the assigning authority may have more than one coding system. (The PATIENT_MASTER table contains a constraint that prevents multiple patients from being identified by the same combination of field values.)  This PATIENT_MASTER entry will be searched against on the PHARMACY_DISPENSE_TRANSACTION table to retrieve the rows fulfilling the query conditions.   If this field is not valued, all values for this field are considered to be a match.  If one PID.3 is specified, only 1 segment pattern will be returned.
</TD>
</TR>
<TR>
<TD>
<br>
</TD><TD>
ID
</TD><TD>
ID
</TD><TD>
If this field, PID.3.1, is not valued, all values for this field are considered to be a match.
</TD>
</TR>
<TR>
<TD>
<br>
</TD><TD>
Assigning Authority
</TD><TD>
HD
</TD><TD>
If this field, PID.3.4, is not valued, all values for this field are considered to be a match.
</TD>
</TR>
<TR>
<TD>
<br>
</TD><TD>
Identifier type code
</TD><TD>
IS
</TD><TD>
If this field, PID.3.5, is not valued, all values for this field are considered to be a match.
</TD>
</TR>
<TR>
<TD>
MedicationDispensed
</TD><TD>
<br>
</TD><TD>
CWE
</TD><TD>
If this field is not valued, all values for this field are considered to be a match.
</TD>
</TR>
<TR>
<TD>
DispenseDate.LL
</TD><TD>
<br>
</TD><TD>
DTM
</TD><TD>
This is the earliest value to be returned for Date/Time Dispensed. If this field is not valued, all values for this field are considered to be a match.
</TD>
</TR>
<TR>
<TD>
DispenseDate.UL
</TD><TD>
<br>
</TD><TD>
DTM
</TD><TD>
This is the latest value to be returned for Date/Time Dispensed. If this field is not valued, all values for this field are considered to be a match.
</TD>
</TR>
</TABLE><p>
<a id="Heading26">
<H4 class="css_Überschrift4" >
</H4>
<a id="Heading27">
<H4 class="css_Überschrift4" >
4.A.20.1 Example
</H4>
<p>
Example:  The user wishes to know all the medications dispensed for the patient whose medical record number is "555444222111" for the period beginning 5/31/2005 and ending 5/31/2006.  The following QBP message is generated.
</p>
<p>
MSH|^&~\|PCR|Gen Hosp|Pharm||200611201400-0800||QBP^Q31^QBP_Q11|ACK9901|P|2.8|
</p>
<p>
QPD|Q31^Dispense History^HL70471|Q001|555444222111^^^MPI^MR||20050531|20060531|
</p>
<p>
RCP|I|999^RD|
</p>
<p>
The pharmacy system identifies medical record number "555444222111" as belonging to Adam Everyman and locates 4 prescription dispenses for the period beginning 5/31/2005 and ending 5/31/2006 and returns the following RSP message:
</p>
<p>
MSH|^&~\|Pharm|Gen hosp|PCR||200611201400-0800||RSP^K31^RSP_K31|8858|P|2.8|
</p>
<p>
MSA|AA|ACK9901|
</p>
<p>
QAK|Q001|OK|Q31^Dispense History^HL70471|4|
</p>
<p>
QPD|Q31^Dispense History^HL70471|Q001|444-33-3333^^^MPI^MR||20050531|20060531|
</p>
<p>
PID|||444-33-3333^^^MPI^MR||Everyman^Adam||19600614|M||C|2222 Home Street ^^Anytown^US^12345||^^^^^555^5552004|
</p>
<p>
ORC|RE||89968665||||||200505121345-0700|||444-44-4444^HIPPOCRATES^HAROLD^^^^MD||^^^^^555^5551003|
</p>
<p>
RXE|1^BID^^20050529|00378112001^Verapamil Hydrochloride 120 mg TAB^NDC |120||mgm|
</p>
<p>
RXD|1|00378112001^Verapamil Hydrochloride 120 mg TAB^NDC |200505291115-0700|100|||1331665|3|
</p>
<p>
RXR|PO|
</p>
<p>
ORC|RE||89968665||||||200505291030-0700|||444-44-4444^HIPPOCRATES^HAROLD^^^^MD||^^^^^555^5551003|
</p>
<p>
RXE|1^^D100^^20070731^^^TAKE 1 TABLET DAILY --GENERIC FOR CALAN SR|00182196901^VERAPAMIL HCL ER TAB 180MG ER^NDC |100||180MG|TABLET SA|||G|||0|BC3126631^CHU^Y^L||213220929|0|0|19980821|
</p>
<p>
RXD|1|00182196901^VERAPAMIL HCL ER TAB 180MG ER^NDC |20050821|100|||213220929|0|TAKE 1 TABLET DAILY --GENERIC FOR CALAN SR|
</p>
<p>
RXR|PO|
</p>
<p>
ORC|RE||235134037||||||200509221330-0700|||444-44-4444^HIPPOCRATES^HAROLD^^^^MD||^^^^^555^5551003|
</p>
<p>
RXD|1|00172409660^BACLOFEN 10MG TABS^NDC|200509221415-0700|10|||235134037|5|AS DIRECTED|
</p>
<p>
RXR|PO|
</p>
<p>
ORC|RE||235134030||||||200510121030-0700|||222-33-4444^PUMP^PATRICK^^^^MD ||^^^^^555^5551027|
</p>
<p>
RXD|1|00054384163^THEOPHYLLINE 80MG/15ML SOLN^NDC|200510121145-0700|10|||235134030|5|AS DIRECTED|
</p>
<p>
RXR|PO|
</p>
<a id="Heading28">
<H2 class="css_Überschrift2" >
4.A PHARMACY/TREATMENT SEGMENTS
</H2>
<a id="Heading29">
<H3 class="css_Überschrift3" >
4.A.1 RXO - Pharmacy/Treatment Order Segment
</H3>
<p>
This is the "master" pharmacy/treatment order segment.  It contains order data not specific to components or additives.  Unlike the OBR, it does not contain status fields or other data that are results-only.
</p>
<p>
It can be used for any type of pharmacy order, including inpatient (unit dose and compound unit dose), outpatient, IVs, and hyperalimentation IVs (nutritional IVs), as well as other non-pharmacy treatments, e.g., respiratory therapy, oxygen, and many nursing treatments.
</p>
<p>
In addition to the pharmaceutical/treatment information, this segment contains additional data such as provider and text comments.
</p>
<p>
A quantity/timing field is not needed in the RXO segment.  The ORC segment contains the requested ORC-7-quantity/timing of the original order which does not change as the order is encoded, dispensed, or administered.
</p>
<a id="RXO">
<p>
HL7 Attribute Table - RXO - Pharmacy/Treatment Order
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading31">00292</a>
</TD><TD>
Requested Give Code
</TD>
<td><a href="../hl7v28datel.htm#00292">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading32">00293</a>
</TD><TD>
Requested Give Amount - Minimum
</TD>
<td><a href="../hl7v28datel.htm#00293">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading33">00294</a>
</TD><TD>
Requested Give Amount - Maximum
</TD>
<td><a href="../hl7v28datel.htm#00294">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading34">00295</a>
</TD><TD>
Requested Give Units
</TD>
<td><a href="../hl7v28datel.htm#00295">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading35">00296</a>
</TD><TD>
Requested Dosage Form
</TD>
<td><a href="../hl7v28datel.htm#00296">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading36">00297</a>
</TD><TD>
Provider's Pharmacy/Treatment Instructions
</TD>
<td><a href="../hl7v28datel.htm#00297">DB</a></td>
</TR>
<TR>
<TD>
7
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading37">00298</a>
</TD><TD>
Provider's Administration Instructions
</TD>
<td><a href="../hl7v28datel.htm#00298">DB</a></td>
</TR>
<TR>
<TD>
8
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
W
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
Deliver-To Location
</TD>
<td><a href="../hl7v28datel.htm#">DB</a></td>
</TR>
<TR>
<TD>
9
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading122">0161</a>
</TD><TD>
<a href="ch04a.html#Heading39">00300</a>
</TD><TD>
Allow Substitutions
</TD>
<td><a href="../hl7v28datel.htm#00300">DB</a></td>
</TR>
<TR>
<TD>
10
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading40">00301</a>
</TD><TD>
Requested Dispense Code
</TD>
<td><a href="../hl7v28datel.htm#00301">DB</a></td>
</TR>
<TR>
<TD>
11
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading41">00302</a>
</TD><TD>
Requested Dispense Amount
</TD>
<td><a href="../hl7v28datel.htm#00302">DB</a></td>
</TR>
<TR>
<TD>
12
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading42">00303</a>
</TD><TD>
Requested Dispense Units
</TD>
<td><a href="../hl7v28datel.htm#00303">DB</a></td>
</TR>
<TR>
<TD>
13
</TD><TD>
<br>
</TD><TD>
3=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading43">00304</a>
</TD><TD>
Number Of Refills
</TD>
<td><a href="../hl7v28datel.htm#00304">DB</a></td>
</TR>
<TR>
<TD>
14
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XCN">XCN</a>
</TD><TD>
B
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading44">00305</a>
</TD><TD>
Ordering Provider's DEA Number
</TD>
<td><a href="../hl7v28datel.htm#00305">DB</a></td>
</TR>
<TR>
<TD>
15
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XCN">XCN</a>
</TD><TD>
C
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading45">00306</a>
</TD><TD>
Pharmacist/Treatment Supplier's Verifier ID
</TD>
<td><a href="../hl7v28datel.htm#00306">DB</a></td>
</TR>
<TR>
<TD>
16
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading102">0136</a>
</TD><TD>
<a href="ch04a.html#Heading46">00307</a>
</TD><TD>
Needs Human Review
</TD>
<td><a href="../hl7v28datel.htm#00307">DB</a></td>
</TR>
<TR>
<TD>
17
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading47">00308</a>
</TD><TD>
Requested Give Per (Time Unit)
</TD>
<td><a href="../hl7v28datel.htm#00308">DB</a></td>
</TR>
<TR>
<TD>
18
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading48">01121</a>
</TD><TD>
Requested Give Strength
</TD>
<td><a href="../hl7v28datel.htm#01121">DB</a></td>
</TR>
<TR>
<TD>
19
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading49">01122</a>
</TD><TD>
Requested Give Strength Units
</TD>
<td><a href="../hl7v28datel.htm#01122">DB</a></td>
</TR>
<TR>
<TD>
20
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading50">01123</a>
</TD><TD>
Indication
</TD>
<td><a href="../hl7v28datel.htm#01123">DB</a></td>
</TR>
<TR>
<TD>
21
</TD><TD>
<br>
</TD><TD>
6=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading51">01218</a>
</TD><TD>
Requested Give Rate Amount
</TD>
<td><a href="../hl7v28datel.htm#01218">DB</a></td>
</TR>
<TR>
<TD>
22
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading52">01219</a>
</TD><TD>
Requested Give Rate Units
</TD>
<td><a href="../hl7v28datel.htm#01219">DB</a></td>
</TR>
<TR>
<TD>
23
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CQ">CQ</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading53">00329</a>
</TD><TD>
Total Daily Dose
</TD>
<td><a href="../hl7v28datel.htm#00329">DB</a></td>
</TR>
<TR>
<TD>
24
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading54">01476</a>
</TD><TD>
Supplementary Code
</TD>
<td><a href="../hl7v28datel.htm#01476">DB</a></td>
</TR>
<TR>
<TD>
25
</TD><TD>
<br>
</TD><TD>
5#
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading55">01666</a>
</TD><TD>
Requested Drug Strength Volume
</TD>
<td><a href="../hl7v28datel.htm#01666">DB</a></td>
</TR>
<TR>
<TD>
26
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading56">01667</a>
</TD><TD>
Requested Drug Strength Volume Units
</TD>
<td><a href="../hl7v28datel.htm#01667">DB</a></td>
</TR>
<TR>
<TD>
27
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading411">0480</a>
</TD><TD>
<a href="ch04a.html#Heading57">01668</a>
</TD><TD>
Pharmacy Order Type
</TD>
<td><a href="../hl7v28datel.htm#01668">DB</a></td>
</TR>
<TR>
<TD>
28
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading58">01669</a>
</TD><TD>
Dispensing Interval
</TD>
<td><a href="../hl7v28datel.htm#01669">DB</a></td>
</TR>
<TR>
<TD>
29
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#EI">EI</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading59">02149</a>
</TD><TD>
Medication Instance Identifier
</TD>
<td><a href="../hl7v28datel.htm#02149">DB</a></td>
</TR>
<TR>
<TD>
30
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#EI">EI</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading60">02150</a>
</TD><TD>
Segment Instance Identifier
</TD>
<td><a href="../hl7v28datel.htm#02150">DB</a></td>
</TR>
<TR>
<TD>
31
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CNE">CNE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading512">0725</a>
</TD><TD>
<a href="ch04a.html#Heading61">02151</a>
</TD><TD>
Mood Code
</TD>
<td><a href="../hl7v28datel.htm#02151">DB</a></td>
</TR>
<TR>
<TD>
32
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
B
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading62">01681</a>
</TD><TD>
Dispensing Pharmacy
</TD>
<td><a href="../hl7v28datel.htm#01681">DB</a></td>
</TR>
<TR>
<TD>
33
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
B
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading63">01682</a>
</TD><TD>
Dispensing Pharmacy Address
</TD>
<td><a href="../hl7v28datel.htm#01682">DB</a></td>
</TR>
<TR>
<TD>
34
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#PL">PL</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading64">01683</a>
</TD><TD>
Deliver-to Patient Location
</TD>
<td><a href="../hl7v28datel.htm#01683">DB</a></td>
</TR>
<TR>
<TD>
35
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading65">01684</a>
</TD><TD>
Deliver-to Address
</TD>
<td><a href="../hl7v28datel.htm#01684">DB</a></td>
</TR>
<TR>
<TD>
36
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XTN">XTN</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading66">2309</a>
</TD><TD>
Pharmacy Phone Number
</TD>
<td><a href="../hl7v28datel.htm#2309">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading30">
<H4 class="css_Überschrift4" >
4.A.1.0 RXO field definitions
</H4>
<a id="Heading31">
<H4 class="css_Überschrift4" >
4.A.1.1 RXO-1   Requested Give Code   (CWE)   00292
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the treatment product or treatment ordered to be given to the patient; it is analogous to OBR-4-universal service ID in function. Examples of treatments products include medications and certain devices or supplies, e.g., inhaler spacers, blood glucose monitors, syringes, infusion sets, which might require prescription.
</p>
<p>
Often the coded entry implies dosage form and a dosage form is required in addition to the product name. When the give code does not include the dosage form, use RXO-5-requested dosage form. When the give code does not include the strength, use RXO-18-requested give strength and the RXO-19-requested give units. Realize that strengths do not apply to some such orders.
</p>
<p>
The RXO-1, RXO-2 and RXO-4 are mandatory unless the prescription/treatment is transmitted as free text using RXO-6; then RXO-1, RXO-2, and RXO-4 may be blank and the first subcomponent of RXO-6 must be blank.
</p>
<p>
Use of the RXO-6.2 versus the RXO-1.2 for a free text order is dependent on whether or not the free text describes a product or if it is more commentary in nature.
</p>
<p>
Please refer to the request -to-dispense fields RXO-10, RXO-11, and RXO-12 for a discussion of the interrelationship with the request-to-give fields.
</p>
<a id="Heading32">
<H4 class="css_Überschrift4" >
4.A.1.2 RXO-2   Requested Give Amount - Minimum   (NM)   00293
</H4>
<p>
Definition:  This field is the ordered amount.  In a variable dose order, this is the minimum ordered amount.  In a non-varying dose order, this is the exact amount of the order.
</p>
<p>
The RXO-1, RXO-2 and RXO-4 are mandatory unless the prescription/treatment is transmitted as free text using RXO-6, then RXO-1, RXO-2, and RXO-4 may be blank and the first subcomponent of RXO-6 must be blank.
</p>
<p>
Note:  This field is not a duplication of the first component of the quantity/timing field, since in non-pharmacy/treatment orders, that component can be used to specify multiples of an ordered amount.  Another way to say this is that, for pharmacy/treatment orders, the quantity component of the quantity/timing field refers to what is to be given out at each service interval; thus, in terms of the RX order, that first component always defaults to 1.  Hence, in the actual execution of the order, the value of 1 in the first component of the quantity/timing field always refers to one administration of the amount specified in this field (the Requested Give Amount field).
</p>
<a id="Heading33">
<H4 class="css_Überschrift4" >
4.A.1.3 RXO-3   Requested Give Amount - Maximum   (NM)   00294
</H4>
<p>
Definition:  In a variable dose order, this is the maximum ordered amount.  In a non-varying dose order, this field is not used.
</p>
<a id="Heading34">
<H4 class="css_Überschrift4" >
4.A.1.4 RXO-4   Requested Give Units   (CWE)   00295
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the units for the give amount.
</p>
<p>
The RXO-1, RXO-2 and RXO-4 are mandatory unless the prescription is transmitted as free text using RXO-6, then RXO-1, RXO-2, and RXO-4 may be blank and the first subcomponent of RXO-6 must be blank.
</p>
<p>
Note:  These units can be a "compound quantity"; i.e., the units may contain the word "per."  For example, micrograms per KG (micg/kg) is an acceptable value, which means that the units are micrograms per KG (of body weight).  See Chapter 7 for full definition of ISO+ units.
</p>
<p>
A table of standard units is needed to define standard abbreviations for compound units.  Until such a table is agreed on, a user-defined table is needed for each site.  If the interpretation of a compound unit requires knowledge of some observation results (such as body weight or height), these results can be sent in the same order message using the optional OBX segments.
</p>
<a id="Heading35">
<H4 class="css_Überschrift4" >
4.A.1.5 RXO-5   Requested Dosage Form   (CWE)   00296
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the manner in which the treatment is aggregated for dispensing, e.g., tablets, capsules suppositories.  In some cases, this information is implied by the dispense/give code in RXO-1-requested give code or RXO-10-Requested dispense code.   Required when both RXO-1-Requested give code and RXO-10-Requested dispense code do not specify the drug/treatment form; optionally included otherwise.
</p>
<a id="Heading36">
<H4 class="css_Überschrift4" >
4.A.1.6 RXO-6   Provider's Pharmacy/Treatment Instructions   (CWE)   00297
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the ordering provider's instructions to the pharmacy or the non-pharmacy treatment provider (e.g., respiratory therapy).  If coded, a user-defined table must be used.  If transmitted as a free text field, place a null in the first component and the text in the second, e.g., |^this is a free text treatment instruction|.
</p>
<p>
If the prescription is transmitted as free text using RXO-6, then RXO-1, RXO-2, and RXO-4 may be blank and the first subcomponent of RXO-6 must be blank. Otherwise, RXO-1, RXO-2 and RXO-4 are mandatory.
</p>
<a id="Heading37">
<H4 class="css_Überschrift4" >
4.A.1.7 RXO-7   Provider's Administration Instructions   (CWE)   00298
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the ordering provider's instructions to the patient or to the provider administering the drug or treatment.  If coded, a user-defined table must be used. If transmitted as free text, place a null in the first component and the text in the second, e.g., |^this is a free text administration instruction|.
</p>
<a id="Heading38">
<H4 class="css_Überschrift4" >
4.A.1.8 RXO-8   Deliver-to Location
</H4>
<p>
Attention: The RXO-8 field was retained for backward compatibilty only as of v 2.6 and the detail was withdrawn and removed from the standard as of v 2.8.
</p>
<a id="Heading39">
<H4 class="css_Überschrift4" >
4.A.1.9 RXO-9   Allow Substitutions   (ID)   00300
</H4>
<p>
Definition:  Coded values indicate whether substitutions are allowed, and, if yes, what type of substitutions.  Refer to HL7 Table 0161 - Allow Substitution in Chapter 2C, Code Tables, for valid codes.
</p>
<a id="Heading40">
<H4 class="css_Überschrift4" >
4.A.1.10 RXO-10   Requested Dispense Code   (CWE)   00301
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates what is to be/was dispensed; it is analogous to OBR-4-universal service ID in function.  It may be present in the order or not, depending on the application.  If not present, and values are given for RXO-11-requested dispense amount and RXO-12-requested dispense units, the RXO-1-requested give code is assumed.  If the requested dispense code does not include the dosage form, then RXO-5-requested dosage form is required
</p>
<p>
Note on request-to-dispense fields:	
</p>
<p>
Sometimes an order will be written in which the total amount of the drug or treatment requested to be dispensed has no direct relationship with the give amounts and schedule.  For example, an outpatient pharmacy/treatment order might be take four tablets a day of &lt;drug name, value&gt;, Q6H (every 6 hours) -- dispense 30 tablets.  An inpatient order might be NS/D5W (normal saline with 5% dextrose) at 1000cc/hour-dispense 3 1-liter bottles of NSD5W solution.  The request-to-dispense fields support this common style of ordering.
</p>
<a id="Heading41">
<H4 class="css_Überschrift4" >
4.A.1.11 RXO-11   Requested Dispense Amount   (NM)   00302
</H4>
<p>
Definition:  This field specifies the amount to be dispensed. See above note.
</p>
<a id="Heading42">
<H4 class="css_Überschrift4" >
4.A.1.12 RXO-12   Requested Dispense Units   (CWE)   00303
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the units for the dispense amount.  This must be in simple units that reflect the actual quantity of the substance to be dispensed.  It does not include compound units. See above note.
</p>
<a id="Heading43">
<H4 class="css_Überschrift4" >
4.A.1.13 RXO-13   Number of Refills   (NM)   00304
</H4>
<p>
Definition:  This field defines the number of times the requested dispense amount can be given to the patient, subject to local regulation.  Refers to outpatient only.
</p>
<a id="Heading44">
<H4 class="css_Überschrift4" >
4.A.1.14 RXO-14   Ordering Provider's DEA Number   (XCN)   00305
</H4>
<i>
<p>
Components:  &lt;Person Identifier (ST)&gt; ^ &lt;Family Name (FN)&gt; ^ &lt;Given Name (ST)&gt; ^ &lt;Second and Further Given Names or Initials Thereof (ST)&gt; ^ &lt;Suffix (e.g., JR or III) (ST)&gt; ^ &lt;Prefix (e.g., DR) (ST)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;DEPRECATED-Source Table (CWE)&gt; ^ &lt;Assigning Authority (HD)&gt; ^ &lt;Name Type Code (ID)&gt; ^ &lt;Identifier Check Digit (ST)&gt; ^ &lt;Check Digit Scheme (ID)&gt; ^ &lt;Identifier Type Code (ID)&gt; ^ &lt;Assigning Facility (HD)&gt; ^ &lt;Name Representation Code (ID)&gt; ^ &lt;Name Context (CWE)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Name Assembly Order (ID)&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Professional Suffix (ST)&gt; ^ &lt;Assigning Jurisdiction (CWE)&gt; ^ &lt;Assigning Agency or Department (CWE)&gt; ^ &lt;Security Check  (ST)&gt; ^ &lt;Security Check Scheme (ID)&gt;
</p>
<p>
Subcomponents for Family Name (FN):  &lt;Surname (ST)&gt; & &lt;Own Surname Prefix (ST)&gt; & &lt;Own Surname (ST)&gt; & &lt;Surname Prefix from Partner/Spouse (ST)&gt; & &lt;Surname from Partner/Spouse (ST)&gt;
</p>
<p>
Subcomponents for Source Table (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Authority (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Name Context (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Jurisdiction (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Agency or Department (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The reader is referred to the PRT segment described in Chapter 7.
</p>
<p>
This field identifies the provider's controlled substance number, if required, by site.  It is defined as conditional because it is required when the substance being requested is a controlled substance (e.g., a narcotic). If the person referenced in this field is also referenced in PRT segment, they must contain the same information.  However, if there is a difference, then PRT segment takes precedence.
</p>
<a id="Heading45">
<H4 class="css_Überschrift4" >
4.A.1.15 RXO-15   Pharmacist/Treatment Supplier's Verifier ID   (XCN)   00306
</H4>
<i>
<p>
Components:  &lt;Person Identifier (ST)&gt; ^ &lt;Family Name (FN)&gt; ^ &lt;Given Name (ST)&gt; ^ &lt;Second and Further Given Names or Initials Thereof (ST)&gt; ^ &lt;Suffix (e.g., JR or III) (ST)&gt; ^ &lt;Prefix (e.g., DR) (ST)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;DEPRECATED-Source Table (CWE)&gt; ^ &lt;Assigning Authority (HD)&gt; ^ &lt;Name Type Code (ID)&gt; ^ &lt;Identifier Check Digit (ST)&gt; ^ &lt;Check Digit Scheme (ID)&gt; ^ &lt;Identifier Type Code (ID)&gt; ^ &lt;Assigning Facility (HD)&gt; ^ &lt;Name Representation Code (ID)&gt; ^ &lt;Name Context (CWE)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Name Assembly Order (ID)&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Professional Suffix (ST)&gt; ^ &lt;Assigning Jurisdiction (CWE)&gt; ^ &lt;Assigning Agency or Department (CWE)&gt; ^ &lt;Security Check  (ST)&gt; ^ &lt;Security Check Scheme (ID)&gt;
</p>
<p>
Subcomponents for Family Name (FN):  &lt;Surname (ST)&gt; & &lt;Own Surname Prefix (ST)&gt; & &lt;Own Surname (ST)&gt; & &lt;Surname Prefix from Partner/Spouse (ST)&gt; & &lt;Surname from Partner/Spouse (ST)&gt;
</p>
<p>
Subcomponents for Source Table (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Authority (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Name Context (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Jurisdiction (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Agency or Department (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is the provider ID of the pharmacist/treatment supplier verifier.  Use if required by the pharmacy or treatment application or site on orders (or some subgroup of orders), in addition to ORC-11-verified by.
</p>
<p>
Example:	
</p>
<p>
The site requires a "verified by" provider (such as a nurse) and a "verifying pharmacist/treatment supplier" on the order.  In this case the first field, ORC-11-verified by, is already present; but the second field, RXO-15-pharmacist/treatment supplier's verifier ID, is needed.
</p>
<a id="Heading46">
<H4 class="css_Überschrift4" >
4.A.1.16 RXO-16   Needs Human Review   (ID)   00307
</H4>
<p>
Definition:  This field uses HL7 Table 0136 - Yes/No Indicator in Chapter 2C, Code Tables.  The values have the following meaning for this field:
</p>
<p>
Y	Yes - Indicates that the pharmacist or non-pharmacist treatment supplier filling the order needs to pay special attention to the text in the RXO-6-provider's pharmacy/treatment instructions.  A warning is present.
</p>
<p>
N	No - No warning is present.  This is the equivalent default (null) value.
</p>
<p>
An example of the use of this field is given by the following case:
</p>
<p>
A smart Order Entry application knows of a possible drug or treatment interaction on a certain order, but the provider issuing the order wants to override the condition.  In this case, the pharmacy or treatment application receiving the order will want to have a staff pharmacist or non-pharmacist treatment supplier review the interaction and contact the ordering physician.
</p>
<a id="Heading47">
<H4 class="css_Überschrift4" >
4.A.1.17 RXO-17   Requested Give Per (Time Unit)   (ST)   00308
</H4>
<p>
Definition:  This field identifies the time unit to use to calculate the rate at which the pharmaceutical is to be administered.
</p>
<p>
Format:
</p>
<TABLE width="100%" border=1>
<TR>
<TD>
S<integer>
</TD><TD>
=
</TD><TD>
<integer> seconds
</TD>
</TR>
<TR>
<TD>
M<integer>
</TD><TD>
=
</TD><TD>
<integer> minutes
</TD>
</TR>
<TR>
<TD>
H<integer>
</TD><TD>
=
</TD><TD>
<integer> hours
</TD>
</TR>
<TR>
<TD>
D<integer>
</TD><TD>
=
</TD><TD>
<integer> days
</TD>
</TR>
<TR>
<TD>
W<integer>
</TD><TD>
=
</TD><TD>
<integer> weeks
</TD>
</TR>
<TR>
<TD>
L<integer>
</TD><TD>
=
</TD><TD>
<integer> months
</TD>
</TR>
</TABLE><p>
<p>
Note:   This is the same as the format specified for the DURATION component of the quantity/timing field, excluding the "X" specification.
</p>
<p>
This field is defined as conditional because it is required when the ordered substance is to be administered continuously at a prescribed rate (e.g., certain IVs).  For example, if the "give amount/units" are 300 ml and the "give per" time unit is H1, the rate is 300ml/hr and the duration of this dose is 1 hour.  Thus the give amount and give per time unit define the duration of the service.
</p>
<p>
This field is distinct from the "interval" component of the quantity/timing field, but it could be used in conjunction with it, as in give 300ml of NS per hr for 1 hour, repeat twice a day.
</p>
<a id="Heading48">
<H4 class="css_Überschrift4" >
4.A.1.18 RXO-18   Requested Give Strength   (NM)   01121
</H4>
<p>
Definition:  Required when RXO-1-requested give code does not specify the strength; optionally included otherwise. This is the numeric part of the strength, used in combination with RXO-19-requested give strength units.
</p>
<p>
The need for strength and strength unit fields in addition to the amount and amount units fields included in various RX_ segments requires explanation. Physicians can write a prescription for a drug such as Ampicillin in two ways. One way would be: "Ampicillin 250 mg capsules, 2 capsules four times a day."  In this case the give amount would be 2, the give units would be capsules, the strength would be 250 and the strength units would milligrams.
</p>
<p>
However, the provider could also write the pharmaceutical treatment as "Ampicillin 500 mg four times a day."  In this case the give amount would be 500 and the give units would be milligrams.  The strength would not be reported in the RXO segment because it is not specified; the drug could be given in two 250 mg caps or one 500 mg cap. But the pharmacist would dispense a specific capsule size and would record the strength in the RXE segment as 250 or 500, depending upon which capsule size was dispensed.
</p>
<p>
Some coding systems imply the strength, units, route of administration, and manufacturer of substances within a single instructional code.  NDC codes, for example, usually imply not only the medical substance, but also the strength, the units, and the form, e.g., 0047-0402-30^Ampicillin 250 MG CAPS^NDC.  So all of this information can also be completely specified in RXO-1-requested give code and in the analogous CWE/CNE fields in other pharmacy/treatment segments.  In this case, it is not necessary to use the strength and strength units fields to specify this information.
</p>
<a id="Heading49">
<H4 class="css_Überschrift4" >
4.A.1.19 RXO-19   Requested Give Strength Units   (CWE)   01122
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: Required when both RXO-1-requested give code and RXO-10-requested dispense code do not specify the strength; optionally included otherwise. This is the unit of the strength, used in combination with RXO-18-requested give strength.
</p>
<p>
Note:  These units can be a "compound quantity;" i.e., the units may express a quantity per unit of time.  For example, micrograms per hour (micg/h) is an acceptable value.  These compound units are contained in the ISO+ table. See Chapter 7 for full definition of ISO+ units.
</p>
<a id="Heading50">
<H4 class="css_Überschrift4" >
4.A.1.20 RXO-20   Indication   (CWE)   01123
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the condition or problem for which the drug/treatment was prescribed. May repeat if multiple indications are relevant.
</p>
<a id="Heading51">
<H4 class="css_Überschrift4" >
4.A.1.21 RXO-21   Requested Give Rate Amount   (ST)   01218
</H4>
<p>
Definition:  This field contains the rate at which to administer a treatment, e.g., 150 ml/hr (for an IV) or 4 liters/min for nasal oxygen.
</p>
<a id="Heading52">
<H4 class="css_Überschrift4" >
4.A.1.22 RXO-22   Requested Give Rate Units   (CWE)   01219
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units in which RXO-21-requested give rate amount is denominated.
</p>
<a id="Heading53">
<H4 class="css_Überschrift4" >
4.A.1.23 RXO-23   Total Daily Dose   (CQ)   00329
</H4>
<i>
<p>
Components:  &lt;Quantity (NM)&gt; ^ &lt;Units (CWE)&gt;
</p>
<p>
Subcomponents for Units (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the total daily dose for this particular pharmaceutical as expressed in terms of actual dispense units.
</p>
<a id="Heading54">
<H4 class="css_Überschrift4" >
4.A.1.24 RXO-24   Supplementary Code   (CWE)   01476
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
This field accommodates the identification of any codes that might be associated with the pharmaceutical substance. Common codes include: the Generic Product Identifier (GPI), Generic Code Number_Sequence Number (GCN_SEQNO), National Drug Code (NDC).
</p>
<a id="Heading55">
<H4 class="css_Überschrift4" >
4.A.1.25 RXO-25   Requested Drug Strength Volume   (NM)   01666
</H4>
<p>
Description: This numeric field defines the volume measurement in which the drug strength concentration is contained. For example, Acetaminophen 120 MG/5ML Elixir means that 120 MG of the drug is in a solution with a volume of 5 ML, which would be encoded in RXO-18, RXO-19, RXO-25 and RXO-26 as:
</p>
<p>
RXO||||||||||||||||||120|mg^^ISO||||||5|ml^^ISO ...&lt;cr&gt;
</p>
<a id="Heading56">
<H4 class="css_Überschrift4" >
4.A.1.26 RXO-26   Requested Drug Strength Volume Units   (CWE)   01667
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Description: This field indicates the volumetric unit associated with RXO-25 Requested Drug Strength Volume.  See example in RXO-25.
</p>
<a id="Heading57">
<H4 class="css_Überschrift4" >
4.A.1.27 RXO-27   Pharmacy Order Type   (ID)   01668
</H4>
<p>
Definition: The Pharmacy Order Type field defines the general category of pharmacy order which may be used to determine the processing path the order will take.  Refer to HL7 Table 0480 - Pharmacy Order Types in Chapter 2C, Code Tables, for valid values.
</p>
<p>
This field may also be used for grouping of related orders for processing and/or reports.  For example, Medication Administration Records (MARs) often group large volume solutions, medications and small volume solutions differently based upon site-specific workflow.
</p>
<p>
Usage Rule: This field is optional for all Pharmacy transactions.  When not populated, a default value of "M" is assumed.
</p>
<a id="Heading58">
<H4 class="css_Überschrift4" >
4.A.1.28 RXO-28   Dispensing Interval   (NM)   01669
</H4>
<p>
Definition:  This field specifies the minimum number of days that must occur between dispensing events
</p>
<a id="Heading59">
<H4 class="css_Überschrift4" >
4.A.1.29 RXO-29   Medication Instance Identifier   (EI)   02149
</H4>
<i>
<p>
Components:  &lt;Entity Identifier (ST)&gt; ^ &lt;Namespace ID (IS)&gt; ^ &lt;Universal ID (ST)&gt; ^ &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field contains a value that uniquely identifies the medication associated with this segment.  Rather than identifying the product to be given, as in RXO-1 Requested Give Code, this field serves to identify the medication in association with the order represented by the segment instance.  This identifier is persistent within and across message instances.
</p>
<p>
Note:  RXO-39 Medication Instance Identifier was introduced in v2.6 to support Patient Care messaging concepts and constructs.  At this time, there are no documented use cases for this field in the context of a pharmacy/treatment orders as described in this chapter.  This statement does not preclude the use of RXO-29 in pharmacy messages, but implementers should exercise caution in using this field outside of the Patient Care context until the pharmacy/treatment use cases are established.
</p>
<a id="Heading60">
<H4 class="css_Überschrift4" >
4.A.1.30 RXO-30   Segment Instance Identifier   (EI)   02150
</H4>
<i>
<p>
Components:  &lt;Entity Identifier (ST)&gt; ^ &lt;Namespace ID (IS)&gt; ^ &lt;Universal ID (ST)&gt; ^ &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field contains a value that uniquely identifies this segment across time and messages.  This is not intended as a "Set ID", but as a unique identifier allowing references not only to segments of the same  message, but also to segments of other messages and indirectly to the entities described in those segments if the necessary persistence was manageable by the applications.  This identifier is persistent within and across message instances.
</p>
<p>
Note:  RXO-30 Segment Instance Identifier was introduced in v 2.6 to support Patient Care messaging concepts and constructs.  At this time, there are no documented use cases for this field in the context of a pharmacy/treatment orders as described in this chapter.  This statement does not preclude the use of RXO-30 in pharmacy messages, but implementers should exercise caution in using this field outside of the Patient Care context until the pharmacy/treatment use cases are established.
</p>
<a id="Heading61">
<H4 class="css_Überschrift4" >
4.A.1.31 RXO-31   Mood Code   (CNE)   02151
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field represents the functional state of the order represented by this segment instance.  Refer to HL7 Table 0725 - Mood Codes in Chapter 2C, Code Tables, for valid values.  This field may only be used with new trigger events and new messages from v2.6 onward.   When this field is not valued in a message that qualifies, then the value is assumed to be 'EVN'.
</p>
<p>
There may appear to be overlap between this field and ORC-5 Order Status.  However, the intent of Mood Code is to support the description and documentation of historical events.  In this context, Mood codes may clash with Order Status codes, a Mood code may apply for different Order Status values, or this segment may be being used outside of the order paradigm (e.g., in a patient care plan).  Moods are meant to change the semantics of clinical data in a message when it is not inferable from the trigger event:  when the data can represent a past medication, a future medication (e.g., in a patient care plan), or in a request (e.g., as a reason for referral).  The reader is referred to Chapter 12, Patient Care, for further discussion of patient care plans and referrals.
</p>
<p>
Note:  RXO-31 Mood Code was introduced in v2.6 to support Patient Care messaging concepts and constructs.  At this time, there are no documented use cases for this field in the context of a pharmacy/treatment orders as described in this chapter.  This statement does not preclude the use of RXO-31 in pharmacy messages, but implementers should exercise caution in using this field outside of the Patient Care context until the pharmacy/treatment use cases are established.  While a similar note exists for RXO-29 Medication Instance Identifier and RXO-30 Segment Instance Identifier, particular care should be taken with RXO-31 as this could modify the intent of the segment/message and create backward compatibility problems.
</p>
<a id="Heading62">
<H4 class="css_Überschrift4" >
4.A.1.32 RXO-32   Dispensing Pharmacy   (CWE)   01681
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The information formerly communicated using this field should now be communicated using the PRT segment.  The reader is referred to chapter 7 for a description of that segment.
</p>
<p>
This field specifies the pharmacy that will dispense or has dispensed the prescription.  In the context of an order/request (i.e., in an RXO segment) this field represents the requested dispensing pharmacy.  In the context of a registered order (i.e., in an RXE segment) this field represents the intended dispensing pharmacy, the pharmacy that is expected to dispense the prescription.
</p>
<a id="Heading63">
<H4 class="css_Überschrift4" >
4.A.1.33 RXO-33   Dispensing Pharmacy Address   (XAD)   01682
</H4>
<i>
<p>
Components:  &lt;Street Address (SAD)&gt; ^ &lt;Other Designation (ST)&gt; ^ &lt;City (ST)&gt; ^ &lt;State or Province (ST)&gt; ^ &lt;Zip or Postal Code (ST)&gt; ^ &lt;Country (ID)&gt; ^ &lt;Address Type (ID)&gt; ^ &lt;Other Geographic Designation (ST)&gt; ^ &lt;County/Parish Code (CWE)&gt; ^ &lt;Census Tract (CWE)&gt; ^ &lt;Address Representation Code (ID)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Temporary Indicator (ID)&gt; ^ &lt;Bad Address Indicator (ID)&gt; ^ &lt;Address Usage (ID)&gt; ^ &lt;Addressee (ST)&gt; ^ &lt;Comment (ST)&gt; ^ &lt;Preference Order (NM)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Address Identifier (EI)&gt;
</p>
<p>
Subcomponents for Street Address (SAD):  &lt;Street or Mailing Address (ST)&gt; & &lt;Street Name (ST)&gt; & &lt;Dwelling Number (ST)&gt;
</p>
<p>
Subcomponents for County/Parish Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Census Tract (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Address Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The information formerly communicated using this field should now be communicated using the PRT segment.  The reader is referred to chapter 7 for a description of that segment.
</p>
<p>
This field specifies the address of the dispensing facility.
</p>
<a id="Heading64">
<H4 class="css_Überschrift4" >
4.A.1.34 RXO-34   Deliver-to Patient Location   (PL)   01683
</H4>
<i>
<p>
Components:  &lt;Point of Care (HD)&gt; ^ &lt;Room (HD)&gt; ^ &lt;Bed (HD)&gt; ^ &lt;Facility (HD)&gt; ^ &lt;Location Status (IS)&gt; ^ &lt;Person Location Type (IS)&gt; ^ &lt;Building (HD)&gt; ^ &lt;Floor (HD)&gt; ^ &lt;Location Description (ST)&gt; ^ &lt;Comprehensive Location Identifier (EI)&gt; ^ &lt;Assigning Authority for Location (HD)&gt;
</p>
<p>
Subcomponents for Point of Care (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Room (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Bed (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Building (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Floor (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Comprehensive Location Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Authority for Location (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field specifies the location of the patient to whom the pharmaceutical substance is to be delivered.
</p>
<a id="Heading65">
<H4 class="css_Überschrift4" >
4.A.1.35 RXO-35   Deliver-to Address   (XAD)   01684
</H4>
<i>
<p>
Components:  &lt;Street Address (SAD)&gt; ^ &lt;Other Designation (ST)&gt; ^ &lt;City (ST)&gt; ^ &lt;State or Province (ST)&gt; ^ &lt;Zip or Postal Code (ST)&gt; ^ &lt;Country (ID)&gt; ^ &lt;Address Type (ID)&gt; ^ &lt;Other Geographic Designation (ST)&gt; ^ &lt;County/Parish Code (CWE)&gt; ^ &lt;Census Tract (CWE)&gt; ^ &lt;Address Representation Code (ID)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Temporary Indicator (ID)&gt; ^ &lt;Bad Address Indicator (ID)&gt; ^ &lt;Address Usage (ID)&gt; ^ &lt;Addressee (ST)&gt; ^ &lt;Comment (ST)&gt; ^ &lt;Preference Order (NM)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Address Identifier (EI)&gt;
</p>
<p>
Subcomponents for Street Address (SAD):  &lt;Street or Mailing Address (ST)&gt; & &lt;Street Name (ST)&gt; & &lt;Dwelling Number (ST)&gt;
</p>
<p>
Subcomponents for County/Parish Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Census Tract (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Address Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field specifies the address, either mailing or physical, to which the prescription should be mailed or delivered.
</p>
<a id="Heading66">
<H4 class="css_Überschrift4" >
4.A.1.36 RXO-36   Pharmacy Phone Number   (XTN)   02309
</H4>
<i>
<p>
Components:  &lt;WITHDRAWN Constituent&gt; ^ &lt;Telecommunication Use Code (ID)&gt; ^ &lt;Telecommunication Equipment Type (ID)&gt; ^ &lt;Communication Address (ST)&gt; ^ &lt;Country Code (SNM)&gt; ^ &lt;Area/City Code (SNM)&gt; ^ &lt;Local Number (SNM)&gt; ^ &lt;Extension (SNM)&gt; ^ &lt;Any Text (ST)&gt; ^ &lt;Extension Prefix (ST)&gt; ^ &lt;Speed Dial Code (ST)&gt; ^ &lt;Unformatted Telephone number  (ST)&gt; ^ &lt;Effective Start Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Shared Telecommunication Identifier (EI)&gt; ^ &lt;Preference Order (NM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Shared Telecommunication Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field contains the telecommunication contact information for the pharmacy.  Repetitions may be supplied for various device types or use codes, or multiple instances of the same type or use.  This concept also exists as RXE-45 and RXD-34 to support pharmacy contact information in the context of the order, the encoded order and the dispense.
</p>
<a id="Heading67">
<H3 class="css_Überschrift3" >
4.A.2 RXR - Pharmacy/Treatment Route Segment
</H3>
<p>
The Pharmacy/Treatment Route segment contains the alternative combination of route, site, administration device, and administration method that are prescribed as they apply to a particular order.  The pharmacy, treatment staff and/or nursing staff has a choice between the routes based on either their professional judgment or administration instructions provided by the physician.
</p>
<a id="RXR">
<p>
HL7 Attribute Table - RXR - Pharmacy/Treatment Route
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading123">0162</a>
</TD><TD>
<a href="ch04a.html#Heading69">00309</a>
</TD><TD>
Route
</TD>
<td><a href="../hl7v28datel.htm#00309">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading474">0550</a>
</TD><TD>
<a href="ch04a.html#Heading70">00310</a>
</TD><TD>
Administration Site
</TD>
<td><a href="../hl7v28datel.htm#00310">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading125">0164</a>
</TD><TD>
<a href="ch04a.html#Heading71">00311</a>
</TD><TD>
Administration Device
</TD>
<td><a href="../hl7v28datel.htm#00311">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading126">0165</a>
</TD><TD>
<a href="ch04a.html#Heading72">00312</a>
</TD><TD>
Administration Method
</TD>
<td><a href="../hl7v28datel.htm#00312">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading73">01315</a>
</TD><TD>
Routing Instruction
</TD>
<td><a href="../hl7v28datel.htm#01315">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading424">0495</a>
</TD><TD>
<a href="ch04a.html#Heading74">01670</a>
</TD><TD>
Administration Site Modifier
</TD>
<td><a href="../hl7v28datel.htm#01670">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading68">
<H4 class="css_Überschrift4" >
4.A.2.0 RXR field definitions
</H4>
<a id="Heading69">
<H4 class="css_Überschrift4" >
4.A.2.1 RXR-1   Route   (CWE)   00309
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is the route of administration.
</p>
<p>
Some current "route codes," such as some of the NDC-derived codes include the site already.  In such cases, the entire code can be included in this field as a "locally-defined code" for the CWE data type.  Refer to User-Defined Table 0162 - Route of Administration in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading70">
<H4 class="css_Überschrift4" >
4.A.2.2 RXR-2   Administration Site   (CWE)   00310
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the site of the administration route.  When using a post-coordinated code table in this field, RXR-6 Administration Site may be used to modify the meaning of this field.
</p>
<p>
Refer to HL7 Table 0550 - Body Parts in Chapter 2C, Code Tables, for valid values.  Other appropriate external code sets (e.g., SNOMED) may also be employed.
</p>
<a id="Heading71">
<H4 class="css_Überschrift4" >
4.A.2.3 RXR-3   Administration Device   (CWE)   00311
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the mechanical device used to aid in the administration of the drug or other treatment.  Common examples are IV-sets of different types.  Refer to User-defined Table 0164 - Administration device in Chapter 2C, Code Tables, for valid entries.
</p>
<a id="Heading72">
<H4 class="css_Überschrift4" >
4.A.2.4 RXR-4   Administration Method   (CWE)   00312
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the specific method requested for the administration of the drug or treatment to the patient.  Refer To User-defined Table 0165 - Administration Method in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading73">
<H4 class="css_Überschrift4" >
4.A.2.5 RXR-5   Routing Instruction   (CWE)   01315
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field provides instruction on administration routing, especially in cases where more than one route of administration is possible. A typical case would be designating which IV line should be used when more than one IV line is a possible route for injection.
</p>
<a id="Heading74">
<H4 class="css_Überschrift4" >
4.A.2.6 RXR-6   Administration Site Modifier   (CWE)   01670
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains a modifier which modifies the meaning of RXR-2 Administration Site.
</p>
<p>
The code table used in this field is dependent upon the code table used in RXR-2 Administration site.  If RXR-2 employs HL7 Table 0550 - Body Parts, then this field may only be populated with values from HL7 Table 0495 - Body Parts Modifier.  In the case of other code sets (e.g., SNOMED) in RXR-2, RXR-6 may only be populated if modifiers are defined within, or related to, that code set.
</p>
<p>
Condition Rule: This field may only be populated if RXR-2 Administration Site is populated.  This field is not required if RXR-2 is populated.
</p>
<a id="Heading75">
<H3 class="css_Überschrift3" >
4.A.3 RXC - Pharmacy/Treatment Component Order Segment
</H3>
<p>
If the drug or treatment ordered with the RXO segment is a compound drug OR an IV solution, AND there is not a coded value for OBR-4-universal service ID, which specifies the components (base and all additives), then the components (the base and additives) are specified by two or more RXC segments.  The policy of the pharmacy or treatment application on substitutions at the RXC level is identical to that for the RXO level.
</p>
<a id="RXC">
<p>
HL7 Attribute Table - RXC - Pharmacy/Treatment Component Order
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading127">0166</a>
</TD><TD>
<a href="ch04a.html#Heading77">00313</a>
</TD><TD>
RX Component Type
</TD>
<td><a href="../hl7v28datel.htm#00313">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading78">00314</a>
</TD><TD>
Component Code
</TD>
<td><a href="../hl7v28datel.htm#00314">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading79">00315</a>
</TD><TD>
Component Amount
</TD>
<td><a href="../hl7v28datel.htm#00315">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading80">00316</a>
</TD><TD>
Component Units
</TD>
<td><a href="../hl7v28datel.htm#00316">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading81">01124</a>
</TD><TD>
Component Strength
</TD>
<td><a href="../hl7v28datel.htm#01124">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading82">01125</a>
</TD><TD>
Component Strength Units
</TD>
<td><a href="../hl7v28datel.htm#01125">DB</a></td>
</TR>
<TR>
<TD>
7
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading54">01476</a>
</TD><TD>
Supplementary Code
</TD>
<td><a href="../hl7v28datel.htm#01476">DB</a></td>
</TR>
<TR>
<TD>
8
</TD><TD>
<br>
</TD><TD>
5#
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading84">01671</a>
</TD><TD>
Component Drug Strength Volume
</TD>
<td><a href="../hl7v28datel.htm#01671">DB</a></td>
</TR>
<TR>
<TD>
9
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading85">01672</a>
</TD><TD>
Component Drug Strength Volume Units
</TD>
<td><a href="../hl7v28datel.htm#01672">DB</a></td>
</TR>
<TR>
<TD>
10
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading86">03314</a>
</TD><TD>
Dispense Amount
</TD>
<td><a href="../hl7v28datel.htm#03314">DB</a></td>
</TR>
<TR>
<TD>
11
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading87">03315</a>
</TD><TD>
Dispense Units
</TD>
<td><a href="../hl7v28datel.htm#03315">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading76">
<H4 class="css_Überschrift4" >
4.A.3.0 RXC field definitions
</H4>
<a id="Heading77">
<H4 class="css_Überschrift4" >
4.A.3.1 RXC-1   RX Component Type   (ID)   00313
</H4>
<p>
Definition:  Refer to HL7 Table 0166 - RX Component Type in Chapter 2C, Code Tables for valide values.
</p>
<p>
For the non-IV case, the "B" value may still apply.  For example, if a custom dermatologic salve is being prepared, the "B" item might be a standard base ointment into which other components are mixed.
</p>
<p>
The amount of the "base" specified in the "B" segment(s) is defined to be the quantity into which amounts specified in the "A" components are mixed.  Thus the RXC segments as a group define the "recipe" for a particular amount (defined by the base segment(s)).  The give amount, as defined in the RXO, does not need to correspond to this base amount.  For example, the RXC segments may specify a recipe for a liter of a standard type of saline with 1 gram of a particular antimicrobial, while the give amount (from the RXO) may specify the administration of 2 liters of this IV-solution every 24 hours.
</p>
<p>
The amount specified in each "A" segment is defined to be the quantity to be added to the amount of the base as specified in its RXC segment.
</p>
<p>
If any "base" components are present then these should be transmitted first.  The first "base" component in the transmission should be considered the "primary base" if such a distinction is necessary.  Similarly, the first "additive" in the transmission should be considered the "primary additive" if such a distinction is necessary.
</p>
<a id="Heading78">
<H4 class="css_Überschrift4" >
4.A.3.2 RXC-2   Component Code   (CWE)   00314
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is equivalent to OBR-4-universal service ID.  It defines the base or component in the same manner as the give and dispense codes.  As with the give and dispense codes, it may contain text only, code only, text + code, or text + code + units (implied or explicit).  As with the give and dispense codes, if RXC-4-component units is present, this overrides the units implied by the code.  If only text is present, the pharmacy or treatment application must include a manual review or reentering of the component drug or treatment.
</p>
<a id="Heading79">
<H4 class="css_Überschrift4" >
4.A.3.3 RXC-3   Component Amount   (NM)   00315
</H4>
<p>
Definition:  This field identifies the amount of this component to be added to the specified amount of the base.
</p>
<a id="Heading80">
<H4 class="css_Überschrift4" >
4.A.3.4 RXC-4   Component Units   (CWE)   00316
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the units for the component amount.  If present, this overrides the units implied by RXC-2-component code.  This must be in simple units that reflect the actual quantity of the component being added.  It does not include compound units.
</p>
<a id="Heading81">
<H4 class="css_Überschrift4" >
4.A.3.5 RXC-5   Component Strength   (NM)   01124
</H4>
<p>
Definition:  Use when RXC-2-component code does not specify the strength.  This is the numeric part of the strength, used in combination with RXC-6-component strength units.
</p>
<a id="Heading82">
<H4 class="css_Überschrift4" >
4.A.3.6 RXC-6   Component Strength Units   (CWE)   01125
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  Use when RXC-2-component code does not specify the strength.  This is the unit of the strength, used in combination with RXC-5-component strength.
</p>
<p>
Note:  These units can be a "compound quantity;" i.e., the units may express a quantity per unit of time.  For example, micrograms per hour (micg/h) is an acceptable value.  These compound units are contained in the ISO+ table.  See Chapter 7 for full definition of ISO+ units.
</p>
<a id="Heading83">
<H4 class="css_Überschrift4" >
4.A.3.7 RXC-7   Supplementary Code   (CWE)   01476
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
This field accommodates the identification of any codes that might be associated with the pharmaceutical or other treatment substance. Common codes include: the Generic Product Identifier (GPI), Generic Code Number_Sequence Number (GCN_SEQNO), National Drug Code (NDC).
</p>
<a id="Heading84">
<H4 class="css_Überschrift4" >
4.A.3.8 RXC-8   Component Drug Strength Volume   (NM)   01671
</H4>
<p>
Description: This numeric field defines the volume measurement in which the drug strength concentration is contained. For example, Acetaminophen 120 MG/5ML Elixir means that 120 MG of the drug is in a solution with a volume of 5, which would be encoded in RXC-5, RXC-6, RXC-8 and RXC-9 as
</p>
<p>
RXC|||||120|mg^^ISO||5|ml^^ISO ...&lt;cr&gt;
</p>
<a id="Heading85">
<H4 class="css_Überschrift4" >
4.A.3.9 RXC-9   Component Drug Strength Volume Units   (CWE)   01672
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Description: This field indicates the volumetric unit associated with RXC-8 Component Drug Strength Volume.  See example in RXC-8.
</p>
<a id="Heading86">
<H4 class="css_Überschrift4" >
4.A.3.10 RXC-10   Dispense Amount   (NM)   03314
</H4>
<p>
Definition: This field contains the amount to be dispensed as encoded by the pharmacy or treatment supplier.
</p>
<a id="Heading87">
<H4 class="css_Überschrift4" >
4.A.3.11 RXC-11   Dispense Units   (CWE)   03315
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units for the dispense amount as encoded by the pharmacy or treatment supplier.  This field is required if the units are not implied by the actual dispense code. This must be in simple units that reflect the actual quantity of the substance dispensed.  It does not include compound units.
</p>
<a id="Heading88">
<H3 class="css_Überschrift3" >
4.A.4 RXE - Pharmacy/Treatment Encoded Order Segment
</H3>
<p>
The RXE segment details the pharmacy or treatment application's encoding of the order.  It also contains several pharmacy-specific order status fields, such as RXE-16-number of refills remaining, RXE-17-number of refills/doses dispensed, RXE-18-D/T of most recent refill or dose dispensed, and RXE-19-total daily dose.
</p>
<p>
Note that ORC-7-quantity/timing has a different meaning from RXE-1-quantity/timing and RXG-3-quantity/timing.  The pharmacy or treatment department has the "authority" (and/or necessity) to schedule dispense/give events.  Hence, the pharmacy or treatment department has the responsibility to encode this scheduling information in RXE-1-quantity/timing and RXG-3-quantity/timing.  ORC-7-quantity/timing does not change: it always specifies the requested give/dispense schedule of the original order.
</p>
<a id="RXE">
<p>
HL7 Attribute Table - RXE - Pharmacy/Treatment Encoded Order
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
W
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading90">00221</a>
</TD><TD>
Quantity/Timing
</TD>
<td><a href="../hl7v28datel.htm#00221">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
0292/
<p>
<a href="ch02c.html#Heading410">0479</a>
</TD><TD>
<a href="ch04a.html#Heading91">00317</a>
</TD><TD>
Give Code
</TD>
<td><a href="../hl7v28datel.htm#00317">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading92">00318</a>
</TD><TD>
Give Amount - Minimum
</TD>
<td><a href="../hl7v28datel.htm#00318">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading93">00319</a>
</TD><TD>
Give Amount - Maximum
</TD>
<td><a href="../hl7v28datel.htm#00319">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading94">00320</a>
</TD><TD>
Give Units
</TD>
<td><a href="../hl7v28datel.htm#00320">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading95">00321</a>
</TD><TD>
Give Dosage Form
</TD>
<td><a href="../hl7v28datel.htm#00321">DB</a></td>
</TR>
<TR>
<TD>
7
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading37">00298</a>
</TD><TD>
Provider's Administration Instructions
</TD>
<td><a href="../hl7v28datel.htm#00298">DB</a></td>
</TR>
<TR>
<TD>
8
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
W
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading97">00299</a>
</TD><TD>
Deliver-to Location
</TD>
<td><a href="../hl7v28datel.htm#00299">DB</a></td>
</TR>
<TR>
<TD>
9
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading128">0167</a>
</TD><TD>
<a href="ch04a.html#Heading98">00322</a>
</TD><TD>
Substitution Status
</TD>
<td><a href="../hl7v28datel.htm#00322">DB</a></td>
</TR>
<TR>
<TD>
10
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading99">00323</a>
</TD><TD>
Dispense Amount
</TD>
<td><a href="../hl7v28datel.htm#00323">DB</a></td>
</TR>
<TR>
<TD>
11
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading100">00324</a>
</TD><TD>
Dispense Units
</TD>
<td><a href="../hl7v28datel.htm#00324">DB</a></td>
</TR>
<TR>
<TD>
12
</TD><TD>
<br>
</TD><TD>
3=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading43">00304</a>
</TD><TD>
Number of Refills
</TD>
<td><a href="../hl7v28datel.htm#00304">DB</a></td>
</TR>
<TR>
<TD>
13
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XCN">XCN</a>
</TD><TD>
B
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading44">00305</a>
</TD><TD>
Ordering Provider's DEA Number
</TD>
<td><a href="../hl7v28datel.htm#00305">DB</a></td>
</TR>
<TR>
<TD>
14
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XCN">XCN</a>
</TD><TD>
B
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading45">00306</a>
</TD><TD>
Pharmacist/Treatment Supplier's Verifier ID
</TD>
<td><a href="../hl7v28datel.htm#00306">DB</a></td>
</TR>
<TR>
<TD>
15
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading104">00325</a>
</TD><TD>
Prescription Number
</TD>
<td><a href="../hl7v28datel.htm#00325">DB</a></td>
</TR>
<TR>
<TD>
16
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading105">00326</a>
</TD><TD>
Number of Refills Remaining
</TD>
<td><a href="../hl7v28datel.htm#00326">DB</a></td>
</TR>
<TR>
<TD>
17
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading106">00327</a>
</TD><TD>
Number of Refills/Doses Dispensed
</TD>
<td><a href="../hl7v28datel.htm#00327">DB</a></td>
</TR>
<TR>
<TD>
18
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading107">00328</a>
</TD><TD>
D/T of Most Recent Refill or Dose Dispensed
</TD>
<td><a href="../hl7v28datel.htm#00328">DB</a></td>
</TR>
<TR>
<TD>
19
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CQ">CQ</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading53">00329</a>
</TD><TD>
Total Daily Dose
</TD>
<td><a href="../hl7v28datel.htm#00329">DB</a></td>
</TR>
<TR>
<TD>
20
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading102">0136</a>
</TD><TD>
<a href="ch04a.html#Heading46">00307</a>
</TD><TD>
Needs Human Review
</TD>
<td><a href="../hl7v28datel.htm#00307">DB</a></td>
</TR>
<TR>
<TD>
21
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading110">00330</a>
</TD><TD>
Special Dispensing Instructions
</TD>
<td><a href="../hl7v28datel.htm#00330">DB</a></td>
</TR>
<TR>
<TD>
22
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading111">00331</a>
</TD><TD>
Give Per (Time Unit)
</TD>
<td><a href="../hl7v28datel.htm#00331">DB</a></td>
</TR>
<TR>
<TD>
23
</TD><TD>
<br>
</TD><TD>
6=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading112">00332</a>
</TD><TD>
Give Rate Amount
</TD>
<td><a href="../hl7v28datel.htm#00332">DB</a></td>
</TR>
<TR>
<TD>
24
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading113">00333</a>
</TD><TD>
Give Rate Units
</TD>
<td><a href="../hl7v28datel.htm#00333">DB</a></td>
</TR>
<TR>
<TD>
25
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading114">01126</a>
</TD><TD>
Give Strength
</TD>
<td><a href="../hl7v28datel.htm#01126">DB</a></td>
</TR>
<TR>
<TD>
26
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading115">01127</a>
</TD><TD>
Give Strength Units
</TD>
<td><a href="../hl7v28datel.htm#01127">DB</a></td>
</TR>
<TR>
<TD>
27
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading116">01128</a>
</TD><TD>
Give Indication
</TD>
<td><a href="../hl7v28datel.htm#01128">DB</a></td>
</TR>
<TR>
<TD>
28
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading117">01220</a>
</TD><TD>
Dispense Package Size
</TD>
<td><a href="../hl7v28datel.htm#01220">DB</a></td>
</TR>
<TR>
<TD>
29
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading118">01221</a>
</TD><TD>
Dispense Package Size Unit
</TD>
<td><a href="../hl7v28datel.htm#01221">DB</a></td>
</TR>
<TR>
<TD>
30
</TD><TD>
1..2
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading266">0321</a>
</TD><TD>
<a href="ch04a.html#Heading119">01222</a>
</TD><TD>
Dispense Package Method
</TD>
<td><a href="../hl7v28datel.htm#01222">DB</a></td>
</TR>
<TR>
<TD>
31
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading54">01476</a>
</TD><TD>
Supplementary Code
</TD>
<td><a href="../hl7v28datel.htm#01476">DB</a></td>
</TR>
<TR>
<TD>
32
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading121">01673</a>
</TD><TD>
Original Order Date/Time
</TD>
<td><a href="../hl7v28datel.htm#01673">DB</a></td>
</TR>
<TR>
<TD>
33
</TD><TD>
<br>
</TD><TD>
5#
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading122">01674</a>
</TD><TD>
Give Drug Strength Volume
</TD>
<td><a href="../hl7v28datel.htm#01674">DB</a></td>
</TR>
<TR>
<TD>
34
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading123">01675</a>
</TD><TD>
Give Drug Strength Volume Units
</TD>
<td><a href="../hl7v28datel.htm#01675">DB</a></td>
</TR>
<TR>
<TD>
35
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading408">0477</a>
</TD><TD>
<a href="ch04a.html#Heading124">01676</a>
</TD><TD>
Controlled Substance Schedule
</TD>
<td><a href="../hl7v28datel.htm#01676">DB</a></td>
</TR>
<TR>
<TD>
36
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading409">0478</a>
</TD><TD>
<a href="ch04a.html#Heading125">01677</a>
</TD><TD>
Formulary Status
</TD>
<td><a href="../hl7v28datel.htm#01677">DB</a></td>
</TR>
<TR>
<TD>
37
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading126">01678</a>
</TD><TD>
Pharmaceutical Substance Alternative
</TD>
<td><a href="../hl7v28datel.htm#01678">DB</a></td>
</TR>
<TR>
<TD>
38
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading127">01679</a>
</TD><TD>
Pharmacy of Most Recent Fill
</TD>
<td><a href="../hl7v28datel.htm#01679">DB</a></td>
</TR>
<TR>
<TD>
39
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading128">01680</a>
</TD><TD>
Initial Dispense Amount
</TD>
<td><a href="../hl7v28datel.htm#01680">DB</a></td>
</TR>
<TR>
<TD>
40
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
B
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading62">01681</a>
</TD><TD>
Dispensing Pharmacy
</TD>
<td><a href="../hl7v28datel.htm#01681">DB</a></td>
</TR>
<TR>
<TD>
41
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
B
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading63">01682</a>
</TD><TD>
Dispensing Pharmacy Address
</TD>
<td><a href="../hl7v28datel.htm#01682">DB</a></td>
</TR>
<TR>
<TD>
42
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#PL">PL</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading64">01683</a>
</TD><TD>
Deliver-to Patient Location
</TD>
<td><a href="../hl7v28datel.htm#01683">DB</a></td>
</TR>
<TR>
<TD>
43
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading65">01684</a>
</TD><TD>
Deliver-to Address
</TD>
<td><a href="../hl7v28datel.htm#01684">DB</a></td>
</TR>
<TR>
<TD>
44
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading411">0480</a>
</TD><TD>
<a href="ch04a.html#Heading133">01685</a>
</TD><TD>
Pharmacy Order Type
</TD>
<td><a href="../hl7v28datel.htm#01685">DB</a></td>
</TR>
<TR>
<TD>
45
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XTN">XTN</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading134">02310</a>
</TD><TD>
Pharmacy Phone Number
</TD>
<td><a href="../hl7v28datel.htm#02310">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading89">
<H4 class="css_Überschrift4" >
4.A.4.0 RXE field definitions
</H4>
<a id="Heading90">
<H4 class="css_Überschrift4" >
4.A.4.1 RXE-1   Quantity/Timing
</H4>
<p>
Attention: The RXE-1 field was retained for backward compatibilty only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7.
</p>
<a id="Heading91">
<H4 class="css_Überschrift4" >
4.A.4.2 RXE-2   Give Code   (CWE)   00317
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the medical substance or treatment that has been ordered to be given to the patient, as encoded by the pharmacy or treatment supplier; it is equivalent to OBR-4-universal service ID in function.  In the RXE segment, this give code must be fully encoded.  The dispense fields, which define the units and amount of what is to be issued to the patient (see RXE-10-dispense amount and RXE-11-dispense units below) do not necessarily correlate with the instructions of what amount is to be "given" or administered with each dose, and may or may not be specified with the order.  For example, the "give" part of the order may convey the field-representation of give 250 mg of Ampicillin, while the request to dispense part of the order may convey issue 30 tablets of generic equivalent for this outpatient prescription.
</p>
<p>
The coding system used is conditional on both the nature of the medical substance or treatment ordered and site-specific implementation considerations. For vaccines, HL7 Table 0292 - Vaccines Administered is the preferred coding system.  For non-vaccine products, the coding system may be a local implementation of User-defined Table 0479 - Pharmaceutical Substances or an external coding system.  Examples of external coding systems include, but are not limited to, National Drug Codes (NDC), Medispan Generic Product Identifier (MGPI), Drug Descriptor Identifier (DDID), and other drug codes listed in HL7 Table 0396 - Coding Systems.   The following examples illustrate some code tables other than User-defined Table 0479:
</p>
<p>
NDC:				0006915404^Norvasc 10mg Tabs^NDC
</p>
<p>
DDID:				015189^Norvasc 10mg Tabs^DDID
</p>
<p>
CVX (HL70292):			30^HBIG^CVX
</p>
<a id="Heading92">
<H4 class="css_Überschrift4" >
4.A.4.3 RXE-3   Give Amount - Minimum   (NM)   00318
</H4>
<p>
Definition:  This field contains the ordered amount as encoded by the pharmacy or treatment supplier.  In a variable dose order, this is the minimum ordered amount.  In a non-varying dose order, this is the exact amount of the order.
</p>
<p>
Note:	This field is not a duplication of the first component of the quantity/timing field, since in non-pharmacy/treatment orders, that component can be used to specify multiples of an ordered amount.   Another way to say this is that, for pharmacy/treatment orders, the quantity component of the quantity/timing field refers to what is to be given out at each service interval; thus, in terms of the RX order, that first component always defaults to 1.  Hence, in the actual execution of the order, the value of 1 in the first component of the quantity/timing field always refers to one administration of the amount specified in this field (the requested Give Amount field).
</p>
<a id="Heading93">
<H4 class="css_Überschrift4" >
4.A.4.4 RXE-4   Give Amount - Maximum   (NM)   00319
</H4>
<p>
Definition:  In a variable dose order, this is the maximum ordered amount.  In a non-varying dose, this field is not used.
</p>
<a id="Heading94">
<H4 class="css_Überschrift4" >
4.A.4.5 RXE-5   Give Units   (CWE)   00320
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units for the give amount as encoded by the pharmacy or treatment (e.g., respiratory therapy) application.
</p>
<p>
Note:  These units can be a "compound quantity"; i.e., the units may contain the word "per."  For example, micrograms per KG (micg/kg) is an acceptable value, which means that the units are micrograms per KG (of body weight).
</p>
<p>
A table of standard units that contains compound units is needed.  Until such a table is agreed on, a user-defined table is needed for each site.
</p>
<a id="Heading95">
<H4 class="css_Überschrift4" >
4.A.4.6 RXE-6   Give Dosage Form   (CWE)   00321
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  The dosage form indicates the manner in which the medication or treatment is aggregated for dispensing, e.g., tablets, capsules, suppositories.  In some cases, this information is implied by the give code in RXE-2-Give Code.  Use the RXE-6-Give Dosage Form when the give code does not specify the dosage form.
</p>
<a id="Heading96">
<H4 class="css_Überschrift4" >
4.A.4.7 RXE-7   Provider's Administration Instructions   (CWE)   00298
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the ordering provider's instructions to the patient or the provider administering the drug or treatment.  If coded, a user-defined table must be used; if free text (describing a custom IV, mixture, or salve, for example), place the text in the second component, e.g., |^this is a free text administration instruction|.
</p>
<a id="Heading97">
<H4 class="css_Überschrift4" >
4.A.4.8 RXE-8   Deliver-to Location
</H4>
<p>
Attention: The RXE-8 field was retained for backward compatibilty only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7.
</p>
<a id="Heading98">
<H4 class="css_Überschrift4" >
4.A.4.9 RXE-9   Substitution Status   (ID)   00322
</H4>
<p>
Definition:  Refer to HL7 Table 0167 - Substitution Status in Chapter 2C, Code Tables, for valid values.  If a substitution has been made, and a record of the original requested give code (RXO-1-requested give code) is needed, the optional RXO segment can be included in the RDE message.
</p>
<a id="Heading99">
<H4 class="css_Überschrift4" >
4.A.4.10 RXE-10   Dispense Amount   (NM)   00323
</H4>
<p>
Definition: This field contains the amount to be dispensed as encoded by the pharmacy or treatment supplier.
</p>
<a id="Heading100">
<H4 class="css_Überschrift4" >
4.A.4.11 RXE-11   Dispense Units   (CWE)   00324
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units for the dispense amount as encoded by the pharmacy or treatment supplier.  This field is required if the units are not implied by the actual dispense code. This must be in simple units that reflect the actual quantity of the substance dispensed.  It does not include compound units.
</p>
<a id="Heading101">
<H4 class="css_Überschrift4" >
4.A.4.12 RXE-12   Number of Refills   (NM)   00304
</H4>
<p>
Definition:  This field contains the total original number of refills.  Outpatient only.
</p>
<a id="Heading102">
<H4 class="css_Überschrift4" >
4.A.4.13 RXE-13   Ordering Provider's DEA Number   (XCN)   00305
</H4>
<i>
<p>
Components:  &lt;Person Identifier (ST)&gt; ^ &lt;Family Name (FN)&gt; ^ &lt;Given Name (ST)&gt; ^ &lt;Second and Further Given Names or Initials Thereof (ST)&gt; ^ &lt;Suffix (e.g., JR or III) (ST)&gt; ^ &lt;Prefix (e.g., DR) (ST)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;DEPRECATED-Source Table (CWE)&gt; ^ &lt;Assigning Authority (HD)&gt; ^ &lt;Name Type Code (ID)&gt; ^ &lt;Identifier Check Digit (ST)&gt; ^ &lt;Check Digit Scheme (ID)&gt; ^ &lt;Identifier Type Code (ID)&gt; ^ &lt;Assigning Facility (HD)&gt; ^ &lt;Name Representation Code (ID)&gt; ^ &lt;Name Context (CWE)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Name Assembly Order (ID)&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Professional Suffix (ST)&gt; ^ &lt;Assigning Jurisdiction (CWE)&gt; ^ &lt;Assigning Agency or Department (CWE)&gt; ^ &lt;Security Check  (ST)&gt; ^ &lt;Security Check Scheme (ID)&gt;
</p>
<p>
Subcomponents for Family Name (FN):  &lt;Surname (ST)&gt; & &lt;Own Surname Prefix (ST)&gt; & &lt;Own Surname (ST)&gt; & &lt;Surname Prefix from Partner/Spouse (ST)&gt; & &lt;Surname from Partner/Spouse (ST)&gt;
</p>
<p>
Subcomponents for Source Table (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Authority (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Name Context (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Jurisdiction (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Agency or Department (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The reader is referred to the PRT segment described in Chapter 7.
</p>
<p>
This field is defined as conditional because it is required when the substance requested is a controlled substance (e.g., a narcotic). If the person referenced in this field is also referenced in PRT segment, they must contain the same information.  However, if there is a difference, then PRT segment takes precedence.
</p>
<a id="Heading103">
<H4 class="css_Überschrift4" >
4.A.4.14 RXE-14   Pharmacist/Treatment Supplier's Verifier ID   (XCN)   00306
</H4>
<i>
<p>
Components:  &lt;Person Identifier (ST)&gt; ^ &lt;Family Name (FN)&gt; ^ &lt;Given Name (ST)&gt; ^ &lt;Second and Further Given Names or Initials Thereof (ST)&gt; ^ &lt;Suffix (e.g., JR or III) (ST)&gt; ^ &lt;Prefix (e.g., DR) (ST)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;DEPRECATED-Source Table (CWE)&gt; ^ &lt;Assigning Authority (HD)&gt; ^ &lt;Name Type Code (ID)&gt; ^ &lt;Identifier Check Digit (ST)&gt; ^ &lt;Check Digit Scheme (ID)&gt; ^ &lt;Identifier Type Code (ID)&gt; ^ &lt;Assigning Facility (HD)&gt; ^ &lt;Name Representation Code (ID)&gt; ^ &lt;Name Context (CWE)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Name Assembly Order (ID)&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Professional Suffix (ST)&gt; ^ &lt;Assigning Jurisdiction (CWE)&gt; ^ &lt;Assigning Agency or Department (CWE)&gt; ^ &lt;Security Check  (ST)&gt; ^ &lt;Security Check Scheme (ID)&gt;
</p>
<p>
Subcomponents for Family Name (FN):  &lt;Surname (ST)&gt; & &lt;Own Surname Prefix (ST)&gt; & &lt;Own Surname (ST)&gt; & &lt;Surname Prefix from Partner/Spouse (ST)&gt; & &lt;Surname from Partner/Spouse (ST)&gt;
</p>
<p>
Subcomponents for Source Table (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Authority (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Name Context (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Jurisdiction (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Agency or Department (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The reader is referred to the PRT segment described in chapter 7.
</p>
<p>
This field contains the provider ID of Pharmacist/treatment supplier's verifier.  Use if required by the pharmacy or treatment application or site on orders (or some subgroup of orders).  If the person referenced in this field is also referenced in PRT segment, they must contain the same information.  However, if there is a difference, then PRT segment takes precedence.
</p>
<a id="Heading104">
<H4 class="css_Überschrift4" >
4.A.4.15 RXE-15   Prescription Number   (ST)   00325
</H4>
<p>
Definition:  This field contains the prescription number as assigned by the pharmacy or treatment application.  Equivalent in uniqueness to the pharmacy/treatment filler order number.  At some sites, this may be the pharmacy or treatment system (internal) sequential form.  At other sites, this may be an external form.  This is a required field in RXE when used in pharmacy/treatment messages, but it is not required when used in product experience messages (see Chapter 7).
</p>
<a id="Heading105">
<H4 class="css_Überschrift4" >
4.A.4.16 RXE-16   Number of Refills Remaining   (NM)   00326
</H4>
<p>
Definition: Number of refills remaining.  This field is conditional because it is required when a prescription is dispensed to an outpatient.  It is not relevant to inpatient treatment orders.
</p>
<a id="Heading106">
<H4 class="css_Überschrift4" >
4.A.4.17 RXE-17   Number of Refills/Doses Dispensed   (NM)   00327
</H4>
<p>
Definition: Number of refills remaining.  This field is conditional because it is required when a prescription is dispensed to an outpatient.  It is not relevant to inpatient treatment orders.
</p>
<a id="Heading107">
<H4 class="css_Überschrift4" >
4.A.4.18 RXE-18   D/T of Most Recent Refill or Dose Dispensed   (DTM)   00328
</H4>
<p>
Definition: Date/time of the most recent refill or dose dispensed.
</p>
<a id="Heading108">
<H4 class="css_Überschrift4" >
4.A.4.19 RXE-19   Total Daily Dose   (CQ)   00329
</H4>
<i>
<p>
Components:  &lt;Quantity (NM)&gt; ^ &lt;Units (CWE)&gt;
</p>
<p>
Subcomponents for Units (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the total daily dose for this particular pharmaceutical as expressed in terms of actual dispense units.
</p>
<a id="Heading109">
<H4 class="css_Überschrift4" >
4.A.4.20 RXE-20   Needs Human Review   (ID)   00307
</H4>
<p>
Definition:  This field uses HL7 Table 0136 - Yes/No Indicator in Chapter 2C, Code Tables. The values have the following meaning for this field:
</p>
<p>
Y	Yes - Indicates that a warning is present.  The application receiving the encoded order needs to warn the person administering the drug or treatment to pay attention to the text in RXE-21-pharmacy/treatment special dispensing instructions.
</p>
<p>
N	No - Indicates no warning is present.  This is the equivalent default (null) value.
</p>
<a id="Heading110">
<H4 class="css_Überschrift4" >
4.A.4.21 RXE-21   Special Dispensing Instructions   (CWE)   00330
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the pharmacy or treatment supplier's provider-generated special instructions to the provider dispensing/administering the order.
</p>
<a id="Heading111">
<H4 class="css_Überschrift4" >
4.A.4.22 RXE-22   Give Per (Time Unit)    (ST)   00331
</H4>
<p>
Definition:  This field contains the time unit to use to calculate the rate at which the pharmaceutical is to be administered.
</p>
<p>
Format:
</p>
<TABLE width="100%" border=1>
<TR>
<TD>
S<integer>
</TD><TD>
=
</TD><TD>
<integer> seconds
</TD>
</TR>
<TR>
<TD>
M<integer>
</TD><TD>
=
</TD><TD>
<integer> minutes
</TD>
</TR>
<TR>
<TD>
H<integer>
</TD><TD>
=
</TD><TD>
<integer> hours
</TD>
</TR>
<TR>
<TD>
D<integer>
</TD><TD>
=
</TD><TD>
<integer> days
</TD>
</TR>
<TR>
<TD>
W<integer>
</TD><TD>
=
</TD><TD>
<integer> weeks
</TD>
</TR>
<TR>
<TD>
L<integer>
</TD><TD>
=
</TD><TD>
<integer> months
</TD>
</TR>
<TR>
<TD>
T<integer>
</TD><TD>
=
</TD><TD>
at the interval and amount stated until a total of <integer> "DOSAGE" is accumulated.  Units would be assumed to be the same as in the QUANTITY field.
</TD>
</TR>
<TR>
<TD>
INDEF
</TD><TD>
=
</TD><TD>
do indefinitely - also the default
</TD>
</TR>
</TABLE><p>
<p>
This is the same as the format specified for the DURATION component of the quantity/timing field, excluding the "X" specification.
</p>
<p>
This field is defined as conditional because it is required when the ordered substance is to be administered continuously at a prescribed rate (e.g., certain IVs).  For example, if the "give amount/units" were 300 ml and the "give per" time unit were H1 (equivalent to one hour), the rate is 300ml/hr.
</p>
<a id="Heading112">
<H4 class="css_Überschrift4" >
4.A.4.23 RXE-23   Give Rate Amount   (ST)   00332
</H4>
<p>
Definition:  This field contains the rate at which the substance should be administered.
</p>
<a id="Heading113">
<H4 class="css_Überschrift4" >
4.A.4.24 RXE-24   Give Rate Units   (CWE)   00333
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units for RXE-23-give rate amount.  May be composite.  The ratio of the RXE-23-give rate amount and RXE-24-give rate units defines the actual rate of administration.  Thus, if RXE-23-give rate amount = 100 and RXE-24-give rate units = ml/hr, the requested rate of administration is 100 ml/hr. (See ISO+ figure 7-9 in Chapter 7 for possible compound units codes.)
</p>
<a id="Heading114">
<H4 class="css_Überschrift4" >
4.A.4.25 RXE-25   Give Strength   (NM)   01126
</H4>
<p>
Definition:  Use when RXE-2-give code does not specify the strength.  This is the numeric part of the strength, used in combination with RXE-26-give strength units.
</p>
<a id="Heading115">
<H4 class="css_Überschrift4" >
4.A.4.26 RXE-26   Give Strength Units   (CWE)   01127
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  Use when RXE-2-Give Code does not specify the strength.  This is the unit of the strength, used in combination with RXE-25-Give Strength.
</p>
<p>
Note:  These units can be a "compound quantity"; i.e., the units may express a quantity per unit of time.  For example, micrograms per hour (micg/h) is an acceptable value.  These compound units are contained in the ISO+ table. See Chapter 7 for full definition of ISO+ units.
</p>
<a id="Heading116">
<H4 class="css_Überschrift4" >
4.A.4.27 RXE-27   Give Indication   (CWE)   01128
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the condition or problem for which the drug/treatment was prescribed.  May repeat if multiple indications are relevant.
</p>
<a id="Heading117">
<H4 class="css_Überschrift4" >
4.A.4.28 RXE-28   Dispense Package Size   (NM)   01220
</H4>
<p>
Definition:  This field contains the size of package to be dispensed.  Units are transmitted in RXE-29-dispense package size unit.
</p>
<a id="Heading118">
<H4 class="css_Überschrift4" >
4.A.4.29 RXE-29   Dispense Package Size Unit   (CWE)   01221
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units in which RXE-28-dispense package size is denominated.
</p>
<a id="Heading119">
<H4 class="css_Überschrift4" >
4.A.4.30 RXE-30   Dispense Package Method   (ID)   01222
</H4>
<p>
Definition:  This field contains the method by which treatment is dispensed.  Refer to HL7 Table 0321 - Dispense Method in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading120">
<H4 class="css_Überschrift4" >
4.A.4.31 RXE-31   Supplementary Code   (CWE)   01476
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field accommodates the identification of any codes that might be associated with the pharmaceutical substance. Common codes include: the Generic Product Identifier (GPI), Generic Code Number_Sequence Number (GCN_SEQNO), National Drug Code (NDC).
</p>
<a id="Heading121">
<H4 class="css_Überschrift4" >
4.A.4.32 RXE-32   Original Order Date/Time   (DTM)   01673
</H4>
<p>
Definition:  This field contains the date/time of the original order (ORC-9) when a refill authorization is being requested.  This was represented in the ORC-9 of the original order transaction.
</p>
<a id="Heading122">
<H4 class="css_Überschrift4" >
4.A.4.33 RXE-33   Give Drug Strength Volume   (NM)   01674
</H4>
<p>
Description: This numeric field defines the volume measurement in which the drug strength concentration is contained. For example, Acetaminophen 120 MG/5ML Elixir means that 120 MG of the drug is in a solution with a volume of 5 ML, which would be encoded in RXE-25, RXE-26, RXE-33 and RXE-34 as:
</p>
<p>
RXE|||||||||||||||||||||||||120|mg^^ISO|||||||5|ml^^ISO ...&lt;cr&gt;
</p>
<a id="Heading123">
<H4 class="css_Überschrift4" >
4.A.4.34 RXE-34   Give Drug Strength Volume Units   (CWE)   01675
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Description: This field indicates the volumetric unit associated with RXE-33 Give Drug Strength Volume.  See example in RXE-33.
</p>
<a id="Heading124">
<H4 class="css_Überschrift4" >
4.A.4.35 RXE-35   Controlled Substance Schedule   (CWE)   01676
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field specifies the class of the drug or other substance if its usage is controlled by legislation.  In the USA, such legislation includes the federal Controlled Substance Act (CSA) or a State Uniform Controlled Substance Act. Refer to User-defined table 0477 - Controlled Substance Schedule in Chapter 2C, Code Tables, for valid values for USA usage.  Other countries should create their own versions of this table.
</p>
<p>
Because some jurisdictions may extend the list of drugs in a particular class and may create an additional schedule, table 0477 is user-defined.
</p>
<a id="Heading125">
<H4 class="css_Überschrift4" >
4.A.4.36 RXE-36   Formulary Status   (ID)   01677
</H4>
<p>
Definition:  This field specifies whether or not the pharmaceutical substance is part of the local formulary. Refer to HL7 table 0478 - Formulary Status in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading126">
<H4 class="css_Überschrift4" >
4.A.4.37 RXE-37   Pharmaceutical Substance Alternative   (CWE)   01678
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field specifies a pharmaceutical substance that is in the formulary that could be prescribed in lieu of the substance being prescribed. In the case where the specified medication is non-formulary this field would contain therapeutic alternatives that are on the formulary.
</p>
<a id="Heading127">
<H4 class="css_Überschrift4" >
4.A.4.38 RXE-38   Pharmacy of Most Recent Fill   (CWE)   01679
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field specifies the pharmacy that last filled the prescription.
</p>
<a id="Heading128">
<H4 class="css_Überschrift4" >
4.A.4.39 RXE-39   Initial Dispense Amount   (NM)   01680
</H4>
<p>
Definition:  This field specifies the quantity dispensed on the original fill (first fill) of a prescription when that amount is not the same as the quantity to be used in refills.  One use case is when a new medication is being prescribed and the prescriber wants to determine if the patient will tolerate the medication.  The prescriber indicates that the medication should be filled for an initial amount of 30 tablets and, if tolerated, refilled using a quantity of 100 tablets.   In this case, RXE-39 would contain 30 and RXE-10 would contain 100.
</p>
<p>
If this field is not populated, then the initial dispense amount is the same as RXE-10.
</p>
<p>
The units are identified in RXE-11.
</p>
<a id="Heading129">
<H4 class="css_Überschrift4" >
4.A.4.40 RXE-40   Dispensing Pharmacy   (CWE)   01681
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The information formerly communicated using this field should now be communicated using the PRT segment.  The reader is referred to chapter 7 for a description of that segment.
</p>
<p>
This field specifies the pharmacy that will dispense or has dispensed the prescription.  In the context of an order/request (i.e., in an RXO segment) this field represents the requested dispensing pharmacy.  In the context of a registered order (i.e., in an RXE segment) this field represents the intended dispensing pharmacy, the pharmacy that is expected to dispense the prescription.
</p>
<a id="Heading130">
<H4 class="css_Überschrift4" >
4.A.4.41 RXE-41   Dispensing Pharmacy Address   (XAD)   01682
</H4>
<i>
<p>
Components:  &lt;Street Address (SAD)&gt; ^ &lt;Other Designation (ST)&gt; ^ &lt;City (ST)&gt; ^ &lt;State or Province (ST)&gt; ^ &lt;Zip or Postal Code (ST)&gt; ^ &lt;Country (ID)&gt; ^ &lt;Address Type (ID)&gt; ^ &lt;Other Geographic Designation (ST)&gt; ^ &lt;County/Parish Code (CWE)&gt; ^ &lt;Census Tract (CWE)&gt; ^ &lt;Address Representation Code (ID)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Temporary Indicator (ID)&gt; ^ &lt;Bad Address Indicator (ID)&gt; ^ &lt;Address Usage (ID)&gt; ^ &lt;Addressee (ST)&gt; ^ &lt;Comment (ST)&gt; ^ &lt;Preference Order (NM)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Address Identifier (EI)&gt;
</p>
<p>
Subcomponents for Street Address (SAD):  &lt;Street or Mailing Address (ST)&gt; & &lt;Street Name (ST)&gt; & &lt;Dwelling Number (ST)&gt;
</p>
<p>
Subcomponents for County/Parish Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Census Tract (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Address Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The information formerly communicated using this field should now be communicated using the PRT segment.  The reader is referred to chapter 7 for a description of that segment.
</p>
<p>
This field specifies the address of the dispensing facility.
</p>
<a id="Heading131">
<H4 class="css_Überschrift4" >
4.A.4.42 RXE-42   Deliver-To Patient Location   (PL)   01683
</H4>
<i>
<p>
Components:  &lt;Point of Care (HD)&gt; ^ &lt;Room (HD)&gt; ^ &lt;Bed (HD)&gt; ^ &lt;Facility (HD)&gt; ^ &lt;Location Status (IS)&gt; ^ &lt;Person Location Type (IS)&gt; ^ &lt;Building (HD)&gt; ^ &lt;Floor (HD)&gt; ^ &lt;Location Description (ST)&gt; ^ &lt;Comprehensive Location Identifier (EI)&gt; ^ &lt;Assigning Authority for Location (HD)&gt;
</p>
<p>
Subcomponents for Point of Care (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Room (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Bed (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Building (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Floor (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Comprehensive Location Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Authority for Location (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field specifies the location of the patient to whom the pharmaceutical substance is to be delivered.
</p>
<a id="Heading132">
<H4 class="css_Überschrift4" >
4.A.4.43 RXE-43   Deliver-to Address   (XAD)   01684
</H4>
<i>
<p>
Components:  &lt;Street Address (SAD)&gt; ^ &lt;Other Designation (ST)&gt; ^ &lt;City (ST)&gt; ^ &lt;State or Province (ST)&gt; ^ &lt;Zip or Postal Code (ST)&gt; ^ &lt;Country (ID)&gt; ^ &lt;Address Type (ID)&gt; ^ &lt;Other Geographic Designation (ST)&gt; ^ &lt;County/Parish Code (CWE)&gt; ^ &lt;Census Tract (CWE)&gt; ^ &lt;Address Representation Code (ID)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Temporary Indicator (ID)&gt; ^ &lt;Bad Address Indicator (ID)&gt; ^ &lt;Address Usage (ID)&gt; ^ &lt;Addressee (ST)&gt; ^ &lt;Comment (ST)&gt; ^ &lt;Preference Order (NM)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Address Identifier (EI)&gt;
</p>
<p>
Subcomponents for Street Address (SAD):  &lt;Street or Mailing Address (ST)&gt; & &lt;Street Name (ST)&gt; & &lt;Dwelling Number (ST)&gt;
</p>
<p>
Subcomponents for County/Parish Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Census Tract (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Address Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field specifies the address, either mailing or physical, to which the prescription should be mailed or delivered.
</p>
<a id="Heading133">
<H4 class="css_Überschrift4" >
4.A.4.44 RXE-44   Pharmacy Order Type   (ID)   01685
</H4>
<p>
Definition: The Pharmacy Order Type field defines the general category of pharmacy order which may be used to determine the processing path the order will take.  Refer to HL7 Table 0480 Pharmacy Order Types in Chapter 2C, Code Tables, for valid values.
</p>
<p>
This field may also be used for grouping of related orders for processing and/or reports.  For example, Medication Administration Records (MARs) often group large volume solutions, medications and small volume solutions differently based upon site-specific workflow.
</p>
<p>
Usage Rule: This field is optional for all Pharmacy transactions.  When not populated, a default value of "M" is assumed.
</p>
<a id="Heading134">
<H4 class="css_Überschrift4" >
4.A.4.45 RXE-45   Pharmacy Phone Number   (XTN)   02310
</H4>
<i>
<p>
Components:  &lt;WITHDRAWN Constituent&gt; ^ &lt;Telecommunication Use Code (ID)&gt; ^ &lt;Telecommunication Equipment Type (ID)&gt; ^ &lt;Communication Address (ST)&gt; ^ &lt;Country Code (SNM)&gt; ^ &lt;Area/City Code (SNM)&gt; ^ &lt;Local Number (SNM)&gt; ^ &lt;Extension (SNM)&gt; ^ &lt;Any Text (ST)&gt; ^ &lt;Extension Prefix (ST)&gt; ^ &lt;Speed Dial Code (ST)&gt; ^ &lt;Unformatted Telephone number  (ST)&gt; ^ &lt;Effective Start Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Shared Telecommunication Identifier (EI)&gt; ^ &lt;Preference Order (NM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Shared Telecommunication Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field contains the telecommunication contact information for the pharmacy.  Repetitions may be supplied for various device types or use codes, or multiple instances of the same type or use.  This concept also exists as RXO-36 and RXD-34 to support pharmacy contact information in the context of the order, the encoded order and the dispense.
</p>
<a id="Heading135">
<H3 class="css_Überschrift3" >
4.A.5 RXD - Pharmacy/Treatment Dispense Segment
</H3>
<a id="RXD">
<p>
HL7 Attribute Table - RXD - Pharmacy/Treatment Dispense
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
<br>
</TD><TD>
4=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading137">00334</a>
</TD><TD>
Dispense Sub-ID Counter
</TD>
<td><a href="../hl7v28datel.htm#00334">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading240">0292</a>
</TD><TD>
<a href="ch04a.html#Heading138">00335</a>
</TD><TD>
Dispense/Give Code
</TD>
<td><a href="../hl7v28datel.htm#00335">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading139">00336</a>
</TD><TD>
Date/Time Dispensed
</TD>
<td><a href="../hl7v28datel.htm#00336">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading140">00337</a>
</TD><TD>
Actual Dispense Amount
</TD>
<td><a href="../hl7v28datel.htm#00337">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading141">00338</a>
</TD><TD>
Actual Dispense Units
</TD>
<td><a href="../hl7v28datel.htm#00338">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading142">00339</a>
</TD><TD>
Actual Dosage Form
</TD>
<td><a href="../hl7v28datel.htm#00339">DB</a></td>
</TR>
<TR>
<TD>
7
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading104">00325</a>
</TD><TD>
Prescription Number
</TD>
<td><a href="../hl7v28datel.htm#00325">DB</a></td>
</TR>
<TR>
<TD>
8
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading105">00326</a>
</TD><TD>
Number of Refills Remaining
</TD>
<td><a href="../hl7v28datel.htm#00326">DB</a></td>
</TR>
<TR>
<TD>
9
</TD><TD>
<br>
</TD><TD>
200=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading145">00340</a>
</TD><TD>
Dispense Notes
</TD>
<td><a href="../hl7v28datel.htm#00340">DB</a></td>
</TR>
<TR>
<TD>
10
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XCN">XCN</a>
</TD><TD>
B
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading146">00341</a>
</TD><TD>
Dispensing Provider
</TD>
<td><a href="../hl7v28datel.htm#00341">DB</a></td>
</TR>
<TR>
<TD>
11
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading128">0167</a>
</TD><TD>
<a href="ch04a.html#Heading98">00322</a>
</TD><TD>
Substitution Status
</TD>
<td><a href="../hl7v28datel.htm#00322">DB</a></td>
</TR>
<TR>
<TD>
12
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CQ">CQ</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading53">00329</a>
</TD><TD>
Total Daily Dose
</TD>
<td><a href="../hl7v28datel.htm#00329">DB</a></td>
</TR>
<TR>
<TD>
13
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
W
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading149">01303</a>
</TD><TD>
Dispense-to Location
</TD>
<td><a href="../hl7v28datel.htm#01303">DB</a></td>
</TR>
<TR>
<TD>
14
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading102">0136</a>
</TD><TD>
<a href="ch04a.html#Heading46">00307</a>
</TD><TD>
Needs Human Review
</TD>
<td><a href="../hl7v28datel.htm#00307">DB</a></td>
</TR>
<TR>
<TD>
15
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading110">00330</a>
</TD><TD>
Special Dispensing Instructions
</TD>
<td><a href="../hl7v28datel.htm#00330">DB</a></td>
</TR>
<TR>
<TD>
16
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading152">01132</a>
</TD><TD>
Actual Strength
</TD>
<td><a href="../hl7v28datel.htm#01132">DB</a></td>
</TR>
<TR>
<TD>
17
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading153">01133</a>
</TD><TD>
Actual Strength Unit
</TD>
<td><a href="../hl7v28datel.htm#01133">DB</a></td>
</TR>
<TR>
<TD>
18
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading154">01129</a>
</TD><TD>
Substance Lot Number
</TD>
<td><a href="../hl7v28datel.htm#01129">DB</a></td>
</TR>
<TR>
<TD>
19
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading155">01130</a>
</TD><TD>
Substance Expiration Date
</TD>
<td><a href="../hl7v28datel.htm#01130">DB</a></td>
</TR>
<TR>
<TD>
20
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading156">01131</a>
</TD><TD>
Substance Manufacturer Name
</TD>
<td><a href="../hl7v28datel.htm#01131">DB</a></td>
</TR>
<TR>
<TD>
21
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading50">01123</a>
</TD><TD>
Indication
</TD>
<td><a href="../hl7v28datel.htm#01123">DB</a></td>
</TR>
<TR>
<TD>
22
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading117">01220</a>
</TD><TD>
Dispense Package Size
</TD>
<td><a href="../hl7v28datel.htm#01220">DB</a></td>
</TR>
<TR>
<TD>
23
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading118">01221</a>
</TD><TD>
Dispense Package Size Unit
</TD>
<td><a href="../hl7v28datel.htm#01221">DB</a></td>
</TR>
<TR>
<TD>
24
</TD><TD>
1..2
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading266">0321</a>
</TD><TD>
<a href="ch04a.html#Heading119">01222</a>
</TD><TD>
Dispense Package Method
</TD>
<td><a href="../hl7v28datel.htm#01222">DB</a></td>
</TR>
<TR>
<TD>
25
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading54">01476</a>
</TD><TD>
Supplementary Code
</TD>
<td><a href="../hl7v28datel.htm#01476">DB</a></td>
</TR>
<TR>
<TD>
26
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading162">01477</a>
</TD><TD>
Initiating Location
</TD>
<td><a href="../hl7v28datel.htm#01477">DB</a></td>
</TR>
<TR>
<TD>
27
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading163">01478</a>
</TD><TD>
Packaging/Assembly Location
</TD>
<td><a href="../hl7v28datel.htm#01478">DB</a></td>
</TR>
<TR>
<TD>
28
</TD><TD>
<br>
</TD><TD>
5=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading164">01686</a>
</TD><TD>
Actual Drug Strength Volume
</TD>
<td><a href="../hl7v28datel.htm#01686">DB</a></td>
</TR>
<TR>
<TD>
29
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading165">01687</a>
</TD><TD>
Actual Drug Strength Volume Units
</TD>
<td><a href="../hl7v28datel.htm#01687">DB</a></td>
</TR>
<TR>
<TD>
30
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
B
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading166">01688</a>
</TD><TD>
Dispense to Pharmacy
</TD>
<td><a href="../hl7v28datel.htm#01688">DB</a></td>
</TR>
<TR>
<TD>
31
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
B
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading167">01689</a>
</TD><TD>
Dispense to Pharmacy Address
</TD>
<td><a href="../hl7v28datel.htm#01689">DB</a></td>
</TR>
<TR>
<TD>
32
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading411">0480</a>
</TD><TD>
<a href="ch04a.html#Heading168">01690</a>
</TD><TD>
Pharmacy Order Type
</TD>
<td><a href="../hl7v28datel.htm#01690">DB</a></td>
</TR>
<TR>
<TD>
33
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading414">0484</a>
</TD><TD>
<a href="ch04a.html#Heading169">01691</a>
</TD><TD>
Dispense Type
</TD>
<td><a href="../hl7v28datel.htm#01691">DB</a></td>
</TR>
<TR>
<TD>
34
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XTN">XTN</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading170">02311</a>
</TD><TD>
Pharmacy Phone Number
</TD>
<td><a href="../hl7v28datel.htm#02311">DB</a></td>
</TR>
<TR>
<TD>
35
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#EI">EI</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading171">03392</a>
</TD><TD>
Dispense Tag Identifier
</TD>
<td><a href="../hl7v28datel.htm#03392">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading136">
<H4 class="css_Überschrift4" >
4.A.5.0 RXD field definitions
</H4>
<a id="Heading137">
<H4 class="css_Überschrift4" >
4.A.5.1 RXD-1   Dispense Sub-ID counter   (NM)   00334
</H4>
<p>
Definition:  This field starts with 1 the first time that medication/treatment is delivered/dispensed for this order.  Increments by one with each additional issuance.
</p>
<a id="Heading138">
<H4 class="css_Überschrift4" >
4.A.5.2 RXD-2   Dispense/Give Code   (CWE)   00335
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field identifies the medical substance or treatment ordered to be given to the patient; it is equivalent to OBR-4-Universal Service ID.  See the RXE segment for a complete definition of the RXE-2-give code.  If the substance dispensed is a vaccine, CVX codes may be used to code this field (see HL7 Table 0292 - Vaccines Administered in Chapter 2C, Code Tables).
</p>
<p>
Note:  The contents of RXD-2-dispense/give code should be compatible with the comparable field in the RXE (RXE-2-give code).  The RDS message refers ONLY to the dispensing of the drug or treatment by the pharmacy or treatment supplier.
</p>
<a id="Heading139">
<H4 class="css_Überschrift4" >
4.A.5.3 RXD-3   Date/Time Dispensed   (DTM)   00336
</H4>
<p>
Definition:  This field indicates when the pharmaceutical/treatment is dispensed from the pharmacy or treatment supplier.  Use the time stamp format.
</p>
<a id="Heading140">
<H4 class="css_Überschrift4" >
4.A.5.4 RXD-4   Actual Dispense Amount   (NM)   00337
</H4>
<p>
Definition:  This field indicates the amount dispensed.
</p>
<a id="Heading141">
<H4 class="css_Überschrift4" >
4.A.5.5 RXD-5   Actual Dispense Units   (CWE)   00338
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the units dispensed.  Site-defined table.  This field is required if the units are not implied by the actual dispense code.  If present, it overrides units implied by the actual dispense code.  This must be in simple units that reflect the actual quantity of the substance dispensed.  It does not include compound units.
</p>
<a id="Heading142">
<H4 class="css_Überschrift4" >
4.A.5.6 RXD-6   Actual Dosage Form   (CWE)   00339
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  The dosage form indicates the manner in which the medication/treatment is aggregated for dispensing, e.g., tablets, capsules, suppositories.  In some cases, this information is implied by the dispense/give code in RXD-2-dispense/give code.  Use this field when the give code and the dispense code do not specify the dosage form.
</p>
<a id="Heading143">
<H4 class="css_Überschrift4" >
4.A.5.7 RXD-7   Prescription Number   (ST)   00325
</H4>
<p>
Definition:  This field is equivalent in uniqueness to the pharmacy/treatment supplier filler order number.  At some sites, this may be the pharmacy/treatment supplier (internal) sequential form.  At other sites, this may be an external number.
</p>
<a id="Heading144">
<H4 class="css_Überschrift4" >
4.A.5.8 RXD-8   Number of Refills Remaining   (NM)   00326
</H4>
<p>
Definition:   This field is conditional because it is required when a prescription is dispensed to an outpatient. It is not relevant to inpatient treatment orders.
</p>
<a id="Heading145">
<H4 class="css_Überschrift4" >
4.A.5.9 RXD-9   Dispense Notes   (ST)   00340
</H4>
<p>
Definition:  This field contains free text notes to the person dispensing the medication/treatment (may include the ordering provider's original notes, as well as any notes from the formulary or the pharmacy or treatment supplier).  This may contain free text describing a custom IV, mixture, or salve for example.
</p>
<a id="Heading146">
<H4 class="css_Überschrift4" >
4.A.5.10 RXD-10   Dispensing Provider   (XCN)   00341
</H4>
<i>
<p>
Components:  &lt;Person Identifier (ST)&gt; ^ &lt;Family Name (FN)&gt; ^ &lt;Given Name (ST)&gt; ^ &lt;Second and Further Given Names or Initials Thereof (ST)&gt; ^ &lt;Suffix (e.g., JR or III) (ST)&gt; ^ &lt;Prefix (e.g., DR) (ST)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;DEPRECATED-Source Table (CWE)&gt; ^ &lt;Assigning Authority (HD)&gt; ^ &lt;Name Type Code (ID)&gt; ^ &lt;Identifier Check Digit (ST)&gt; ^ &lt;Check Digit Scheme (ID)&gt; ^ &lt;Identifier Type Code (ID)&gt; ^ &lt;Assigning Facility (HD)&gt; ^ &lt;Name Representation Code (ID)&gt; ^ &lt;Name Context (CWE)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Name Assembly Order (ID)&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Professional Suffix (ST)&gt; ^ &lt;Assigning Jurisdiction (CWE)&gt; ^ &lt;Assigning Agency or Department (CWE)&gt; ^ &lt;Security Check  (ST)&gt; ^ &lt;Security Check Scheme (ID)&gt;
</p>
<p>
Subcomponents for Family Name (FN):  &lt;Surname (ST)&gt; & &lt;Own Surname Prefix (ST)&gt; & &lt;Own Surname (ST)&gt; & &lt;Surname Prefix from Partner/Spouse (ST)&gt; & &lt;Surname from Partner/Spouse (ST)&gt;
</p>
<p>
Subcomponents for Source Table (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Authority (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Name Context (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Jurisdiction (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Agency or Department (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The reader is referred to the PRT segment described in Chapter.7.
</p>
<p>
This field contains the provider ID of the person dispensing the pharmaceutical. If the person referenced in this field is also referenced in PRT segment, they must contain the same information.  However, if there is a difference, then PRT segment takes precedence.
</p>
<a id="Heading147">
<H4 class="css_Überschrift4" >
4.A.5.11 RXD-11   Substitution Status   (ID)   00322
</H4>
<p>
Definition:  Refer to HL7 Table 0167 - Substitution Status in Chapter 2C, Code Tables, for suggested values.
</p>
<a id="Heading148">
<H4 class="css_Überschrift4" >
4.A.5.12 RXD-12   Total Daily Dose   (CQ)   00329
</H4>
<i>
<p>
Components:  &lt;Quantity (NM)&gt; ^ &lt;Units (CWE)&gt;
</p>
<p>
Subcomponents for Units (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the total daily dose being dispensed as expressed in terms of the actual dispense units.
</p>
<p>
Note:	The next two fields are equivalent to the corresponding fields of the RXE segment.  They are included (optionally) in the RXD so that it may "stand alone" as a dispense result instruction segment.
</p>
<a id="Heading149">
<H4 class="css_Überschrift4" >
4.A.5.13 RXD-13   Dispense-to Location
</H4>
<p>
Definition:  This field is retained for backward compatibility only as of v 2.6 and withdrawn from the standard as of v 2.8. The reader is referred toRXD-30 and RXD-31.
</p>
<a id="Heading150">
<H4 class="css_Überschrift4" >
4.A.5.14 RXD-14   Needs Human Review   (ID)   00307
</H4>
<p>
Definition:  Refer to HL7 Table 0136 - Yes/no indicator for valid values.  The values have the following meaning for this field:
</p>
<p>
Y	Yes - Indicates that a warning is present.  The application receiving the dispense order needs to warn the person dispensing/administering the drug or treatment to pay attention to the text in RXD-15-Special dispensing instructions.
</p>
<p>
N	No - Indicates no warning is present.  This is the equivalent default (null) value.
</p>
<a id="Heading151">
<H4 class="css_Überschrift4" >
4.A.5.15 RXD-15   Special Dispensing Instructions   (CWE)   00330
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains pharmacy or treatment supplier-generated special instructions to the provider dispensing/administering the order.
</p>
<a id="Heading152">
<H4 class="css_Überschrift4" >
4.A.5.16 RXD-16   Actual Strength   (NM)   01132
</H4>
<p>
Definition:  Use when RXD-2-Dispense/Give Code does not specify the strength.  This is the numeric part of the strength, of a single dosage unit of the dispensed product, used in combination with RXD-17-actual strength unit.
</p>
<a id="Heading153">
<H4 class="css_Überschrift4" >
4.A.5.17 RXD-17   Actual Strength Unit   (CWE)   01133
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  Use when RXD-2-Dispense/Give Code does not specify the strength.  This is the unit of the strength, of a single dosage unit of the dispensed product, used in combination with RXD-16-actual strength.
</p>
<p>
Note:  These units can be a "compound quantity;" i.e., the units may express a quantity per unit of time.  For example, micrograms per hour (micg/h) is an acceptable value.  These compound units are contained in the ISO+ table. See Chapter 7 for full definition of ISO+ units.
</p>
<a id="Heading154">
<H4 class="css_Überschrift4" >
4.A.5.18 RXD-18   Substance Lot Number   (ST)   01129
</H4>
<p>
Definition:  This field contains the lot number of the medical substance administered.
</p>
<p>
Note:  The lot number is the number printed on the label attached to the container holding the substance and on the packaging which houses the container.  If the substance is a vaccine, for example, and a diluent is required, a lot number may appear on the vial containing the diluent; however, any such identifier associated with a diluent is not the identifier of interest. The substance lot number should be reported, not that of the diluent.
</p>
<a id="Heading155">
<H4 class="css_Überschrift4" >
4.A.5.19 RXD-19   Substance Expiration Date   (DTM)   01130
</H4>
<p>
Definition:  This field contains the expiration date of the medical substance administered.
</p>
<p>
Note:  Vaccine expiration date does not always have a "day" component; therefore, such a date may be transmitted as YYYYMM^L.
</p>
<a id="Heading156">
<H4 class="css_Überschrift4" >
4.A.5.20 RXD-20   Substance Manufacturer Name   (CWE)   01131
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the manufacturer of the medical substance administered when it is a manufactured substance.
</p>
<p>
Note:  For vaccines, code system MVX may be used to code this field.  See Section 4A.7.1, "Vaccine administration data".  This field may be used if the manufacturer of the substance is not identified by the code used in RXA-5-Administered code.
</p>
<a id="Heading157">
<H4 class="css_Überschrift4" >
4.A.5.21 RXD-21   Indication   (CWE)   01123
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the identifier of the condition or problem for which the drug/treatment was prescribed.  May repeat if multiple indications are relevant.
</p>
<a id="Heading158">
<H4 class="css_Überschrift4" >
4.A.5.22 RXD-22   Dispense Package Size   (NM)   01220
</H4>
<p>
Definition:  This field contains the size of package to be dispensed.  Units are transmitted in RXD-23-dispense package size unit.
</p>
<a id="Heading159">
<H4 class="css_Überschrift4" >
4.A.5.23 RXD-23   Dispense Package Size Unit   (CWE)   01221
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units in which RXE-28-dispense package size is denominated.  The advertised number of units in the manufacturer's package, i.e., the package as it comes from the supplier.
</p>
<a id="Heading160">
<H4 class="css_Überschrift4" >
4.A.5.24 RXD-24   Dispense Package Method   (ID)   01222
</H4>
<p>
Definition:  This field contains the method by which treatment is dispensed.  Refer To HL7 Table 0321 - Dispense Method in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading161">
<H4 class="css_Überschrift4" >
4.A.5.25 RXD-25   Supplementary code   (CWE)   01476
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field accommodates the identification of any codes that might be associated with the pharmaceutical substance. Common codes include: the Generic Product Identifier (GPI), Generic Code Number_Sequence Number (GCN_SEQNO), National Drug Code (NDC).
</p>
<a id="Heading162">
<H4 class="css_Überschrift4" >
4.A.5.26 RXD-26   Initiating Location   (CWE)   01477 
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field identifies the pharmacy or other treatment dispensing service (e.g., respiratory) that received the initial request.
</p>
<p>
Example: Pharmacy A (the Intake/Receiving) receives a phone call from the patient requesting a medication refill, but stipulates that the prescription will be picked up in pharmacy B. In accordance with the business process the prescription will be packaged/assembled in Pharmacy C.
</p>
<a id="Heading163">
<H4 class="css_Überschrift4" >
4.A.5.27 RXD-27   Packaging/Assembly Location   (CWE)   01478
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field identifies the pharmacy which packaged/assembled request.
</p>
<a id="Heading164">
<H4 class="css_Überschrift4" >
4.A.5.28 RXD-28   Actual Drug Strength Volume   (NM)   01686
</H4>
<p>
Description: This numeric field defines the volume measurement in which the drug strength concentration is contained. For example, Acetaminophen 120 MG/5ML Elixir means that 120 MG of the drug is in a solution with a volume of 5 ML , which would be encoded in RXD-16, RXD-17, RXD-28 and RXD-29 as
</p>
<p>
RXD||||||||||||||||120|mg^^ISO|||||||||||5|ml^^ISO ...&lt;cr&gt;
</p>
<a id="Heading165">
<H4 class="css_Überschrift4" >
4.A.5.29 RXD-29   Actual Drug Strength Volume Units   (CWE)   01687
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Description: This field indicates the volumetric unit associated with RXD-28 Actual Drug Strength Volume.  See example in RXD-28.
</p>
<a id="Heading166">
<H4 class="css_Überschrift4" >
4.A.5.30 RXD-30   Dispense to Pharmacy   (CWE)   01688
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The information formerly communicated using this field should now be communicated using the PRT segment.  The reader is referred to chapter 7 for a description of that segment.
</p>
<p>
This field specifies the pharmacy that will dispense or has dispensed the prescription.  In the context of an order/request (i.e., in an RXO segment) this field represents the requested dispensing pharmacy.  In the context of a registered order (i.e., in an RXE segment) this field represents the intended dispensing pharmacy, the pharmacy that is expected to dispense the prescription.
</p>
<a id="Heading167">
<H4 class="css_Überschrift4" >
4.A.5.31 RXD-31   Dispense to Pharmacy Address   (XAD)   01689
</H4>
<i>
<p>
Components:  &lt;Street Address (SAD)&gt; ^ &lt;Other Designation (ST)&gt; ^ &lt;City (ST)&gt; ^ &lt;State or Province (ST)&gt; ^ &lt;Zip or Postal Code (ST)&gt; ^ &lt;Country (ID)&gt; ^ &lt;Address Type (ID)&gt; ^ &lt;Other Geographic Designation (ST)&gt; ^ &lt;County/Parish Code (CWE)&gt; ^ &lt;Census Tract (CWE)&gt; ^ &lt;Address Representation Code (ID)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Temporary Indicator (ID)&gt; ^ &lt;Bad Address Indicator (ID)&gt; ^ &lt;Address Usage (ID)&gt; ^ &lt;Addressee (ST)&gt; ^ &lt;Comment (ST)&gt; ^ &lt;Preference Order (NM)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Address Identifier (EI)&gt;
</p>
<p>
Subcomponents for Street Address (SAD):  &lt;Street or Mailing Address (ST)&gt; & &lt;Street Name (ST)&gt; & &lt;Dwelling Number (ST)&gt;
</p>
<p>
Subcomponents for County/Parish Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Census Tract (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Address Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 27. The information formerly communicated using this field should now be communicated using the PRT segment.  The reader is referred to chapter 7 for a description of that segment.
</p>
<p>
This field specifies the address of the dispensing facility or the patient's location where the dispensing will occur.
</p>
<a id="Heading168">
<H4 class="css_Überschrift4" >
4.A.5.32 RXD-32   Pharmacy Order Type   (ID)   01690
</H4>
<p>
Definition: The Pharmacy Order Type field defines the general category of pharmacy order which may be used to determine the processing path the order will take.  Refer to HL7 Table 0480 - Pharmacy Order Types in Chapter 2C, Code Tables, for valid values.
</p>
<p>
This field may also be used for grouping of related orders for processing and/or reports.  For example, Medication Administration Records (MARs) often group large volume solutions, medications and small volume solutions differently based upon site-specific workflow.
</p>
<p>
Usage Rule: This field is optional for all Pharmacy transactions.  When not populated, a default value of "M" is assumed.
</p>
<a id="Heading169">
<H4 class="css_Überschrift4" >
4.A.5.33 RXD-33   Dispense Type   (CWE)   01691
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This is the type of dispensing event that occurred.  Refer to User-defined Table 0484 - Dispense Type for suggested values.
</p>
<a id="Heading170">
<H4 class="css_Überschrift4" >
4.A.5.34 RXD-34   Pharmacy Phone Number   (XTN)   02311
</H4>
<i>
<p>
Components:  &lt;WITHDRAWN Constituent&gt; ^ &lt;Telecommunication Use Code (ID)&gt; ^ &lt;Telecommunication Equipment Type (ID)&gt; ^ &lt;Communication Address (ST)&gt; ^ &lt;Country Code (SNM)&gt; ^ &lt;Area/City Code (SNM)&gt; ^ &lt;Local Number (SNM)&gt; ^ &lt;Extension (SNM)&gt; ^ &lt;Any Text (ST)&gt; ^ &lt;Extension Prefix (ST)&gt; ^ &lt;Speed Dial Code (ST)&gt; ^ &lt;Unformatted Telephone number  (ST)&gt; ^ &lt;Effective Start Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Shared Telecommunication Identifier (EI)&gt; ^ &lt;Preference Order (NM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Shared Telecommunication Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field contains the telecommunication contact information for the pharmacy.  Repetitions may be supplied for various device types or use codes, or multiple instances of the same type or use.  This concept also exists as RXO-36 and RXE-45 to support pharmacy contact information in the context of the order, the encoded order and the dispense.
</p>
<a id="Heading171">
<H4 class="css_Überschrift4" >
4.A.5.35 RXD-35   Dispense Tag Identifier   (EI)   03392
</H4>
<i>
<p>
Components:  &lt;Entity Identifier (ST)&gt; ^ &lt;Namespace ID (IS)&gt; ^ &lt;Universal ID (ST)&gt; ^ &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition: This field contains an identifier for the individual product instance for the dispense occurrence.  This may represent a barcode, RFID or other means of automatically-readable product instance.  Repetitions represent the same instance where more than one barcode, RFID or other identification is present.
</p>
<p>
For example, the medication preparer, e.g., a semi-automatic system, can inform the nurse that "for the 8 a.m. administration event, the medication that has been assigned and available at the patient bedside has the barcode BBBBBBBBBBB." The nurse would scan the barcode to ensure that the right medication is being administered.
</p>
<a id="Heading172">
<H3 class="css_Überschrift3" >
4.A.6 RXG - Pharmacy/Treatment Give Segment
</H3>
<a id="RXG">
<p>
HL7 Attribute Table - RXG - Pharmacy/Treatment Give
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
<br>
</TD><TD>
4=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading174">00342</a>
</TD><TD>
Give Sub-ID Counter
</TD>
<td><a href="../hl7v28datel.htm#00342">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
4=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading137">00334</a>
</TD><TD>
Dispense Sub-ID Counter
</TD>
<td><a href="../hl7v28datel.htm#00334">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
W
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading90">00221</a>
</TD><TD>
Quantity/Timing
</TD>
<td><a href="../hl7v28datel.htm#00221">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading240">0292</a>
</TD><TD>
<a href="ch04a.html#Heading91">00317</a>
</TD><TD>
Give Code
</TD>
<td><a href="../hl7v28datel.htm#00317">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading92">00318</a>
</TD><TD>
Give Amount - Minimum
</TD>
<td><a href="../hl7v28datel.htm#00318">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading93">00319</a>
</TD><TD>
Give Amount - Maximum
</TD>
<td><a href="../hl7v28datel.htm#00319">DB</a></td>
</TR>
<TR>
<TD>
7
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading94">00320</a>
</TD><TD>
Give Units
</TD>
<td><a href="../hl7v28datel.htm#00320">DB</a></td>
</TR>
<TR>
<TD>
8
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading95">00321</a>
</TD><TD>
Give Dosage Form
</TD>
<td><a href="../hl7v28datel.htm#00321">DB</a></td>
</TR>
<TR>
<TD>
9
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading182">00351</a>
</TD><TD>
Administration Notes
</TD>
<td><a href="../hl7v28datel.htm#00351">DB</a></td>
</TR>
<TR>
<TD>
10
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading128">0167</a>
</TD><TD>
<a href="ch04a.html#Heading98">00322</a>
</TD><TD>
Substitution Status
</TD>
<td><a href="../hl7v28datel.htm#00322">DB</a></td>
</TR>
<TR>
<TD>
11
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
W
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading149">01303</a>
</TD><TD>
Dispense-To Location
</TD>
<td><a href="../hl7v28datel.htm#01303">DB</a></td>
</TR>
<TR>
<TD>
12
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading102">0136</a>
</TD><TD>
<a href="ch04a.html#Heading46">00307</a>
</TD><TD>
Needs Human Review
</TD>
<td><a href="../hl7v28datel.htm#00307">DB</a></td>
</TR>
<TR>
<TD>
13
</TD><TD>
1..250
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading186">00343</a>
</TD><TD>
Special Administration Instructions
</TD>
<td><a href="../hl7v28datel.htm#00343">DB</a></td>
</TR>
<TR>
<TD>
14
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading111">00331</a>
</TD><TD>
Give Per (Time Unit)
</TD>
<td><a href="../hl7v28datel.htm#00331">DB</a></td>
</TR>
<TR>
<TD>
15
</TD><TD>
<br>
</TD><TD>
6=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading112">00332</a>
</TD><TD>
Give Rate Amount
</TD>
<td><a href="../hl7v28datel.htm#00332">DB</a></td>
</TR>
<TR>
<TD>
16
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading113">00333</a>
</TD><TD>
Give Rate Units
</TD>
<td><a href="../hl7v28datel.htm#00333">DB</a></td>
</TR>
<TR>
<TD>
17
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading114">01126</a>
</TD><TD>
Give Strength
</TD>
<td><a href="../hl7v28datel.htm#01126">DB</a></td>
</TR>
<TR>
<TD>
18
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading115">01127</a>
</TD><TD>
Give Strength Units
</TD>
<td><a href="../hl7v28datel.htm#01127">DB</a></td>
</TR>
<TR>
<TD>
19
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading154">01129</a>
</TD><TD>
Substance Lot Number
</TD>
<td><a href="../hl7v28datel.htm#01129">DB</a></td>
</TR>
<TR>
<TD>
20
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading155">01130</a>
</TD><TD>
Substance Expiration Date
</TD>
<td><a href="../hl7v28datel.htm#01130">DB</a></td>
</TR>
<TR>
<TD>
21
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading156">01131</a>
</TD><TD>
Substance Manufacturer Name
</TD>
<td><a href="../hl7v28datel.htm#01131">DB</a></td>
</TR>
<TR>
<TD>
22
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading50">01123</a>
</TD><TD>
Indication
</TD>
<td><a href="../hl7v28datel.htm#01123">DB</a></td>
</TR>
<TR>
<TD>
23
</TD><TD>
<br>
</TD><TD>
5#
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading196">01692</a>
</TD><TD>
Give Drug Strength Volume
</TD>
<td><a href="../hl7v28datel.htm#01692">DB</a></td>
</TR>
<TR>
<TD>
24
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading197">01693</a>
</TD><TD>
Give Drug Strength Volume Units
</TD>
<td><a href="../hl7v28datel.htm#01693">DB</a></td>
</TR>
<TR>
<TD>
25
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading198">01694</a>
</TD><TD>
Give Barcode Identifier
</TD>
<td><a href="../hl7v28datel.htm#01694">DB</a></td>
</TR>
<TR>
<TD>
26
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading411">0480</a>
</TD><TD>
<a href="ch04a.html#Heading199">01695</a>
</TD><TD>
Pharmacy Order Type
</TD>
<td><a href="../hl7v28datel.htm#01695">DB</a></td>
</TR>
<TR>
<TD>
27
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
B
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading166">01688</a>
</TD><TD>
Dispense to Pharmacy
</TD>
<td><a href="../hl7v28datel.htm#01688">DB</a></td>
</TR>
<TR>
<TD>
28
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
B
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading167">01689</a>
</TD><TD>
Dispense to Pharmacy Address
</TD>
<td><a href="../hl7v28datel.htm#01689">DB</a></td>
</TR>
<TR>
<TD>
29
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#PL">PL</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading64">01683</a>
</TD><TD>
Deliver-to Patient Location
</TD>
<td><a href="../hl7v28datel.htm#01683">DB</a></td>
</TR>
<TR>
<TD>
30
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading65">01684</a>
</TD><TD>
Deliver-to Address
</TD>
<td><a href="../hl7v28datel.htm#01684">DB</a></td>
</TR>
<TR>
<TD>
31
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#EI">EI</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading204">03393</a>
</TD><TD>
Give Tag Identifier
</TD>
<td><a href="../hl7v28datel.htm#03393">DB</a></td>
</TR>
<TR>
<TD>
32
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading205">03316</a>
</TD><TD>
Dispense Amount
</TD>
<td><a href="../hl7v28datel.htm#03316">DB</a></td>
</TR>
<TR>
<TD>
33
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading206">03317</a>
</TD><TD>
Dispense Units
</TD>
<td><a href="../hl7v28datel.htm#03317">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading173">
<H4 class="css_Überschrift4" >
4.A.6.0 RXG fields definitions
</H4>
<a id="Heading174">
<H4 class="css_Überschrift4" >
4.A.6.1 RXG-1   Give Sub-ID Counter   (NM)   00342
</H4>
<p>
Definition:  Use if this RXG segment carries information about a single administration. This field must contain a unique number for the placer order number.  This field along with the placer order number provides a unique reference to the specific scheduled give date/time transmitted by the pharmacy/treatment supplier for this order.
</p>
<p>
If the RXG segment carries information about multiple administrations, this field's value is zero (0), since in this case a one-to-one matching with the RXA segment is ambiguous.
</p>
<a id="Heading175">
<H4 class="css_Überschrift4" >
4.A.6.2 RXG-2   Dispense Sub-ID Counter   (NM)   00334
</H4>
<p>
Definition:  This is the dispense sub-ID to which this give message is related.
</p>
<a id="Heading176">
<H4 class="css_Überschrift4" >
4.A.6.3 RXG-3   Quantity/Timing
</H4>
<p>
Attention: The RXG-3 field was retained for backward compatibilty only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7.
</p>
<p>
Note:  The contents of fields 3-8 should be identical to the comparable fields in the RXE (RXE-2 thru 5).
</p>
<a id="Heading177">
<H4 class="css_Überschrift4" >
4.A.6.4 RXG-4   Give Code   (CWE)   00317
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is the identifier of the medical substance/treatment ordered to be given to the patient; it is equivalent to OBR-4-Universal service ID in function.  See the RXE segment for a complete definition of the RXE-2-Give code.  If the substance given is a vaccine, CVX codes may be used to code this field (see HL7 Table 0292 - Vaccines administered in Chapter 2C, Code Tables).
</p>
<a id="Heading178">
<H4 class="css_Überschrift4" >
4.A.6.5 RXG-5   Give Amount - Minimum   (NM)   00318
</H4>
<p>
Definition:  This field contains the ordered amount as encoded by the pharmacy/treatment supplier.  In a variable dose order, this is the minimum ordered amount.  In a non-varying dose order, this is the exact amount of the order.
</p>
<p>
Note:  This field is not a duplication of the first component of the quantity/timing field, since in non-pharmacy/treatment orders, that component can be used to specify multiples of an ordered amount.
</p>
<p>
Another way to say this is that, for pharmacy/treatment orders, the quantity component of the quantity/timing field refers to what is to be given out at each service interval; and thus, in terms of the RX order, that first component always defaults to 1.  Hence, in the actual execution of the order, the value of 1 in the first component of the quantity/timing field always refers to one administration of the amount specified in this field (the requested Give Amount field).
</p>
<a id="Heading179">
<H4 class="css_Überschrift4" >
4.A.6.6 RXG-6   Give Amount - Maximum   (NM)   00319
</H4>
<p>
Definition:  In a variable dose order, this is the maximum ordered amount.  In a non-varying dose order, this field is not used.
</p>
<a id="Heading180">
<H4 class="css_Überschrift4" >
4.A.6.7 RXG-7   Give Units   (CWE)   00320
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units for the give amount.
</p>
<p>
Note:  These units can be a "compound quantity;" i.e., the units may contain the word "per."  For example, micrograms per KG (micg/kg) is an acceptable value, which means that the units are micrograms per KG (of body weight).
</p>
<p>
A table of standard units that contains compound units is needed.  Until such a table is agreed on, a user-defined table is needed for each site.
</p>
<a id="Heading181">
<H4 class="css_Überschrift4" >
4.A.6.8 RXG-8   Give Dosage Form   (CWE)   00321
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  The dosage form indicates the manner in which the medication/treatment is aggregated for dispensing, e.g., tablets, capsules, suppositories.  In some cases, this information is implied by the give code in RXG-4-Give Code.  Use this field when the give code does not specify the dosage form.
</p>
<a id="Heading182">
<H4 class="css_Überschrift4" >
4.A.6.9 RXG-9   Administration Notes   (CWE)   00351
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains notes to the person administering the medication/treatment (may include the ordering provider's original notes, as well as any notes from the formulary or the pharmacy or treatment supplier).  If coded, a user-defined table must be used.  If free text, place a null in the first component and the text in the second, e.g., |^this is a free text administration note|.
</p>
<a id="Heading183">
<H4 class="css_Überschrift4" >
4.A.6.10 RXG-10   Substitution Status   (ID)   00322
</H4>
<p>
Definition:  Refer to HL7 Table 0167 - Substitution Status in Chapter 2C, Code Tables, for valid values.
</p>
<p>
Note:  The next two fields are equivalent to the corresponding fields of the RXE segment.  They are included (optionally) in the RXG so that it may "stand alone" as a "give" instruction segment.
</p>
<a id="Heading184">
<H4 class="css_Überschrift4" >
4.A.6.11 RXG-11   Dispense-to Location
</H4>
<p>
Definition:  This field is retained for backward compatibility only as of v 2.6 and removed from the standard as of v 2.8. The reader is referred to RXG-27 and RXG-28.
</p>
<a id="Heading185">
<H4 class="css_Überschrift4" >
4.A.6.12 RXG-12   Needs Human Review   (ID)   00307
</H4>
<p>
Definition:  Refer to HL7 Table 0136 - Yes/No Indicator for valid values.  The values have the following meaning for this field:
</p>
<p>
Y	Yes - Indicates that a warning is present.  The application receiving the dispense order needs to warn the person dispensing/administering the drug or treatment to pay attention to the text in RXG-13-Special administration instructions.
</p>
<p>
N	No - Indicates no warning is present.  This is the equivalent default (null) value.
</p>
<a id="Heading186">
<H4 class="css_Überschrift4" >
4.A.6.13 RXG-13   Special Administration Instructions   (CWE)   00343
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains pharmacy/treatment supplier-generated special instructions to the provider administering the order.
</p>
<a id="Heading187">
<H4 class="css_Überschrift4" >
4.A.6.14 RXG-14   Give Per (Time Unit)   (ST)   00331
</H4>
<p>
Definition:  This field contains the time unit to use to calculate the rate at which the pharmaceutical/treatment is to be administered.
</p>
<p>
Format:
</p>
<TABLE width="100%" border=1>
<TR>
<TD>
S<integer>
</TD><TD>
=
</TD><TD>
<integer> seconds
</TD>
</TR>
<TR>
<TD>
M<integer>
</TD><TD>
=
</TD><TD>
<integer> minutes
</TD>
</TR>
<TR>
<TD>
H<integer>
</TD><TD>
=
</TD><TD>
<integer> hours
</TD>
</TR>
<TR>
<TD>
D<integer>
</TD><TD>
=
</TD><TD>
<integer> days
</TD>
</TR>
<TR>
<TD>
W<integer>
</TD><TD>
=
</TD><TD>
<integer> weeks
</TD>
</TR>
<TR>
<TD>
L<integer>
</TD><TD>
=
</TD><TD>
<integer> months
</TD>
</TR>
<TR>
<TD>
T<integer>
</TD><TD>
=
</TD><TD>
at the interval and amount stated until a total of <integer> "DOSAGE" is accumulated.  Units would be assumed to be the same as in the QUANTITY field.
</TD>
</TR>
<TR>
<TD>
INDEF
</TD><TD>
=
</TD><TD>
do indefinitely - also the default
</TD>
</TR>
</TABLE><p>
<p>
This is the same as the format specified for the DURATION component of the quantity/timing field, excluding the "X" specification.
</p>
<p>
Required when relevant (e.g., certain IVs). For example, if the "give amount/units" were 300 ml and the "give per" time unit were H1 (equivalent to one hour), the rate is 300ml/hr.
</p>
<a id="Heading188">
<H4 class="css_Überschrift4" >
4.A.6.15 RXG-15   Give Rate Amount   (ST)   00332
</H4>
<p>
Definition:  This field contains the amount (number) of substance/treatment to be administered.
</p>
<a id="Heading189">
<H4 class="css_Überschrift4" >
4.A.6.16 RXG-16   Give Rate Units   (CWE)   00333
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units for RXG-15-give rate amount.  May be composite.  The ratio of the RXG-15-give rate amount and RXG-16-give rate units fields define the actual rate of administration.  Thus, if RXG-15-give rate amount = 100 and RXG-16-give rate units = ml/hr, the requested rate of administration is 100 ml/hr.
</p>
<a id="Heading190">
<H4 class="css_Überschrift4" >
4.A.6.17 RXG-17   Give Strength   (NM)   01126
</H4>
<p>
Definition:  Use when RXG-4-Give code does not specify the strength.  This is the numeric part of the strength, used in combination with RXG-18-Give strength units.
</p>
<a id="Heading191">
<H4 class="css_Überschrift4" >
4.A.6.18 RXG-18   Give Strength Units   (CWE)   01127
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  Use when RXG-4-Give Code does not specify the strength.  This is the unit of the strength, used in combination with RXG-17-Give Strength.
</p>
<p>
Note:  These units can be a "compound quantity"; i.e., the units may express a quantity per unit of time.  For example, micrograms per hour (micg/h) is an acceptable value.  These compound units are contained in the ISO+ table. See Chapter 7 for full definition of ISO+ units.
</p>
<a id="Heading192">
<H4 class="css_Überschrift4" >
4.A.6.19 RXG-19   Substance Lot Number   (ST)   01129
</H4>
<p>
Definition:  This field contains the lot number of the medical substance administered.
</p>
<p>
Note:  The lot number is the number printed on the label attached to the container holding the substance and on the packaging which houses the container.  If the substance is a vaccine, for example, and a diluent is required, a lot number may appear on the vial containing the diluent; however, any such identifier associated with a diluent is not the identifier of interest. The substance lot number should be reported, not that of the diluent.
</p>
<a id="Heading193">
<H4 class="css_Überschrift4" >
4.A.6.20 RXG-20   Substance Expiration Date   (DTM)   01130
</H4>
<p>
Definition:  This field contains the expiration date of the medical substance administered.
</p>
<p>
Note:  Vaccine expiration date does not always have a "day" component; therefore, such a date may be transmitted as YYYYMM.
</p>
<a id="Heading194">
<H4 class="css_Überschrift4" >
4.A.6.21 RXG-21   Substance Manufacturer Name   (CWE)   01131
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the manufacturer of the medical substance administered.
</p>
<p>
Note:  For vaccines, code system MVX may be used to code this field (see section 4A.7.1, "Vaccine administration data"). This field may be used if the manufacturer of the substance is not identified by the code used in RXA-5-administered code.
</p>
<a id="Heading195">
<H4 class="css_Überschrift4" >
4.A.6.22 RXG-22   Indication   (CWE)   01123
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the identifier of the condition or problem for which the drug/treatment was prescribed.  May repeat if multiple indications are relevant.
</p>
<a id="Heading196">
<H4 class="css_Überschrift4" >
4.A.6.23 RXG-23   Give Drug Strength Volume   (NM)   01692
</H4>
<p>
Description: This numeric field defines the volume measurement in which the drug strength concentration is contained. For example, Acetaminophen 120 MG/5ML Elixir means that 120 MG of the drug is in a solution with a volume of 5 ML, which would be encoded in RXG-17, RXG-18, RXG-23 and RXG-24 as:
</p>
<p>
RXG|||||||||||||||||120|mg^^ISO|||||5|ml^^ISO ...&lt;cr&gt;
</p>
<a id="Heading197">
<H4 class="css_Überschrift4" >
4.A.6.24 RXG-24   Give Drug Strength Volume Units   (CWE)   01693
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Description: This field indicates the volumetric unit associated with RXG-23 Give Drug Strength Volume.  See example in RXG-23.
</p>
<a id="Heading198">
<H4 class="css_Überschrift4" >
4.A.6.25 RXG-25   Give Barcode Identifier   (CWE)   01694
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field contains the pharmacy system's assigned barcode number for the give occurrence.  For IV orders, many pharmacy systems generate a barcode number to identify a specific bag/bottle of the order. This number can be an instance identifier; unique for the patient, drug combination, and schedule instance or it may be just a drug identifier.
</p>
<p>
The composition and use of the barcode number is dependent on application negotiation. An example of this field follows: The barcode number is in the following format, 9XXXXXXX000.  The number '9' is a constant, XXXXXXX is seven (7) characters for a unique identifier assigned or derived from the patient account and order ID and 000 is the zero-filled three (3) character IV bottle number.
</p>
<p>
The maximum length of the first component of this field is 40 characters to allow for the maximum existing barcode length in use today.  The second component contains the description of the item being coded and the third component may define the barcode type.
</p>
<p>
12345678901^IV bottle^3X9
</p>
<a id="Heading199">
<H4 class="css_Überschrift4" >
4.A.6.26 RXG-26   Pharmacy Order Type   (ID)   01695
</H4>
<p>
Definition: The Pharmacy Order Type field defines the general category of pharmacy order which may be used to determine the processing path the order will take.  Refer to HL7 Table 0480 Pharmacy Order Types in Chapter 2C, Code Tables, for valid values.
</p>
<p>
This field may also be used for grouping of related orders for processing and/or reports.  For example, Medication Administration Records (MARs) often group large volume solutions, medications and small volume solutions differently based upon site-specific workflow.
</p>
<p>
Usage Rule: This field is optional for all Pharmacy transactions.  When not populated, a default value of "M" is assumed.
</p>
<a id="Heading200">
<H4 class="css_Überschrift4" >
4.A.6.27 RXG-27   Dispense to Pharmacy   (CWE)   01688
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 2.7. The information formerly communicated using this field should now be communicated using the PRT segment.  The reader is referred to Chapter 7 for a description of that segment.
</p>
<p>
This field specifies the pharmacy that will dispense the prescription.
</p>
<a id="Heading201">
<H4 class="css_Überschrift4" >
4.A.6.28 RXG-28   Dispense to Pharmacy Address   (XAD)   01689
</H4>
<i>
<p>
Components:  &lt;Street Address (SAD)&gt; ^ &lt;Other Designation (ST)&gt; ^ &lt;City (ST)&gt; ^ &lt;State or Province (ST)&gt; ^ &lt;Zip or Postal Code (ST)&gt; ^ &lt;Country (ID)&gt; ^ &lt;Address Type (ID)&gt; ^ &lt;Other Geographic Designation (ST)&gt; ^ &lt;County/Parish Code (CWE)&gt; ^ &lt;Census Tract (CWE)&gt; ^ &lt;Address Representation Code (ID)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Temporary Indicator (ID)&gt; ^ &lt;Bad Address Indicator (ID)&gt; ^ &lt;Address Usage (ID)&gt; ^ &lt;Addressee (ST)&gt; ^ &lt;Comment (ST)&gt; ^ &lt;Preference Order (NM)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Address Identifier (EI)&gt;
</p>
<p>
Subcomponents for Street Address (SAD):  &lt;Street or Mailing Address (ST)&gt; & &lt;Street Name (ST)&gt; & &lt;Dwelling Number (ST)&gt;
</p>
<p>
Subcomponents for County/Parish Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Census Tract (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Address Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 2.7. The information formerly communicated using this field should now be communicated using the PRT segment.  The reader is referred to Chapter 7 for a description of that segment.
</p>
<p>
This field specifies the address of the dispensing facility or the patient's location where the dispensing will occur.
</p>
<a id="Heading202">
<H4 class="css_Überschrift4" >
4.A.6.29 RXG-29   Deliver-to Patient Location   (PL)   01683
</H4>
<i>
<p>
Components:  &lt;Point of Care (HD)&gt; ^ &lt;Room (HD)&gt; ^ &lt;Bed (HD)&gt; ^ &lt;Facility (HD)&gt; ^ &lt;Location Status (IS)&gt; ^ &lt;Person Location Type (IS)&gt; ^ &lt;Building (HD)&gt; ^ &lt;Floor (HD)&gt; ^ &lt;Location Description (ST)&gt; ^ &lt;Comprehensive Location Identifier (EI)&gt; ^ &lt;Assigning Authority for Location (HD)&gt;
</p>
<p>
Subcomponents for Point of Care (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Room (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Bed (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Building (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Floor (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Comprehensive Location Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Authority for Location (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field specifies the location of the patient to whom the pharmaceutical substance is to be delivered.
</p>
<a id="Heading203">
<H4 class="css_Überschrift4" >
4.A.6.30 RXG-30   Deliver-to Address   (XAD)   01684
</H4>
<i>
<p>
Components:  &lt;Street Address (SAD)&gt; ^ &lt;Other Designation (ST)&gt; ^ &lt;City (ST)&gt; ^ &lt;State or Province (ST)&gt; ^ &lt;Zip or Postal Code (ST)&gt; ^ &lt;Country (ID)&gt; ^ &lt;Address Type (ID)&gt; ^ &lt;Other Geographic Designation (ST)&gt; ^ &lt;County/Parish Code (CWE)&gt; ^ &lt;Census Tract (CWE)&gt; ^ &lt;Address Representation Code (ID)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Temporary Indicator (ID)&gt; ^ &lt;Bad Address Indicator (ID)&gt; ^ &lt;Address Usage (ID)&gt; ^ &lt;Addressee (ST)&gt; ^ &lt;Comment (ST)&gt; ^ &lt;Preference Order (NM)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Address Identifier (EI)&gt;
</p>
<p>
Subcomponents for Street Address (SAD):  &lt;Street or Mailing Address (ST)&gt; & &lt;Street Name (ST)&gt; & &lt;Dwelling Number (ST)&gt;
</p>
<p>
Subcomponents for County/Parish Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Census Tract (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Address Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field specifies the address, either mailing or physical, to which the prescription should be mailed or delivered.
</p>
<a id="Heading204">
<H4 class="css_Überschrift4" >
4.A.6.31 RXG-31   Give Tag Identifier   (EI)   03393
</H4>
<i>
<p>
Components:  &lt;Entity Identifier (ST)&gt; ^ &lt;Namespace ID (IS)&gt; ^ &lt;Universal ID (ST)&gt; ^ &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition: This field contains an identifier for the individual product instance for the dispense occurrence.  This may represent a barcode, RFID or other means of automatically-readable product instance.  Repetitions represent the same instance where more than one barcode, RFID or other identification is present.
</p>
<p>
For example, the medication preparer, e.g., a semi-automated system, can inform the nurse that "for the 8.am administration event, the medication that has been assigned and available at the patient bedside has the barcode BBBBBBBBBBB." The nurse would scan the barcode to ensure that the right medication is being administered.
</p>
<p>
This differs from RXG-25 Give Barcode Identifier in that RXG-25 may include other workflow content or the product at various levels of granularity.  RXG-31 specifically identifies the product instance.
</p>
<a id="Heading205">
<H4 class="css_Überschrift4" >
4.A.6.32 RXG-32   Dispense Amount   (NM)   03316
</H4>
<p>
Definition: This field contains the amount to be dispensed as encoded by the pharmacy or treatment supplier.
</p>
<a id="Heading206">
<H4 class="css_Überschrift4" >
4.A.6.33 RXG-33   Dispense Units   (CWE)   03317
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the units for the dispense amount as encoded by the pharmacy or treatment supplier.  This field is required if the units are not implied by the actual dispense code. This must be in simple units that reflect the actual quantity of the substance dispensed.  It does not include compound units.
</p>
<a id="Heading207">
<H3 class="css_Überschrift3" >
4.A.7 RXA - Pharmacy/Treatment Administration Segment
</H3>
<p>
The ORC must have the filler order number and the order control code RE.  As a site-specific variant, the RXO and associated RXCs and/or the RXE (and associated RXCs) may be present if the receiving application needs any of their data.  The RXA carries the administration data.
</p>
<a id="RXA">
<p>
HL7 Attribute Table - RXA - Pharmacy/Treatment Administration
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
<br>
</TD><TD>
4=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading174">00342</a>
</TD><TD>
Give Sub-ID Counter
</TD>
<td><a href="../hl7v28datel.htm#00342">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
4=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading210">00344</a>
</TD><TD>
Administration Sub-ID Counter
</TD>
<td><a href="../hl7v28datel.htm#00344">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading211">00345</a>
</TD><TD>
Date/Time Start of Administration
</TD>
<td><a href="../hl7v28datel.htm#00345">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading212">00346</a>
</TD><TD>
Date/Time End of Administration
</TD>
<td><a href="../hl7v28datel.htm#00346">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading240">0292</a>
</TD><TD>
<a href="ch04a.html#Heading213">00347</a>
</TD><TD>
Administered Code
</TD>
<td><a href="../hl7v28datel.htm#00347">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading214">00348</a>
</TD><TD>
Administered Amount
</TD>
<td><a href="../hl7v28datel.htm#00348">DB</a></td>
</TR>
<TR>
<TD>
7
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading215">00349</a>
</TD><TD>
Administered Units
</TD>
<td><a href="../hl7v28datel.htm#00349">DB</a></td>
</TR>
<TR>
<TD>
8
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading216">00350</a>
</TD><TD>
Administered Dosage Form
</TD>
<td><a href="../hl7v28datel.htm#00350">DB</a></td>
</TR>
<TR>
<TD>
9
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading182">00351</a>
</TD><TD>
Administration Notes
</TD>
<td><a href="../hl7v28datel.htm#00351">DB</a></td>
</TR>
<TR>
<TD>
10
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XCN">XCN</a>
</TD><TD>
B
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading218">00352</a>
</TD><TD>
Administering Provider
</TD>
<td><a href="../hl7v28datel.htm#00352">DB</a></td>
</TR>
<TR>
<TD>
11
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
W
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading219">00353</a>
</TD><TD>
Administered-at Location
</TD>
<td><a href="../hl7v28datel.htm#00353">DB</a></td>
</TR>
<TR>
<TD>
12
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading220">00354</a>
</TD><TD>
Administered Per (Time Unit)
</TD>
<td><a href="../hl7v28datel.htm#00354">DB</a></td>
</TR>
<TR>
<TD>
13
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading221">01134</a>
</TD><TD>
Administered Strength
</TD>
<td><a href="../hl7v28datel.htm#01134">DB</a></td>
</TR>
<TR>
<TD>
14
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading222">01135</a>
</TD><TD>
Administered Strength Units
</TD>
<td><a href="../hl7v28datel.htm#01135">DB</a></td>
</TR>
<TR>
<TD>
15
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading154">01129</a>
</TD><TD>
Substance Lot Number
</TD>
<td><a href="../hl7v28datel.htm#01129">DB</a></td>
</TR>
<TR>
<TD>
16
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading155">01130</a>
</TD><TD>
Substance Expiration Date
</TD>
<td><a href="../hl7v28datel.htm#01130">DB</a></td>
</TR>
<TR>
<TD>
17
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading156">01131</a>
</TD><TD>
Substance Manufacturer Name
</TD>
<td><a href="../hl7v28datel.htm#01131">DB</a></td>
</TR>
<TR>
<TD>
18
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading226">01136</a>
</TD><TD>
Substance/Treatment Refusal Reason
</TD>
<td><a href="../hl7v28datel.htm#01136">DB</a></td>
</TR>
<TR>
<TD>
19
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading50">01123</a>
</TD><TD>
Indication
</TD>
<td><a href="../hl7v28datel.htm#01123">DB</a></td>
</TR>
<TR>
<TD>
20
</TD><TD>
2..2
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading267">0322</a>
</TD><TD>
<a href="ch04a.html#Heading228">01223</a>
</TD><TD>
Completion Status
</TD>
<td><a href="../hl7v28datel.htm#01223">DB</a></td>
</TR>
<TR>
<TD>
21
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading159">0206</a>
</TD><TD>
<a href="ch04a.html#Heading229">01224</a>
</TD><TD>
Action Code - RXA
</TD>
<td><a href="../hl7v28datel.htm#01224">DB</a></td>
</TR>
<TR>
<TD>
22
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading230">01225</a>
</TD><TD>
System Entry Date/Time
</TD>
<td><a href="../hl7v28datel.htm#01225">DB</a></td>
</TR>
<TR>
<TD>
23
</TD><TD>
<br>
</TD><TD>
5=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading231">01696</a>
</TD><TD>
Administered Drug Strength Volume
</TD>
<td><a href="../hl7v28datel.htm#01696">DB</a></td>
</TR>
<TR>
<TD>
24
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading232">01697</a>
</TD><TD>
Administered Drug Strength Volume Units
</TD>
<td><a href="../hl7v28datel.htm#01697">DB</a></td>
</TR>
<TR>
<TD>
25
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading233">01698</a>
</TD><TD>
Administered Barcode Identifier
</TD>
<td><a href="../hl7v28datel.htm#01698">DB</a></td>
</TR>
<TR>
<TD>
26
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading411">0480</a>
</TD><TD>
<a href="ch04a.html#Heading234">01699</a>
</TD><TD>
Pharmacy Order Type
</TD>
<td><a href="../hl7v28datel.htm#01699">DB</a></td>
</TR>
<TR>
<TD>
27
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#PL">PL</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading235">02264</a>
</TD><TD>
Administer-at
</TD>
<td><a href="../hl7v28datel.htm#02264">DB</a></td>
</TR>
<TR>
<TD>
28
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading236">02265</a>
</TD><TD>
Administered-at Address
</TD>
<td><a href="../hl7v28datel.htm#02265">DB</a></td>
</TR>
<TR>
<TD>
29
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#EI">EI</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading237">03396</a>
</TD><TD>
Administered Tag Identifier
</TD>
<td><a href="../hl7v28datel.htm#03396">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading208">
<H4 class="css_Überschrift4" >
4.A.7.0 RXA field definitions
</H4>
<a id="Heading209">
<H4 class="css_Überschrift4" >
4.A.7.1 RXA-1   Give Sub-ID Counter   (NM)   00342
</H4>
<p>
Definition:  Use this field if matching this RXA segment to its corresponding RXG segment.  If the two applications are not matching RXG and RXA segments, this field's value is zero (0).
</p>
<a id="Heading210">
<H4 class="css_Überschrift4" >
4.A.7.2 RXA-2   Administration Sub-ID Counter   (NM)   00344
</H4>
<p>
Definition:  This field starts with 1 the first time that medication/treatment is administered for this order.  Increments by one with each additional administration of the medication/treatment.
</p>
<p>
Note:  More than one RXA segment can be "matched" to a single RXG segment, as is the case when recording a change of the rate of administration of an IV solution.
</p>
<a id="Heading211">
<H4 class="css_Überschrift4" >
4.A.7.3 RXA-3   Date/Time Start of Administration   (DTM)   00345
</H4>
<p>
Definition:  If the order is for a continuous administration (such as an IV), and the rate is changed at a certain time after the start, an RAS message can be issued to record the change.  For such an RAS message, this field records the time the rate was changed to the new value recorded in the RXA-12-Administered Per (time unit) of the same message.
</p>
<a id="Heading212">
<H4 class="css_Überschrift4" >
4.A.7.4 RXA-4   Date/Time End of Administration   (DTM)   00346
</H4>
<p>
Definition:  If null, the date/time of RXA-3-Date/Time Start of Administration is assumed.
</p>
<a id="Heading213">
<H4 class="css_Überschrift4" >
4.A.7.5 RXA-5   Administered Code   (CWE)   00347
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the identifier of the medical substance/treatment administered.  It is equivalent to OBR-4-universal service ID in function. If the substance administered is a vaccine, CVX codes may be used to code this field (see HL7 Table 0292 - Vaccines Administered).  If CVX code is used to identify vaccines, the coding system component (RXA-5.3) should be valued as "CVX", not as "HL70292."
</p>
<a id="Heading214">
<H4 class="css_Überschrift4" >
4.A.7.6 RXA-6   Administered Amount   (NM)   00348
</H4>
<p>
Definition:  This field contains the amount administered.
</p>
<a id="Heading215">
<H4 class="css_Überschrift4" >
4.A.7.7 RXA-7   Administered units   (CWE)   00349
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is conditional because it is required if the administered amount code does not imply units.  This field must be in simple units that reflect the actual quantity of the substance administered.  It does not include compound units.
</p>
<a id="Heading216">
<H4 class="css_Überschrift4" >
4.A.7.8 RXA-8   Administered Dosage Form   (CWE)   00350
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  The dosage form indicates the manner in which the medication/treatment is aggregated for dispensing, e.g., tablets, capsules, suppositories.  In some cases, this information is implied by the dispense/give code in RXA-5-Administered Code.  Use this field when the administered code does not specify the dosage form.
</p>
<a id="Heading217">
<H4 class="css_Überschrift4" >
4.A.7.9 RXA-9   Administration Notes   (CWE)   00351
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains notes from the provider administering the medication/treatment.  If coded, requires a user-defined table.  If free text (describing a custom IV, mixture, or salve, for example) place a null in the first component and the text in the second, e.g., |^this is a free text administration note|.
</p>
<a id="Heading218">
<H4 class="css_Überschrift4" >
4.A.7.10 RXA-10   Administering Provider   (XCN)   00352
</H4>
<i>
<p>
Components:  &lt;Person Identifier (ST)&gt; ^ &lt;Family Name (FN)&gt; ^ &lt;Given Name (ST)&gt; ^ &lt;Second and Further Given Names or Initials Thereof (ST)&gt; ^ &lt;Suffix (e.g., JR or III) (ST)&gt; ^ &lt;Prefix (e.g., DR) (ST)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;DEPRECATED-Source Table (CWE)&gt; ^ &lt;Assigning Authority (HD)&gt; ^ &lt;Name Type Code (ID)&gt; ^ &lt;Identifier Check Digit (ST)&gt; ^ &lt;Check Digit Scheme (ID)&gt; ^ &lt;Identifier Type Code (ID)&gt; ^ &lt;Assigning Facility (HD)&gt; ^ &lt;Name Representation Code (ID)&gt; ^ &lt;Name Context (CWE)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Name Assembly Order (ID)&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Professional Suffix (ST)&gt; ^ &lt;Assigning Jurisdiction (CWE)&gt; ^ &lt;Assigning Agency or Department (CWE)&gt; ^ &lt;Security Check  (ST)&gt; ^ &lt;Security Check Scheme (ID)&gt;
</p>
<p>
Subcomponents for Family Name (FN):  &lt;Surname (ST)&gt; & &lt;Own Surname Prefix (ST)&gt; & &lt;Own Surname (ST)&gt; & &lt;Surname Prefix from Partner/Spouse (ST)&gt; & &lt;Surname from Partner/Spouse (ST)&gt;
</p>
<p>
Subcomponents for Source Table (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Authority (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Name Context (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Jurisdiction (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Assigning Agency or Department (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field is retained for backward compatibility only as of v 2.7. The reader is referred to the PRT segment described in Chapter 7.
</p>
<p>
This field contains the provider ID of the person administering the pharmaceutical/treatment. If the person referenced in this field is also referenced in PRT segment, they must contain the same information.  However, if there is a difference, then PRT segment takes precedence.
</p>
<a id="Heading219">
<H4 class="css_Überschrift4" >
4.A.7.11 RXA-11   Administered-at Location
</H4>
<p>
Definition:  This field is retained for backward compatibility only as of v 2.6 and withdrawn from the standard as of v 2.8. The reader is referred to RXA-27 and RXA-28..
</p>
<a id="Heading220">
<H4 class="css_Überschrift4" >
4.A.7.12 RXA-12   Administered Per (Time Unit)   (ST)   00354
</H4>
<p>
Definition:  This field contains the rate at which this medication/treatment was administered as calculated by using RXA-6-administered amount and RXA-7-administered units.  This field is conditional because it is required when a treatment is administered continuously at a prescribed rate, e.g., certain IV solutions.
</p>
<a id="Heading221">
<H4 class="css_Überschrift4" >
4.A.7.13 RXA-13   Administered Strength   (NM)   01134
</H4>
<p>
Definition:  Use when RXA-5-Administered Code does not specify the strength.  This is the numeric part of the strength, used in combination with RXA-14-Administered Strength Units.
</p>
<a id="Heading222">
<H4 class="css_Überschrift4" >
4.A.7.14 RXA-14   Administered Strength Units   (CWE)   01135
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  Use when RXA-5-Administered Code does not specify the strength.  This is the unit of the strength, used in combination with RXA-13-Administered Strength.
</p>
<p>
Note:  These units can be a "compound quantity;" i.e., the units may express a quantity per unit of time.  For example, micrograms per hour (micg/h) is an acceptable value.  These compound units are contained in the ISO+ table. See Chapter 7 for full definition of ISO+ units.
</p>
<a id="Heading223">
<H4 class="css_Überschrift4" >
4.A.7.15 RXA-15   Substance Lot Number   (ST)   01129
</H4>
<p>
Definition:  This field contains the lot number of the medical substance administered.
</p>
<p>
Note:  The lot number is the number printed on the label attached to the container holding the substance and on the packaging which houses the container.  If the substance is a vaccine, for example, and a diluent is required, a lot number may appear on the vial containing the diluent; however, any such identifier associated with a diluent is not the identifier of interest. The substance lot number should be reported, not that of the diluent.
</p>
<a id="Heading224">
<H4 class="css_Überschrift4" >
4.A.7.16 RXA-16   Substance Expiration Date   (DTM)   01130
</H4>
<p>
Definition:  This field contains the expiration date of the medical substance administered.
</p>
<p>
Note:  Vaccine expiration date does not always have a "day" component; therefore, such a date may be transmitted as YYYYMM.
</p>
<a id="Heading225">
<H4 class="css_Überschrift4" >
4.A.7.17 RXA-17   Substance Manufacturer Name   (CWE)   01131
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field contains the manufacturer of the medical substance administered.
</p>
<p>
Note:  For vaccines, code system MVX may be used to code this field.   See section 4A.7.1, "Vaccine administration data." This field may be used if the manufacturer of the substance is not identified by the code used in RXA-5- administered code.  When using this code system to identify vaccines, the coding system component of the CWE field should be valued as "MVX", not as "HL70227."
</p>
<a id="Heading226">
<H4 class="css_Überschrift4" >
4.A.7.18 RXA-18   Substance/Treatment Refusal Reason   (CWE)   01136
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the reason the patient refused the medical substance/treatment.  Any entry in the field indicates that the patient did not take the substance.
</p>
<a id="Heading227">
<H4 class="css_Überschrift4" >
4.A.7.19 RXA-19   Indication   (CWE)   01123
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field contains the identifier of the condition or problem for which the drug/treatment was prescribed.  May repeat if multiple indications are relevant.
</p>
<a id="Heading228">
<H4 class="css_Überschrift4" >
4.A.7.20 RXA-20   Completion Status   (ID)   01223 
</H4>
<p>
Definition:  Status of treatment administration event.  Refer to HL7 Table 0322 - Completion Status in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading229">
<H4 class="css_Überschrift4" >
4.A.7.21 RXA-21   Action Code - RXA   (ID)   01224 
</H4>
<p>
Definition:  Status of record. The information in this field enables the use of the RXA in the vaccine messages (see Section 4A.8, "Vaccine Segments"), where a method of correcting vaccination information transmitted with incorrect patient identifying information is needed.  Refer To HL7 Table 0206 - Segment Action Code in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading230">
<H4 class="css_Überschrift4" >
4.A.7.22 RXA-22   System Entry Date/Time   (DTM)   01225 
</H4>
<p>
Definition: Date/time the administration information was entered into the source system.  This field is used to detect instances where treatment administration information is inadvertently entered multiple times by providing a unique identification field.  Under usual circumstances, this field would be provided automatically by the computer system rather than being entered by a person.
</p>
<a id="Heading231">
<H4 class="css_Überschrift4" >
4.A.7.23 RXA-23   Administered Drug Strength Volume   (NM)   01696
</H4>
<p>
Description: This numeric field defines the volume measurement in which the drug strength concentration is contained. For example, Acetaminophen 120 MG/5ML Elixir means that 120 MG of the drug is in a solution with a volume of 5 ML , which would be encoded in RXA-13, RXA-14, RXA-23 and RXA-24 as:
</p>
<p>
RXA|||||||||||||120|mg^^ISO|||||||||5|ml^^ISO ...&lt;cr&gt;
</p>
<a id="Heading232">
<H4 class="css_Überschrift4" >
4.A.7.24 RXA-24   Administered Drug Strength Volume Units   (CWE)   01697
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Description: This field indicates the volumetric unit associated with RXA-23 Administered Drug Strength Volume.  See example in RXA-23.
</p>
<a id="Heading233">
<H4 class="css_Überschrift4" >
4.A.7.25 RXA-25   Administered Barcode Identifier   (CWE)   01698
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field contains the pharmacy system's assigned barcode number for the give occurrence.  For IV orders, many pharmacy systems generate a barcode number to identify a specific bag/bottle of the order. This number can be an instance identifier; unique for the patient, drug combination, and schedule instance or it may be just a drug identifier.
</p>
<p>
The composition and use of the barcode number is dependent on application negotiation. An example of this field follows:  The barcode number is in the following format, 9XXXXXXX000.  The number '9' is a constant, XXXXXXX is seven (7) characters for a unique identifier assigned or derived from the patient account and order ID and 000 is the zero-filled three (3) character IV bottle number.
</p>
<p>
The maximum length of the first component of this field is 40 characters to allow for the maximum existing barcode length in use today.  The second component contains the description of the item being coded and the third component may define the barcode type.
</p>
<p>
Example: 12345678901^IV bottle^3X9
</p>
<a id="Heading234">
<H4 class="css_Überschrift4" >
4.A.7.26 RXA-26   Pharmacy Order Type   (ID)   01699
</H4>
<p>
Definition: The Pharmacy Order Type field defines the general category of pharmacy order which may be used to determine the processing path the order will take.  Refer to HL7 Table 0480 - Pharmacy Order Types in Chapter 2C, Code Tables, for valid values.
</p>
<p>
This field may also be used for grouping of related orders for processing and/or reports.  For example, Medication Administration Records (MARs) often group large volume solutions, medications and small volume solutions differently based upon site-specific workflow.
</p>
<p>
Usage Rule: This field is optional for all Pharmacy transactions.  When not populated, a default value of "M" is assumed.
</p>
<a id="Heading235">
<H4 class="css_Überschrift4" >
4.A.7.27 RXA-27   Administered-At   (PL)   02264
</H4>
<i>
<p>
Components:  &lt;Point of Care (HD)&gt; ^ &lt;Room (HD)&gt; ^ &lt;Bed (HD)&gt; ^ &lt;Facility (HD)&gt; ^ &lt;Location Status (IS)&gt; ^ &lt;Person Location Type (IS)&gt; ^ &lt;Building (HD)&gt; ^ &lt;Floor (HD)&gt; ^ &lt;Location Description (ST)&gt; ^ &lt;Comprehensive Location Identifier (EI)&gt; ^ &lt;Assigning Authority for Location (HD)&gt;
</p>
<p>
Subcomponents for Point of Care (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Room (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Bed (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Facility (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Building (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Floor (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Comprehensive Location Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
<p>
Subcomponents for Assigning Authority for Location (HD):  &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition:  This field specifies the location where the drug or treatment was administered.
</p>
<a id="Heading236">
<H4 class="css_Überschrift4" >
4.A.7.28 RXA-28   Administered-at Address   (XAD)   02265
</H4>
<i>
<p>
Components:  &lt;Street Address (SAD)&gt; ^ &lt;Other Designation (ST)&gt; ^ &lt;City (ST)&gt; ^ &lt;State or Province (ST)&gt; ^ &lt;Zip or Postal Code (ST)&gt; ^ &lt;Country (ID)&gt; ^ &lt;Address Type (ID)&gt; ^ &lt;Other Geographic Designation (ST)&gt; ^ &lt;County/Parish Code (CWE)&gt; ^ &lt;Census Tract (CWE)&gt; ^ &lt;Address Representation Code (ID)&gt; ^ &lt;WITHDRAWN Constituent&gt; ^ &lt;Effective Date (DTM)&gt; ^ &lt;Expiration Date (DTM)&gt; ^ &lt;Expiration Reason (CWE)&gt; ^ &lt;Temporary Indicator (ID)&gt; ^ &lt;Bad Address Indicator (ID)&gt; ^ &lt;Address Usage (ID)&gt; ^ &lt;Addressee (ST)&gt; ^ &lt;Comment (ST)&gt; ^ &lt;Preference Order (NM)&gt; ^ &lt;Protection Code (CWE)&gt; ^ &lt;Address Identifier (EI)&gt;
</p>
<p>
Subcomponents for Street Address (SAD):  &lt;Street or Mailing Address (ST)&gt; & &lt;Street Name (ST)&gt; & &lt;Dwelling Number (ST)&gt;
</p>
<p>
Subcomponents for County/Parish Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Census Tract (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Expiration Reason (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Protection Code (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
<p>
Subcomponents for Address Identifier (EI):  &lt;Entity Identifier (ST)&gt; & &lt;Namespace ID (IS)&gt; & &lt;Universal ID (ST)&gt; & &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition: This field specifies the address of the location where the drug or treatment was administered.
</p>
<a id="Heading237">
<H4 class="css_Überschrift4" >
4.A.7.29 RXA-29   Administration Tag Identifier   (EI)   03396
</H4>
<i>
<p>
Components:  &lt;Entity Identifier (ST)&gt; ^ &lt;Namespace ID (IS)&gt; ^ &lt;Universal ID (ST)&gt; ^ &lt;Universal ID Type (ID)&gt;
</p>
</i>
<p>
Definition: This field contains an identifier for the individual product instance for the dispense occurrence.  This may represent a barcode, RFID or other means of automatically-readable product instance.  Repetitions represent the same instance where more than one barcode, RFID or other identification is present.
</p>
<p>
For example, the medication preparer, e.g., a semi-automatic system, can inform the nurse that "for the 8.am administration event, the medication that has been assigned and available at the patient bedside has the barcode BBBBBBBBBBB." The nurse would scan the barcode, to ensure that the right medication is being administered.
</p>
<p>
This differs from RXA-25 Administered Barcode Identifier in that RXA-25 may include other workflow content or the product at various levels of granularity.  RXA-29 specifically identifies the product instance.
</p>
<a id="Heading238">
<H3 class="css_Überschrift3" >
4.A.8 RXV - Pharmacy/Treatment Infusion Segment
</H3>
<p>
The RXV segment details the pharmacy or treatment application's encoding of specific infusion order parameters
</p>
<a id="RXV">
<p>
HL7 Attribute Table - RXV - Pharmacy/Treatment Infusion
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#SI">SI</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading240">03318</a>
</TD><TD>
Set ID - RXV
</TD>
<td><a href="../hl7v28datel.htm#03318">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading557">0917</a>
</TD><TD>
<a href="ch04a.html#Heading241">03319</a>
</TD><TD>
Bolus Type
</TD>
<td><a href="../hl7v28datel.htm#03319">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading242">03320</a>
</TD><TD>
Bolus Dose Amount
</TD>
<td><a href="../hl7v28datel.htm#03320">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading243">03321</a>
</TD><TD>
Bolus Dose Amount Units
</TD>
<td><a href="../hl7v28datel.htm#03321">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading244">03322</a>
</TD><TD>
Bolus Dose Volume
</TD>
<td><a href="../hl7v28datel.htm#03322">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading245">03323</a>
</TD><TD>
Bolus Dose Volume Units
</TD>
<td><a href="../hl7v28datel.htm#03323">DB</a></td>
</TR>
<TR>
<TD>
7
</TD><TD>
1..2
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading558">0918</a>
</TD><TD>
<a href="ch04a.html#Heading246">03324</a>
</TD><TD>
PCA Type
</TD>
<td><a href="../hl7v28datel.htm#03324">DB</a></td>
</TR>
<TR>
<TD>
8
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading247">03325</a>
</TD><TD>
PCA Dose Amount
</TD>
<td><a href="../hl7v28datel.htm#03325">DB</a></td>
</TR>
<TR>
<TD>
9
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading248">03326</a>
</TD><TD>
PCA Dose Amount Units
</TD>
<td><a href="../hl7v28datel.htm#03326">DB</a></td>
</TR>
<TR>
<TD>
10
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading249">03327</a>
</TD><TD>
PCA Dose Amount Volume
</TD>
<td><a href="../hl7v28datel.htm#03327">DB</a></td>
</TR>
<TR>
<TD>
11
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading250">03328</a>
</TD><TD>
PCA Dose Amount Volume Units
</TD>
<td><a href="../hl7v28datel.htm#03328">DB</a></td>
</TR>
<TR>
<TD>
12
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading251">03329</a>
</TD><TD>
Max Dose Amount
</TD>
<td><a href="../hl7v28datel.htm#03329">DB</a></td>
</TR>
<TR>
<TD>
13
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading252">03330</a>
</TD><TD>
Max Dose Amount Units
</TD>
<td><a href="../hl7v28datel.htm#03330">DB</a></td>
</TR>
<TR>
<TD>
14
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading253">03331</a>
</TD><TD>
Max Dose Amount Volume
</TD>
<td><a href="../hl7v28datel.htm#03331">DB</a></td>
</TR>
<TR>
<TD>
15
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading254">03332</a>
</TD><TD>
Max Dose Amount Volume Units
</TD>
<td><a href="../hl7v28datel.htm#03332">DB</a></td>
</TR>
<TR>
<TD>
16
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CQ">CQ</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading255">03333</a>
</TD><TD>
Max Dose per Time
</TD>
<td><a href="../hl7v28datel.htm#03333">DB</a></td>
</TR>
<TR>
<TD>
17
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CQ">CQ</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading256">03334</a>
</TD><TD>
Lockout Interval
</TD>
<td><a href="../hl7v28datel.htm#03334">DB</a></td>
</TR>
<TR>
<TD>
18
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading257">03339</a>
</TD><TD>
Syringe Manufacturer
</TD>
<td><a href="../hl7v28datel.htm#03339">DB</a></td>
</TR>
<TR>
<TD>
19
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading258">03385</a>
</TD><TD>
Syringe Model Number
</TD>
<td><a href="../hl7v28datel.htm#03385">DB</a></td>
</TR>
<TR>
<TD>
20
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading259">03386</a>
</TD><TD>
Syringe Size
</TD>
<td><a href="../hl7v28datel.htm#03386">DB</a></td>
</TR>
<TR>
<TD>
21
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading260">03431</a>
</TD><TD>
Syringe Size Units
</TD>
<td><a href="../hl7v28datel.htm#03431">DB</a></td>
</TR>
<TR>
<TD>
22
</TD><TD>
2..2
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading159">0206</a>
</TD><TD>
<a href="ch04a.html#Heading261">00816</a>
</TD><TD>
Action Code
</TD>
<td><a href="../hl7v28datel.htm#00816">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading239">
<H4 class="css_Überschrift4" >
4.A.8.0 RXV Field Definitions
</H4>
<a id="Heading240">
<H4 class="css_Überschrift4" >
4.A.8.1 RXV-1   Set ID    (SI)   03318
</H4>
<p>
Definition:  For the first timing specification transmitted, the sequence number shall be 1; for the second timing specification, it shall be 2; and so on.
</p>
<a id="Heading241">
<H4 class="css_Überschrift4" >
4.A.8.2 RXV-2   Bolus Type    (ID)   03319
</H4>
<p>
Definition:  This field identifies the type of bolus being ordered.  See HL7 Defined Table 0917 - Bolus Type in Chapter 2C, Code Tables, for example values.
</p>
<a id="Heading242">
<H4 class="css_Überschrift4" >
4.A.8.3 RXV-3   Bolus Dose Amount    (NM)   03320
</H4>
<p>
Definition:  This field contains the ordered bolus amount.  For example, if the ordered bolus is 50 mg, this field contains the value of 50.
</p>
<a id="Heading243">
<H4 class="css_Überschrift4" >
4.A.8.4 RXV-4   Bolus Dose Amount Units    (CWE)   03321
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the amount units associated with the bolus dose amount.  The preferred coding system is MDC; UCUM are also acceptable.
</p>
<p>
Examples:	
</p>
<p>
263890^MDC_DIM_MILLI_G^MDC
</p>
<p>
mg^milligram^UCUM
</p>
<a id="Heading244">
<H4 class="css_Überschrift4" >
4.A.8.5 RXV-5   Bolus Dose Volume    (NM)   03322
</H4>
<p>
Definition:  This field defines the volume measurement for the ordered bolus amount.  For example, if the ordered bolus is 5 ml, this field contains the value of 5.
</p>
<a id="Heading245">
<H4 class="css_Überschrift4" >
4.A.8.6 RXV-6   Bolus Dose Volume Units    (CWE)   03323
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the amount units associated with the bolus dose volume.  The preferred coding system is MDC; UCUM are also acceptable.
</p>
<p>
Examples:
</p>
<p>
263890^MDC_DIM_MILLI_G^MDC
</p>
<p>
mg^milligram^UCUM
</p>
<a id="Heading246">
<H4 class="css_Überschrift4" >
4.A.8.7 RXV-7   PCA Type    (ID)   03324
</H4>
<p>
Definition:  This field identifies the type of bolus being ordered. See HL7 Defined Table 0918 - PCA Type in Chapter 2C, Code Tables, for example values.
</p>
<a id="Heading247">
<H4 class="css_Überschrift4" >
4.A.8.8 RXV-8   PCA Dose Amount    (NM)   03325
</H4>
<p>
Definition:  This field contains the order's PCA dose amount.   Example:  if the ordered bolus is 3 mg, this field contains the value of 3.
</p>
<a id="Heading248">
<H4 class="css_Überschrift4" >
4.A.8.9 RXV-9   PCA Dose Amount Units    (CWE)   03326
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the amount units associated with the PCA dose amount.  The preferred coding system is MDC; UCUM are also acceptable.
</p>
<p>
Examples:
</p>
<p>
263890^MDC_DIM_MILLI_G^MDC
</p>
<p>
mg^milligram^UCUM
</p>
<a id="Heading249">
<H4 class="css_Überschrift4" >
4.A.8.10 RXV-10   PCA Dose Amount Volume    (NM)   03327
</H4>
<p>
Definition: This field defines the volume measurement for the ordered PCA amount volume.   For example, if the ordered bolus is 5 ml, this field contains the value of 5.
</p>
<a id="Heading250">
<H4 class="css_Überschrift4" >
4.A.8.11 RXV-11   PCA Dose Amount Volume Units    (CWE)   03328
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the amount units associated with the PCA dose volume.  The preferred coding system is MDC; UCUM are also acceptable.
</p>
<p>
Examples:
</p>
<p>
263890^MDC_DIM_MILLI_G^MDC
</p>
<p>
mg^milligram^UCUM
</p>
<a id="Heading251">
<H4 class="css_Überschrift4" >
4.A.8.12 RXV-12   Max Dose Amount    (NM)   03329
</H4>
<p>
Definition: This field contains the order's maximum dose amount.  For example, if the ordered bolus is 50 mg, this field contains the value of 50.
</p>
<a id="Heading252">
<H4 class="css_Überschrift4" >
4.A.8.13 RXV-13   Max Dose Amount Units    (CWE)   03330
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the amount units associated with the maximum dose volume.  The preferred coding system is MDC; UCUM are also acceptable.
</p>
<p>
Examples:
</p>
<p>
263890^MDC_DIM_MILLI_G^MDC
</p>
<p>
mg^milligram^UCUM
</p>
<a id="Heading253">
<H4 class="css_Überschrift4" >
4.A.8.14 RXV-14   Max Dose Amount Volume    (NM)   03331
</H4>
<p>
Definition: This field defines the volume measurement for the ordered max dose amount.  For example, if the ordered bolus is 5 ml, this field contains the value of 5.
</p>
<a id="Heading254">
<H4 class="css_Überschrift4" >
4.A.8.15 RXV-15   Max Dose Amount Volume Units    (CWE)   03332
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the amount units associated with the maximum dose volume.  The preferred coding system is MDC; UCUM are also acceptable.
</p>
<p>
Examples:
</p>
<p>
263890^MDC_DIM_MILLI_G^MDC
</p>
<p>
mg^milligram^UCUM
</p>
<a id="Heading255">
<H4 class="css_Überschrift4" >
4.A.8.16 RXV-16   Max Dose per Time    (CQ)   03333
</H4>
<i>
<p>
Components:  &lt;Quantity (NM)&gt; ^ &lt;Units (CWE)&gt;
</p>
<p>
Subcomponents for Units (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field contains the time unit expression of the lock out parameter.  For example, if the ordered max dose per time is 4 hours, this field format is "4^h&hours&UCUM".
</p>
<a id="Heading256">
<H4 class="css_Überschrift4" >
4.A.8.17 RXV-17   Lockout Interval    (CQ)   03334
</H4>
<i>
<p>
Components:  &lt;Quantity (NM)&gt; ^ &lt;Units (CWE)&gt;
</p>
<p>
Subcomponents for Units (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field contains the length of time that must expire between deliveries of PCA doses. For example, if the ordered max dose per time is 10 minutes, this field format is "10^min&minute&UCUM".
</p>
<a id="Heading257">
<H4 class="css_Überschrift4" >
4.A.8.18 RXV-18   Syringe Manufacturer    (CWE)   03339
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field contains the manufacturer of the syringe containing the ordered medication.
</p>
<a id="Heading258">
<H4 class="css_Überschrift4" >
4.A.8.19 RXV-19   Syringe Model Number    (CWE)   03385
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition: This field contains the model number of the syringe containing the ordered medication.
</p>
<a id="Heading259">
<H4 class="css_Überschrift4" >
4.A.8.20 RXV-20   Syringe Size    (NM)   03386
</H4>
<p>
Definition: This field contains the syringe's numeric total volume size.
</p>
<a id="Heading260">
<H4 class="css_Überschrift4" >
4.A.8.21 RXV-21   Syringe Size Units    (CWE)   03431
</H4>
<i>
<p>
Components:  &lt;Identifier (ST)&gt; ^ &lt;Text (ST)&gt; ^ &lt;Name of Coding System (ID)&gt; ^ &lt;Alternate Identifier (ST)&gt; ^ &lt;Alternate Text (ST)&gt; ^ &lt;Name of Alternate Coding System (ID)&gt; ^ &lt;Coding System Version ID (ST)&gt; ^ &lt;Alternate Coding System Version ID (ST)&gt; ^ &lt;Original Text (ST)&gt; ^ &lt;Second Alternate Identifier (ST)&gt; ^ &lt;Second Alternate Text (ST)&gt; ^ &lt;Name of Second Alternate Coding System (ID)&gt; ^ &lt;Second Alternate Coding System Version ID (ST)&gt; ^ &lt;Coding System OID (ST)&gt; ^ &lt;Value Set OID (ST)&gt; ^ &lt;Value Set Version ID (DTM)&gt; ^ &lt;Alternate Coding System OID (ST)&gt; ^ &lt;Alternate Value Set OID (ST)&gt; ^ &lt;Alternate Value Set Version ID (DTM)&gt; ^ &lt;Second Alternate Coding System OID (ST)&gt; ^ &lt;Second Alternate Value Set OID (ST)&gt; ^ &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  This field indicates the amount units associated with the syringe size.  The preferred coding system is MDC; UCUM are also acceptable.
</p>
<p>
Examples:
</p>
<p>
263890^MDC_DIM_MILLI_G^MDC
</p>
<p>
mg^milligram^UCUM
</p>
<a id="Heading261">
<H4 class="css_Überschrift4" >
4.A.8.22 RXV-22   Action Code    (ID)   00816
</H4>
<p>
Definition:   The intended handling by the receiver of the infusion order is represented by this segment.  Refer to HL7 Table 0206 - Segment Action Code in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading262">
<H3 class="css_Überschrift3" >
4.A.9 CDO - Cumulative Dosage Segment
</H3>
<p>
The Cumulative Dosage segment allows for the communication of cumulative dosage limits that administrations against this medication order should stay within.  As part of one of the pharmacy messages, one may want to indicate one or more limits that apply, e.g., limit for the duration of the order, lifetime limit, or weekly limit.
</p>
<a id="CDO">
<p>
HL7 Attribute Table - CDO - Cumulative Dosage
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
1..4
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#SI">SI</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading264">03430</a>
</TD><TD>
Set ID - CDO
</TD>
<td><a href="../hl7v28datel.htm#03430">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading159">0206</a>
</TD><TD>
<a href="ch04a.html#Heading261">00816</a>
</TD><TD>
Action Code
</TD>
<td><a href="../hl7v28datel.htm#00816">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CQ">CQ</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading266">03397</a>
</TD><TD>
Cumulative Dosage Limit
</TD>
<td><a href="../hl7v28datel.htm#03397">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CQ">CQ</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading564">0924</a>
</TD><TD>
<a href="ch04a.html#Heading267">03398</a>
</TD><TD>
Cumulative Dosage Limit Time Interval
</TD>
<td><a href="../hl7v28datel.htm#03398">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading263">
<H4 class="css_Überschrift4" >
4.A.9.0 CDO fields definitions
</H4>
<a id="Heading264">
<H4 class="css_Überschrift4" >
4.A.9.1 CDO-1   Set ID - CDO   (SI)   03430
</H4>
<p>
Definition:  For the first cumulative dose specification transmitted, the sequence number shall be 1; for the second cumulative dose, it shall be 2; and so on.
</p>
<a id="Heading265">
<H4 class="css_Überschrift4" >
4.A.9.2 CDO-2   Action Code   (ID)   00816
</H4>
<p>
Definition:  The Action Code indicates whether the cumulative dosage segment is intended to be added, deleted, updated, or did not change.  If the field is not valued in any CDO segments for the order, the segments are considered to have been sent in snapshot mode.  If some but not all CDO segments for the order do not have the action code valued, the default value is Add.  Refer to HL7 Table 0206 - Segment Action Code in Chapter 2C, Code Tables, for valid values.
</p>
<a id="Heading266">
<H4 class="css_Überschrift4" >
4.A.9.3 CDO-3   Cumulative Dosage Limit   (CQ)   03397
</H4>
<i>
<p>
Components:  &lt;Quantity (NM)&gt; ^ &lt;Units (CWE)&gt;
</p>
<p>
Subcomponents for Units (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  The Cumulative Dosage indicates the total dosage that may be administered within the scope of this order or within the interval indicated in CDO-4 Cumulative Dosage Time Interval, if supplied
</p>
<a id="Heading267">
<H4 class="css_Überschrift4" >
4.A.9.4 CDO-4   Cumulative Dosage Limit Time Interval   (CQ)   03398
</H4>
<i>
<p>
Components:  &lt;Quantity (NM)&gt; ^ &lt;Units (CWE)&gt;
</p>
<p>
Subcomponents for Units (CWE):  &lt;Identifier (ST)&gt; & &lt;Text (ST)&gt; & &lt;Name of Coding System (ID)&gt; & &lt;Alternate Identifier (ST)&gt; & &lt;Alternate Text (ST)&gt; & &lt;Name of Alternate Coding System (ID)&gt; & &lt;Coding System Version ID (ST)&gt; & &lt;Alternate Coding System Version ID (ST)&gt; & &lt;Original Text (ST)&gt; & &lt;Second Alternate Identifier (ST)&gt; & &lt;Second Alternate Text (ST)&gt; & &lt;Name of Second Alternate Coding System (ID)&gt; & &lt;Second Alternate Coding System Version ID (ST)&gt; & &lt;Coding System OID (ST)&gt; & &lt;Value Set OID (ST)&gt; & &lt;Value Set Version ID (DTM)&gt; & &lt;Alternate Coding System OID (ST)&gt; & &lt;Alternate Value Set OID (ST)&gt; & &lt;Alternate Value Set Version ID (DTM)&gt; & &lt;Second Alternate Coding System OID (ST)&gt; & &lt;Second Alternate Value Set OID (ST)&gt; & &lt;Second Alternate Value Set Version ID (DTM)&gt;
</p>
</i>
<p>
Definition:  The Cumulative Dosage Time Interval indicates the interval over which the cumulative dosage in CDO-3 Cumulative Dosage Limit is measured.  If this field is not valued, the Cumulative Dosage Limit applies to the scope of the order.
</p>
<p>
Refer to HL7 Table 924 - Cumulative Dosage Limit UoM in Chapter 2C, Code Tables, for a list of suggested values, including applicable values from UCUM.
</p>
<a id="Heading268">
<H2 class="css_Überschrift2" >
4.A PHARMACY/TREATMENT MESSAGE EXAMPLES 
</H2>
<p>
The purpose of this section is to show how certain specific situations would be handled using the pharmacy/treatment protocol.  The ellipses represent uncompleted details.  The symbol // precedes comments for clarification.
</p>
<a id="Heading269">
<H3 class="css_Überschrift3" >
4.A.1 Example of various levels of coding in an order
</H3>
<p>
The order "give 500 mg Ampicillin P.O. Q6H for 10 days for a total of 40 tablets" is sent to the RX application from the OE application.  This order can be coded with various levels of precision by an ordering application:
</p>
<ol type=a>
<li>
<p>
E-mail only version (uses only free text, RXO-6-provider's pharmacy/treatment instructions or RXO-7-provider's administration instructions only); fully encoded version must be re-entered or verified manually by the pharmacy or treatment application.
</p>
</li>
<li>
<p>
With RXO-2-requested give amount-minimum, RXO-4-requested give units, and ORC-7-quantity/timing coded, and RXO-1-requested give code as free text.
</p>
</li>
<li>
<p>
With RXO-1-requested give code, RXO-2-requested give amount-minimum, RXO-4-requested give units, and ORC-7-quantity/timing coded, but where RXO-1-requested give code does not include units.
</p>
</li>
<li>
<p>
With RXO-1-requested give code, RXO-2-requested give amount-minimum, RXO-4-requested give units, and ORC-7-quantity/timing coded, and where RXO-1-requested give code does include units.
</p>
</li>
</ol>
<p>
In this case, the units are optional.  The rule for this case (on orders, dispense results, give results, and administration results) is as follows: if units are coded, they override or supersede the units value implied by the give code.
</p>
<ol type=a>
<li>
<p>
The E-mail only version of the order: no coded fields exist in the RXO.
</p>
</li>
</ol>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006052911150700||OMP^O09^OMP_O09|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|NW|1000^OE||||E|...&lt;cr&gt;
</p>
<p>
RXO||||||500 mg Polycillin Q6H for 10 days, dispense 40 Tablets|...&lt;cr&gt;
</p>
<ol type=a>
<li>
<p>
A partially coded version of the order.  This version has the RXO-2-requested give amount-minimum, RXO-4-requested give units, and ORC-7-quantity/timing coded, but the RXO-1-requested give code as free text.
</p>
</li>
</ol>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006052911150700||OMP^O09^OMP_O09|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|NW|1000^OE||||E|^Q6H^D10^^^R|...&lt;cr&gt;
</p>
<p>
RXO|^Polycillin 500 mg TAB^|500||MG|||||Y||40|...&lt;cr&gt;
</p>
<p>
RXR|PO|...&lt;cr&gt;
</p>
<ol type=a>
<li>
<p>
A more completely coded version of the order, with the RXO-1-requested give code, RXO-2-requested give amount-minimum, RXO-4-requested give units, and ORC-7-quantity/timing coded, but where RXO-1-requested give code does not imply units.
</p>
</li>
</ol>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006052911150700||OMP^O09^OMP_O09|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|NW|1000^OE||||E|^Q6H^D10^^^R|...&lt;cr&gt;
</p>
<p>
RXO|RX1001^Polycillin^L|500||MG|||||Y||40|...&lt;cr&gt;
</p>
<p>
RXR|PO|...&lt;cr&gt;
</p>
<ol type=a>
<li>
<p>
A completely encoded version, with the RXO-1-requested give code, RXO-2-requested give amount-minimum, RXO-4-requested give units, and ORC-7-quantity/timing coded, and where RXO-1-requested give code does imply units.
</p>
</li>
</ol>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006052911150700||OMP^O09^OMP_O09|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|NW|1000^OE||||E|^Q6H^D10^^^R|...&lt;cr&gt;
</p>
<p>
RXO|RX1001^Polycillin 500 mg TAB^L|500||MG|||||G||40|...&lt;cr&gt;
</p>
<p>
RXR|PO|...&lt;cr&gt;
</p>
<ol type=a>
<li>
<p>
Pharmacy or treatment supplier's encoded version (RDE message) sent to nursing application (a generic substitution).
</p>
</li>
</ol>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006052911150700||RDE^O11^RDE_O11|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|RE|1000^OE|9999999^RX|||E|^Q6H^D10^^^R|...&lt;cr&gt;
</p>
<p>
RXE|^^^200612100600^^R|0047-0402-30^Ampicillin 250 MG
</p>
<p>
TAB^NDC|2||TAB|||||G|80||||123456|rx#1001|...&lt;cr&gt;
</p>
<p>
RXR|PO|...&lt;cr&gt;
</p>
<ol type=a>
<li>
<p>
Pharmacy or treatment supplier's dispense results (RDS message).
</p>
</li>
</ol>
<p>
MSH|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|RE|1000^OE|9999999^RX|||E|^Q6H^D10^^^R|...&lt;cr&gt;
</p>
<p>
RXD|1|0047-0402-30^Ampicillin 250 MG TAB^NDC|199012100400|8|TAB||RX#1001|
</p>
<p>
123456|G|8|...&lt;cr&gt;
</p>
<ol type=a>
<li>
<p>
Pharmacy or treatment supplier's give results (RGV message).
</p>
</li>
</ol>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006052911150700||RGV^O15^RGV_O15|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|RE|1000^OE|9999999^RX|||E|^Q6H^D10^^^R|...&lt;cr&gt;
</p>
<p>
RXG|1|1|^^200612100600^^R|0047-0402-30^Ampicillin 250 MG TAB^NDC|500||MG|||G|...&lt;cr&gt;
</p>
<p>
RXR|PO|...&lt;cr&gt;
</p>
<ol type=a>
<li>
<p>
Nursing application Medications Administration results to pharmacy, treatment, or Order Entry application.
</p>
</li>
</ol>
<p>
MSH|^&~\|Pharm|GenHosp|CIS|GenHosp|2006052911150700||RAS^O17^RAS_O17|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
ORC|RE|1000^OE|9999999^RX|||E|^Q6H^D10^^^R|...&lt;cr&gt;
</p>
<p>
RXA|1|1|200612100615||0047-0402-30^Ampicillin 250 MG TAB^NDC|2|TAB|...&lt;cr&gt;
</p>
<p>
RXR|PO|...&lt;cr&gt;
</p>
<a id="Heading270">
<H3 class="css_Überschrift3" >
4.A.2 RXO segment field examples
</H3>
<a id="Heading271">
<H4 class="css_Überschrift4" >
4.A.2.0 RXO segment field examples
</H4>
<a id="Heading272">
<H4 class="css_Überschrift4" >
4.A.2.1 RXO-1 Requested Give code example
</H4>
<p>
RXO|58160040000110^Fluoxetine HCL 10mg Capsule^GPI^00777310402^Prozac 10 mg caps^NDC|...&lt;cr&gt;
</p>
<a id="Heading273">
<H4 class="css_Überschrift4" >
4.A.2.2 RXO-18 and RXO-19 Requested Strength and Strength Unit examples
</H4>
<p>
The need for strength and strength unit fields in addition to the amount and amount units fields included in various RX_ segments requires explanation. Physicians can write a prescription for a drug such as Ampicillin in two ways. One way would be: "Ampicillin 250 mg capsules, 2 capsules four times a day."  In this case the give amount would be 2, the give units would be capsules, the strength would be 250 and the strength units would milligrams.
</p>
<p>
ORC|||||||1^QID|...&lt;cr&gt;
</p>
<p>
RXO|01200020200105^Ampicillin 250 mg capsule^GPI^00047040230^Ampicillin 250 mg caps^NDC|2||caps^capsule^FDB||||||||||||||250|mg|...&lt;cr&gt;
</p>
<p>
However, the provider could also write the prescription as "Ampicillin 500 mg four times a day."  In this case the give amount would be 500 and the give units would be milligrams.  The strength would not be reported in the RXO segment because it is not specified; the drug could be given in two 250 mg caps or one 500 mg cap. But the pharmacist would dispense a specific capsule size and would record the strength in the RXE segment as 250 or 500, depending upon which pill size was dispensed.
</p>
<p>
ORC|||||||1^QID|...&lt;cr&gt;
</p>
<p>
RXO|012000202001^Ampicillin capsule^GPI |500||mg^milligram^ISO||...&lt;cr&gt;
</p>
<a id="Heading274">
<H3 class="css_Überschrift3" >
4.A.3 RXD segment field examples
</H3>
<a id="Heading275">
<H4 class="css_Überschrift4" >
4.A.3.0 RXD segment field examples
</H4>
<a id="Heading276">
<H4 class="css_Überschrift4" >
4.A.3.1 RXD-4 and RXD-5 Dispense amount and Actual dispense units
</H4>
<p>
The RXD-4 and RXD-5 together might say
</p>
<p>
100 tabs:
</p>
<p>
RXD||||100|TAB^tablet^FDB|...&lt;cr&gt;
</p>
<p>
Or, 100 each
</p>
<p>
RXD||||100|EA^each^FDB|...&lt;cr&gt;
</p>
<p>
Or, perhaps a volume, 3 liters
</p>
<p>
RXD||||3|L^liter^ISO|...&lt;cr&gt;
</p>
<a id="Heading277">
<H4 class="css_Überschrift4" >
4.A.3.2 Actual dispense amount, Actual dispense units, Actual strength, Actual strength units
</H4>
<p>
For example, the RXD-4, RXD-5, RXD-16 and RXD-17 together might say
</p>
<p>
100 tabs of 240 mg strength:
</p>
<p>
RXD||||100|tab^tablet^FDB|||||||||||240|mg|...&lt;cr&gt;
</p>
<p>
Or, 100 each of 60 units per cc
</p>
<p>
RXD||||100|EA||||||||||||60|iu/ml^^ISO+|...&lt;cr&gt;
</p>
<p>
Or, perhaps a volume, 3 liters with 60 grams per liter
</p>
<p>
RXD||||3|L^liter^ISO|||||||||||60|g/L^^ISO+|...&lt;cr&gt;
</p>
<a id="Heading278">
<H4 class="css_Überschrift4" >
4.A.3.3 Valuing the Dispense Package Size Unit 
</H4>
<p>
If the package given to the patient is 2, 4 ounce bottles with a strength of 100/5ml, but the cough suppressant is stocked in 1 gallon bottles, then the field contains 1 gallon.
</p>
<p>
RXD||||8|ounce^^ISO|||||||||||20|mg/ml|||||1|gal^gallon^ISO|...&lt;cr&gt;
</p>
<p>
If one were to dispense Mevacor 100 tablets with a strength of 20 mg/tablet, and the package from the manufacturer is a 60 tablet package, then the fields reflect 60 tablets (the size of the package stocked by the pharmacy).
</p>
<p>
RXD||||100|tab^^FDB|||||||||||20|mg|||||60|tab|...&lt;cr&gt;
</p>
<a id="Heading279">
<H3 class="css_Überschrift3" >
4.A.4 RDS with FT1 segments example
</H3>
<p>
Example: Adam Everyman appears in the Pharmacy with a prescription for Veramil 120 mgm B.I.D.  The prescription is filled and the $5 co-pay is collected. The following RDS message is generated:
</p>
<p>
MSH|^&~\|Pharm|GenHosp|IE||2006052911150700||RDS^O13^RDS_O13||...&lt;cr&gt;
</p>
<p>
PID|||444-33-3333^^^MPI&GenHosp&L^MR||Everyman^Adam||19600614|M||C|2222 Home St^^Anytown^US^12345||^^^^^555^5552004| ...&lt;cr&gt;
</p>
<p>
ORC|RE||89968665||||||2006052910300700|||444-44-4444^HIPPOCRATES^HAROLD^^^^MD||^^^^^555^ 5551004|...&lt;cr&gt;
</p>
<p>
RXE|1^BID^^20060529|^Verapamil|120||mg^milligram^FDB.MDDB||...&lt;cr&gt;
</p>
<p>
RXD|1|00378112001^Verapamil Hydrochloride 120 mg TAB^NDC |200605291115-0700|100|||1331665|3|...&lt;cr&gt;
</p>
<p>
RXR|PO|...&lt;cr&gt;
</p>
<p>
FT1|1|||200605291115-0700||CO^Co-Pay^HL70017 |00378112001^Verapamil Hydrochloride 120 mg TAB^NDC |||1|5&USD^TP|...&lt;cr&gt;
</p>
<p>
FT1|2|||200605291115-0700||PY^Payment^HL70017 |00378112001^Verapamil Hydrochloride 120 mg TAB^NDC |||1|5&USD|...&lt;cr&gt;
</p>
<a id="Heading280">
<H3 class="css_Überschrift3" >
4.A.5 Alternating IV order messages
</H3>
<p>
Encoding Note: For readability, these examples do not show encoding of the subcomponents of the Give Codes (CWE data type) in the RXC and RXO segments.  In practice, the subcomponents should be encoded as described in the HL7 specification.
</p>
<ol type=a>
<li>
<p>
Example #1
</p>
</li>
</ol>
<p>
D5/0.45NaCl 1000mL with 20mEq KCl in every 3rd bottle.  Start the KCl in the 3rd bottle of this order.  Run in at a rate of 100mL/hr.
</p>
<p>
(Other message data: placer order #123, placer application ID=SMS, interval=continuous, start date/time=11/28/94 0900, no stop date/time, priority=Routine, order sequencing=Cyclical.)
</p>
<p>
This order may be expressed using a parent/child relationship.  The parent order consists of an ORC (and a RXO, incompletely elaborated in this example) that contains order level information.  The repeating bottle cycle of D5/0.45NaCl 1000mL followed by D5/0.45NaCl 1000mL followed by D5/0.45NaCl + 20mEq KCL 1000mL is represented by three child segments.  The placer system may be treating this as a single order with two bottles, A (D5/0.45NaCl 1000mL @ 100mL/hr) and B (D5/0.45NaCl + 20mEq KCL 1000mL @ 100mL/hr), repeating in the cycle of A-A-B.
</p>
<p>
The parent:
</p>
<p>
ORC|NW|123^SMS|||||1^C^^200611280900^^R^^^^C|...&lt;cr&gt;
</p>
<p>
RXO|Cyclic IV|...&lt;cr&gt;
</p>
<p>
The first child:
</p>
<p>
ORC|CH|123A1^SMS|||||1^C^^^^^^^^C&123B&SMS&&&*ES+0M|123|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|100||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/.45NACL|1000|ML|...&lt;cr&gt;
</p>
<p>
The second child:
</p>
<p>
ORC|CH|123A2^SMS|||||1^C^^^^^^^^C&123A1&SMS&&&ES+0M|123|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|100||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/.45NACL|1000|ML|...&lt;cr&gt;
</p>
<p>
The third child:
</p>
<p>
ORC|CH|123B^SMS|||||1^C^^^^^^^^C&123A2&SMS&&&#ES+0M|123|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|100||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/.45NACL|1000|ML|...&lt;cr&gt;
</p>
<p>
RXC|A|KCL|20|MEQ|...&lt;cr&gt;
</p>
<p>
Discussion points:
</p>
<p>
Placer Order Number - Three alternatives must be discussed for placer order number.
</p>
<ol>
<li>
<p>
Each child could have its own placer order number.
</p>
</li>
<li>
<p>
Each child could have the order number of the parent plus some appended identifier (for examples, 123A or 123.A or 123.1 etc.) that labels each child or each unique combination of ingredients.
</p>
</li>
<li>
<p>
In addition to the appended identifier discussed in 'B' above, a further suffix could be attached to uniquely identify each repetition of a particular member of the sequence.  The example (a cycle of bottles 'A' and 'B' in the sequence A-A-B) identified the order numbers of the children as 123A1, 123A2, and 123B, thereby enabling the quantity/timing to be completely unambiguous.  This could be expressed many other ways, such as 123A.1 or 123.A.1 or 123.A#1 etc.  HL7 does not specify a format for the expression of order number suffixes, nor does it specify a delimiter to use for such a purpose.
</p>
</li>
</ol>
<p>
Sequence Condition Value - In this example, the first child contains an asterisk (*) as the first character of the Sequence Condition Value and the third (last) child contains a pound sign (#).
</p>
<p>
The asterisk and pound sign are important for designating the first and last bottles especially when children are sent in separate messages, although this example is not constructed that way.
</p>
<p>
Note that computing the duration of the bottle is dependent upon the presence of all of the following fields:
</p>
<ul>
<li>
<p>
RXO-2-requested give amount-minimum
</p>
</li>
<li>
<p>
RXO-4-requested give units
</p>
</li>
<li>
<p>
RXC-3-component amount
</p>
</li>
<li>
<p>
RXC-4-component units
</p>
</li>
</ul>
<p>
For cyclic IV orders, these fields are all required in order to determine how long each occurrence of a child will last.
</p>
<p>
While HL7 allows either sending the parent and children in one message or sending the parent and children in separate messages, it appears simpler and therefore recommended to have the parent and all children included in a single message.   The example is constructed that way.
</p>
<ol type=a>
<li>
<p>
Example #2
</p>
</li>
</ol>
<p>
D5W + 40mEq KCl 1000mL alternating with D5/LR + 20mEq KCl 1000mL at 125mL/hr
</p>
<p>
(Other message data: placer order #124, placer application ID=SMS, interval=continuous, start date/time=11/28/94 0900, no stop date/time, priority=Routine, order sequencing=Cyclical)
</p>
<p>
This example is a variation on the first example where two different base solutions are used.  In this example, the placer system deals with this as one order with two alternating bottles, A (D5W + 40mEq KCl 1000mL @ 125mL/hr) and B (D5/LR + 20mEq KCl 1000mL @ 125mL/hr) in the cycle A-B.  The principles discussed in Example #1 apply equally to this example.
</p>
<p>
The parent:
</p>
<p>
ORC|NW|124^SMS|||||1^C^^200611280900^^R^^^^C|...&lt;cr&gt;
</p>
<p>
RXO|Cyclic IV|...&lt;cr&gt;
</p>
<p>
The first child:
</p>
<p>
ORC|CH|124A^SMS|||||1^C^^^^^^^^C&124B&SMS&&&*ES+0M|124|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|125||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5W|1000|ML|...&lt;cr&gt;
</p>
<p>
RXC|A|KCL|40|MEQ|...&lt;cr&gt;
</p>
<p>
The second child:
</p>
<p>
ORC|CH|124B^SMS|||||1^C^^^^^^^^C&124A&SMS&&&#ES+0M|124|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|125||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/LR|1000|ML|...&lt;cr&gt;
</p>
<p>
RXC|A|KCL|20|MEQ|...&lt;cr&gt;
</p>
<ol type=a>
<li>
<p>
Example #3
</p>
</li>
</ol>
<p>
D5/0.45NaCl 1000mL with 20mEq KCl in every 3rd bottle.  Start the KCl in the 3rd bottle of this order.  Add 10mL of multi-vitamins to the one bag daily.  Run in at a rate of 100mL/hr.
</p>
<p>
(Other message data: placer order #134, placer application ID=SMS, interval=continuous, start date/time=11/28/94 0900, no stop date/time, priority=Routine, order sequencing=Cyclical.  Note that the encoding of the multi-vitamins statement in the above order, adding multi-vitamins to one IV bag each day, may vary by institution to put it into the first or last bottle of the day.)
</p>
<p>
This order may be expressed using a parent/child relationship.  The parent order consists of an ORC (and a RXO, although one is not completely elaborated in this example) that contains order level information.  The repeating bottle cycle of D5/0.45NaCl 1000mL followed by D5/0.45NaCl 1000mL followed by D5/0.45NaCl + 20mEq KCL 1000mL is represented by three child segments.  This order is complicated by the request to add one component into any one of the three repeating bottles, depending upon which of the bottles will occur first on any particular day.  Further complicating this order is a rate of infusion (10 hours for a 1000mL bottle) which results in a fractional number of daily administrations.  Most legacy systems have a great deal of trouble accommodating orders like this within their existing database structures; however there a few vendors who now are able to handle the situation.  The placer system may be treating this as a single order with two bottles, A (D5/0.45NaCl 1000mL @ 100mL/hr) and B (D5/0.45NaCl + 20mEq KCL 1000mL @ 100mL/hr), repeating in the cycle of A-A-B with a cyclical component (multi-vitamins).
</p>
<p>
The parent:
</p>
<p>
ORC|NW|134^SMS|||||1^C^^200611280900^^R^^^^C|...&lt;cr&gt;
</p>
<p>
RXO|Cyclic IV|...&lt;cr&gt;
</p>
<p>
The first child:
</p>
<p>
ORC|CH|134A1^SMS|||||1^C^^^^^^^^C&134B&SMS&&&*ES+0M|134|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|100||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/.45NACL|1000|ML|...&lt;cr&gt;
</p>
<p>
The second child:
</p>
<p>
ORC|CH|134A2^SMS|||||1^C^^^^^^^^C&134A1&SMS&&&ES+0M|134|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|100||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/.45NACL|1000|ML|...&lt;cr&gt;
</p>
<p>
The third child:
</p>
<p>
ORC|CH|134B^SMS|||||1^C^^^^^^^^C&134A2&SMS&&&#ES+0M|134|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|100||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/.45NACL|1000|ML|...&lt;cr&gt;
</p>
<p>
RXC|A|KCL|20|MEQ|...&lt;cr&gt;
</p>
<p>
The fourth child:
</p>
<p>
ORC|CH|134X^SMS|||||1^Q1D^^^^^^^^|134|...&lt;cr&gt;
</p>
<p>
RXO|MULTIVITAMINS|10||ML|INJECTABLE|...&lt;cr&gt;
</p>
<p>
Discussion points:
</p>
<p>
This method for accommodating the Multi-vitamins Daily scenario does not pretend to be the best or only way to express the message, but simply demonstrates adapting the current specification to a highly complex order without adding new components.
</p>
<p>
The Multi-vitamins component may be sent as a fourth child.
</p>
<p>
In this example, its ORC-7-quantity/timing includes an interval of "Q1D" (every 1 days).
</p>
<p>
Its order number consists of the placer's parent order number plus an appended identifier ('X' in the above example) that labels this child as a special case.  This convention would need to be agreed upon by sending and receiving applications.
</p>
<ol type=a>
<li>
<p>
Example #4
</p>
</li>
</ol>
<p>
D5W + 40mEq KCl 1000mL alternating with D5/LR + 20mEq KCl 1000mL alternating with D5/0.45NaCl 1000mL.  Infuse the D5W and D5/0.45 at 125mL/hr, and the D5/LR at 100mL/hr.
</p>
<p>
(Other message data: placer order #177, placer application ID=SMS, interval=continuous, start date/time=11/28/94 0900, no stop date/time, priority=Routine, order sequencing=Cyclical)
</p>
<p>
This example is another variation of Example 1 where the rate for each bottle is different, and this can be expressed within the RX segments of the children using current components.  In this example, the placer system deals with this as one order with three alternating bottles, A (D5W + 40mEq KCl 1000mL @ 125mL/hr) , B (D5/LR + 20mEq KCl 1000mL @ 100mL/hr) , and C (D5/0.45NaCl 1000mL @ 125mL/hr) in the cycle A-B-C.  The principles discussed in Example #1 apply equally to this example.
</p>
<p>
The parent:
</p>
<p>
ORC|NW|177^SMS|||||1^C^^200611280900^^R^^^^C|...&lt;cr&gt;
</p>
<p>
RXO|Cyclic IV|...&lt;cr&gt;
</p>
<p>
The first child:
</p>
<p>
ORC|CH|177A^SMS|||||1^C^^^^^^^^C&177C&SMS&&&*ES+0M|177|...&lt;cr&gt;
</p>
<p>
RXO Segment, Requested Give Amount-Minimum: ...|125||ML|...
</p>
<p>
Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5W|1000|ML|...&lt;cr&gt;
</p>
<p>
RXC|A|KCL|40|MEQ|...&lt;cr&gt;
</p>
<p>
The second child:
</p>
<p>
ORC|CH|177B^SMS|||||1^C^^^^^^^^C&177A&SMS&&&ES+0M|177|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|100||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/LR|1000|ML|...&lt;cr&gt;
</p>
<p>
RXC|A|KCL|20|MEQ|...&lt;cr&gt;
</p>
<p>
The third child:
</p>
<p>
ORC|CH|177C^SMS|||||1^C^^^^^^^^C&177B&SMS&&&#ES+0M|177|...&lt;cr&gt;
</p>
<p>
RXO Segment,	Requested Give Amount-Minimum: ...|125||ML|...
</p>
<p>
		Requested Give Per (Time Unit):  ...|H1|...&lt;cr&gt;
</p>
<p>
RXR|IV|...&lt;cr&gt;
</p>
<p>
RXC|B|D5/0.45NACL|1000|ML|...&lt;cr&gt;
</p>
<a id="Heading281">
<H3 class="css_Überschrift3" >
4.A.6 Query examples
</H3>
<p>
Attention:  The original mode query, including QRD and QRF segments were retained for backward compatibility only as of v 2.4 and withdrawn as of v2.7. The reader is therefore referred to chapter 5, section 5.4, for the current query/response message structure.
</p>
<a id="Heading282">
<H2 class="css_Überschrift2" >
4.A PHARMACY/TREATMENT TRANSACTION FLOW DIAGRAM
</H2>
<p>
The following are possible routes at a generic site.
</p>
<p>
<img src="ch04a_01.gif" >
</p>
<a id="Heading283">
<H3 class="css_Überschrift3" >
4.A.1 OMP:
</H3>
<p>
The Ordering application generates a pharmacy/treatment OMP and sends it to the pharmacy or treatment application, Nursing application, and/or other applications as appropriate at the site.
</p>
<a id="Heading284">
<H3 class="css_Überschrift3" >
4.A.2 RDE:
</H3>
<p>
The pharmacy/treatment application may send the RDE, the Pharmacy/Treatment Encoded Order message, a fully encoded order to the Nursing application, Ordering application, and/or other system applications as appropriate at the site.
</p>
<a id="Heading285">
<H3 class="css_Überschrift3" >
4.A.3 RDS:
</H3>
<p>
The pharmacy/treatment application may send the RDS, the Pharmacy/Treatment Dispense message, to the Nursing application or other applications as appropriate at the site, each time a medication is dispensed for this order.  This message may occur multiple times for each order.
</p>
<a id="Heading286">
<H3 class="css_Überschrift3" >
4.A.4 RGV:
</H3>
<p>
The pharmacy application may send the RGV, the Pharmacy/Treatment Give message, to the Nursing application or other applications as appropriate at the site, for each scheduled date/time of administration of a medication for a given order.  This message may occur multiple times for each order.
</p>
<a id="Heading287">
<H3 class="css_Überschrift3" >
4.A.5 RAS:
</H3>
<p>
The Nursing application (and other applications) can generate the RAS, the pharmacy/treatment Administration Results message, whenever a medication is given to the patient.  This message may occur multiple times for each order.
</p>
<p>
Note:	Sites having a long term clinical data repository may wish to route data to the data repository from copies of all or any of the five messages.
</p>
<a id="Heading288">
<H2 class="css_Überschrift2" >
4.A VACCINE TRIGGER EVENTS & MESSAGE DEFINITIONS 
</H2>
<p>
The message header segment will carry one of four event types at MSH-9-Message Type:
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
Event
</TH><TH>
Description
</TH>
</TR>
<TR>
<TD>
V01
</TD><TD>
Query for Vaccination Record
</TD>
</TR>
<TR>
<TD>
V02
</TD><TD>
Response to Vaccination Query (V01) Returning Multiple PID Matches
</TD>
</TR>
<TR>
<TD>
V03
</TD><TD>
Response to Query (V01) Returning Vaccination Record
</TD>
</TR>
<TR>
<TD>
V04
</TD><TD>
Unsolicited Update to Vaccination Record
</TD>
</TR>
</TABLE><p>
<a id="Heading289">
<H3 class="css_Überschrift3" >
4.A.1 Vaccine administration data
</H3>
<p>
Immunization information systems (IIS) that maintain vaccination records need to be able to transmit patient-specific records of vaccine administration to other health information systems to provide access to the record at the time healthcare is given and to allow tracking of progress in reaching age-appropriate immunization coverage.  The transmissions will occur as the result of four activities:  (1) a query from one system for a patient's vaccination record that is held in another system, (2) a response to a query containing multiple patient matches to the query, (3) a response to a query containing the vaccination record, and (4) an unsolicited update to an immunization information system.
</p>
<p>
These messages permit the transmission of immunization records from care providers to immunization registries, queries of these registries for immunization records, and the return of these immunization records to care providers.  Messages containing immunization records carry patient identifying information in the PID segment.  They may also carry parent or guardian information in the NK1 segments to help identify a child. The RXA segment is used to report the details of the immunization event: the type of vaccine (e.g., DPT, polio, MMR), the date administered, the sequence (1st, 2nd, etc.), the amount (e.g., 0.5 ml), and location and provider of the immunization.  In addition, the RXA provides a place to record the lot number, manufacturer and date of expiration of the immunization.  The RXA can also be used to report the fact that a specified immunization was refused.  This section references two tables (CVX and MVX as referenced in HL7 Table 0396 - Coding Systems in Chapter 2C, Code Tables) maintained by the U.S. Centers for Disease Control and Prevention (CDC).  These tables are recommended in the U.S. for identifying the immunization in field RXA-5-Administered Code and the vaccine manufacturer in field RXA-17-substance manufacturer name.
</p>
<a id="Heading290">
<H3 class="css_Überschrift3" >
4.A.2 Queries for immunization records (QRF Segments) 
</H3>
<p>
Attention: Retained for backwards compatibility only as of v 2.4.and withdrawn as of v 2.7. Refer to Chapter 5, section 5.4, for the current query/response message structure.
</p>
<a id="Heading291">
<H3 class="css_Überschrift3" >
4.A.3 XQ - Query for Vaccination Record (Event V01)
</H3>
<p>
Attention: Retained for backwards compatibility only as of v 2.4.and withdrawn as of v 2.7. Refer to Chapter 5, section 5.4, for the current query/response message structure.
</p>
<a id="Heading292">
<H3 class="css_Überschrift3" >
4.A.4 VXX - RESPONSE TO VACCINATION QUERY RETURNING MULTIPLE PID MATCHES (EVENT V02)
</H3>
<p>
Attention: Retained for backwards compatibility only as of v 2.4.and withdrawn as of v 2.7. Refer to Chapter 5, section 5.4, for the current query/response message structure.
</p>
<a id="Heading293">
<H3 class="css_Überschrift3" >
4.A.5 VXR - Vaccination Record Response (Event V03)
</H3>
<p>
Attention: Retained for backwards compatibility only as of v 2.4.and withdrawn as of v 2.7. Refer to Chapter 5, section 5.4, for the current query/response message structure.
</p>
<a id="Heading294">
<H3 class="css_Überschrift3" >
4.A.6 VXU - Unsolicited Vaccination Record Update (Event V04)
</H3>
<p>
Definition:  When a provider wishes to update the patient's vaccination record being held in a registry, the provider will transmit an unsolicited update of the record (a V04 trigger event).
</p>
<p>
An unsolicited update will follow this format.  The three-letter code in the leftmost column indicates the segment that is included; the column on the right specifies the chapter in which that segment is fully defined.
</p>
<a id="CDO">
<p>
VXU^V04^VXU_V04: Unsolicited Vaccination Update
</p>
<tr>
<td>

</td>
<td>
<br>
</td>
</tr>
<TABLE width="100%" border=1>
<TR>
<TD>
<a href="ch02.html#Heading175">MSH</a>
</TD><TD>
Message Header Segment
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmMSH.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading221">SFT</a>
 } 
 ] 
</TD><TD>
Software
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmSFT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch02.html#Heading237">UAC</a>
 ] 
</TD><TD>
User Authentication Credential
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmUAC.htm">DB</a></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading78">PID</a>
</TD><TD>
Patient Identification Segment
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPID.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading330">PD1</a>
 ] 
</TD><TD>
Additional Demographics
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPD1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading228">NK1</a>
 } 
 ] 
</TD><TD>
Next of Kin/Associated Parties
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmNK1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
[
</TD><TD>
--- PATIENT_VISIT begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch03.html#Heading120">PV1</a>
</TD><TD>
Patient Visit
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch03.html#Heading176">PV2</a>
 ] 
</TD><TD>
Patient Visit - Additional Info
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmPV2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch03.html#Heading375">ARV</a>
 } 
 ] 
</TD><TD>
Access Restrictions
</TD><TD>
<br>
</TD><TD>
3
</TD>
<td><a href="../hl7v28segmARV.htm">DB</a></td>
</TR>
<TR>
<TD>
]
</TD><TD>
--- PATIENT_VISIT end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch06.html#Heading151">GT1</a>
 } 
 ] 
</TD><TD>
Guarantor
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmGT1.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- INSURANCE begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch06.html#Heading210">IN1</a>
</TD><TD>
Insurance
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading267">IN2</a>
 ] 
</TD><TD>
Insurance Additional Information
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN2.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch06.html#Heading341">IN3</a>
 ] 
</TD><TD>
Insurance Additional Information, Certification
</TD><TD>
<br>
</TD><TD>
6
</TD>
<td><a href="../hl7v28segmIN3.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- INSURANCE end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- PERSON_OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Observation/Result
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Observation)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes (Regarding Patient Observation)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- PERSON_OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- ORDER begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading37">ORC</a>
</TD><TD>
Common Order
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmORC.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for ORC)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- TIMING begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04.html#Heading135">TQ1</a>
</TD><TD>
Timing/Quantity
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ1.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch04.html#Heading151">TQ2</a>
 } 
 ] 
</TD><TD>
Timing/Quantity Order Sequence
</TD><TD>
<br>
</TD><TD>
4
</TD>
<td><a href="../hl7v28segmTQ2.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- TIMING end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch04a.html#Heading207">RXA</a>
</TD><TD>
Pharmacy Administration Segment
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXA.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
<a href="ch04a.html#Heading67">RXR</a>
 ] 
</TD><TD>
Pharmacy Route
</TD><TD>
<br>
</TD><TD>
4A
</TD>
<td><a href="../hl7v28segmRXR.htm">DB</a></td>
</TR>
<TR>
<TD>
[{
</TD><TD>
--- OBSERVATION begin
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
<a href="ch07.html#Heading113">OBX</a>
</TD><TD>
Observation/Result
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmOBX.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch07.html#Heading177">PRT</a>
 } 
 ] 
</TD><TD>
Participation (for Observation)
</TD><TD>
<br>
</TD><TD>
7
</TD>
<td><a href="../hl7v28segmPRT.htm">DB</a></td>
</TR>
<TR>
<TD>
 [ 
 { 
<a href="ch02.html#Heading204">NTE</a>
 } 
 ] 
</TD><TD>
Notes (Regarding Immunization)
</TD><TD>
<br>
</TD><TD>
2
</TD>
<td><a href="../hl7v28segmNTE.htm">DB</a></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- OBSERVATION end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
<TR>
<TD>
}]
</TD><TD>
--- ORDER end
</TD><TD>
<br>
</TD><TD>
<br>
</TD>
<td><br></td>
</TR>
</TABLE><p>
<a id="Heading295">
<H2 class="css_Überschrift2" >
4.A VACCINE SEGMENTS
</H2>
<a id="Heading296">
<H3 class="css_Überschrift3" >
4.A.1 RXA - segment usage in vaccine messages
</H3>
<p>
With the exception of RXA-5-Administered code and RXA-17-Substance manufacturer name, the structure for the RXA segment below is identical to that documented in section 4A.4.7, "RXA - Pharmacy/Treatment Administration Segment."  When using the RXA segment for vaccine messages, HL7 Table 0292- Vaccines Administered, should be used for RXA-5- Administered code, as noted in Section 4A.8.1.1, "Using RXA-5 in vaccine messages."  Imported Table 0227- Manufacturers of Vaccines, should be used for RXA-17- Substance manufacturer name, as noted in Section 4A.8.1.2, "Using RXA-17 in vaccine messages."
</p>
<a id="RXA">
<p>
HL7 Attribute Table - RXA - Segment Uses in Vaccine Messages
</p>
<TABLE width="100%" border=1>
<TR>
<TH>
SEQ
</TH><TH>
LEN
</TH><TH>
C.LEN
</TH><TH>
DT
</TH><TH>
OPT
</TH><TH>
RP/#
</TH><TH>
TBL#
</TH><TH>
ITEM #
</TH><TH>
ELEMENT NAME
</TH>
<TH>DB Ref.</TH>
</TR>
<TR>
<TD>
1
</TD><TD>
<br>
</TD><TD>
4=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading174">00342</a>
</TD><TD>
Give Sub-ID Counter
</TD>
<td><a href="../hl7v28datel.htm#00342">DB</a></td>
</TR>
<TR>
<TD>
2
</TD><TD>
<br>
</TD><TD>
4=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading210">00344</a>
</TD><TD>
Administration Sub-ID Counter
</TD>
<td><a href="../hl7v28datel.htm#00344">DB</a></td>
</TR>
<TR>
<TD>
3
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading211">00345</a>
</TD><TD>
Date/Time Start of Administration
</TD>
<td><a href="../hl7v28datel.htm#00345">DB</a></td>
</TR>
<TR>
<TD>
4
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading212">00346</a>
</TD><TD>
Date/Time End of Administration
</TD>
<td><a href="../hl7v28datel.htm#00346">DB</a></td>
</TR>
<TR>
<TD>
5
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading240">0292</a>
</TD><TD>
<a href="ch04a.html#Heading213">00347</a>
</TD><TD>
Administered Code
</TD>
<td><a href="../hl7v28datel.htm#00347">DB</a></td>
</TR>
<TR>
<TD>
6
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
R
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading214">00348</a>
</TD><TD>
Administered Amount
</TD>
<td><a href="../hl7v28datel.htm#00348">DB</a></td>
</TR>
<TR>
<TD>
7
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading215">00349</a>
</TD><TD>
Administered Units
</TD>
<td><a href="../hl7v28datel.htm#00349">DB</a></td>
</TR>
<TR>
<TD>
8
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading216">00350</a>
</TD><TD>
Administered Dosage Form
</TD>
<td><a href="../hl7v28datel.htm#00350">DB</a></td>
</TR>
<TR>
<TD>
9
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading182">00351</a>
</TD><TD>
Administration Notes
</TD>
<td><a href="../hl7v28datel.htm#00351">DB</a></td>
</TR>
<TR>
<TD>
10
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XCN">XCN</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading218">00352</a>
</TD><TD>
Administering Provider
</TD>
<td><a href="../hl7v28datel.htm#00352">DB</a></td>
</TR>
<TR>
<TD>
11
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
W
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading219">00353</a>
</TD><TD>
Administered-at Location
</TD>
<td><a href="../hl7v28datel.htm#00353">DB</a></td>
</TR>
<TR>
<TD>
12
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
C
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading220">00354</a>
</TD><TD>
Administered Per (Time Unit)
</TD>
<td><a href="../hl7v28datel.htm#00354">DB</a></td>
</TR>
<TR>
<TD>
13
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading221">01134</a>
</TD><TD>
Administered Strength
</TD>
<td><a href="../hl7v28datel.htm#01134">DB</a></td>
</TR>
<TR>
<TD>
14
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading222">01135</a>
</TD><TD>
Administered Strength Units
</TD>
<td><a href="../hl7v28datel.htm#01135">DB</a></td>
</TR>
<TR>
<TD>
15
</TD><TD>
<br>
</TD><TD>
20=
</TD><TD>
<a href="ch02A.html#ST">ST</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading154">01129</a>
</TD><TD>
Substance Lot Number
</TD>
<td><a href="../hl7v28datel.htm#01129">DB</a></td>
</TR>
<TR>
<TD>
16
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading155">01130</a>
</TD><TD>
Substance Expiration Date
</TD>
<td><a href="../hl7v28datel.htm#01130">DB</a></td>
</TR>
<TR>
<TD>
17
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
<a href="ch02c.html#Heading178">0227</a>
</TD><TD>
<a href="ch04a.html#Heading156">01131</a>
</TD><TD>
Substance Manufacturer Name
</TD>
<td><a href="../hl7v28datel.htm#01131">DB</a></td>
</TR>
<TR>
<TD>
18
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading226">01136</a>
</TD><TD>
Substance/Treatment Refusal Reason
</TD>
<td><a href="../hl7v28datel.htm#01136">DB</a></td>
</TR>
<TR>
<TD>
19
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
Y
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading50">01123</a>
</TD><TD>
Indication
</TD>
<td><a href="../hl7v28datel.htm#01123">DB</a></td>
</TR>
<TR>
<TD>
20
</TD><TD>
2..2
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading267">0322</a>
</TD><TD>
<a href="ch04a.html#Heading228">01223</a>
</TD><TD>
Completion Status
</TD>
<td><a href="../hl7v28datel.htm#01223">DB</a></td>
</TR>
<TR>
<TD>
21
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading159">0206</a>
</TD><TD>
<a href="ch04a.html#Heading229">01224</a>
</TD><TD>
Action Code - RXA
</TD>
<td><a href="../hl7v28datel.htm#01224">DB</a></td>
</TR>
<TR>
<TD>
22
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#DTM">DTM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading230">01225</a>
</TD><TD>
System Entry Date/Time
</TD>
<td><a href="../hl7v28datel.htm#01225">DB</a></td>
</TR>
<TR>
<TD>
23
</TD><TD>
<br>
</TD><TD>
5=
</TD><TD>
<a href="ch02A.html#NM">NM</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading231">01696</a>
</TD><TD>
Administered Drug Strength Volume
</TD>
<td><a href="../hl7v28datel.htm#01696">DB</a></td>
</TR>
<TR>
<TD>
24
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading232">01697</a>
</TD><TD>
Administered Drug Strength Volume Units
</TD>
<td><a href="../hl7v28datel.htm#01697">DB</a></td>
</TR>
<TR>
<TD>
25
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#CWE">CWE</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
9999
</TD><TD>
<a href="ch04a.html#Heading233">01698</a>
</TD><TD>
Administered Barcode Identifier
</TD>
<td><a href="../hl7v28datel.htm#01698">DB</a></td>
</TR>
<TR>
<TD>
26
</TD><TD>
1..1
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#ID">ID</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<a href="ch02c.html#Heading411">0480</a>
</TD><TD>
<a href="ch04a.html#Heading234">01699</a>
</TD><TD>
Pharmacy Order Type
</TD>
<td><a href="../hl7v28datel.htm#01699">DB</a></td>
</TR>
<TR>
<TD>
27
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#PL">PL</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading235">02264</a>
</TD><TD>
Administer-at
</TD>
<td><a href="../hl7v28datel.htm#02264">DB</a></td>
</TR>
<TR>
<TD>
28
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch02A.html#XAD">XAD</a>
</TD><TD>
O
</TD><TD>
<br>
</TD><TD>
<br>
</TD><TD>
<a href="ch04a.html#Heading236">02265</a>
</TD><TD>
Administered-at Address
</TD>
<td><a href="../hl7v28datel.htm#02265">DB</a></td>
</TR>
</TABLE><p>
<a id="Heading297">
<H4 class="css_Überschrift4" >
4.A.1.0 RXA field definitions
</H4>
<a id="Heading298">
<H4 class="css_Überschrift4" >
4.A.1.1 Using RXA-5 in vaccine messages
</H4>
<p>
Use in RXA-5- administered code to identify the particular vaccine administered.  The codes listed are used by immunization by immunization registries in the U.S.  Entries will be added as needed to accommodate international requirements.  Refer to chapter 2C Imported Table 0292 - Vaccines administered in Chapter 2C, Code Tables, for valid values.  If CVX code is used to identify vaccines, the coding system component (RXA-5.3) should be valued as "CVX", not as "HL70292."
</p>
<a id="Heading299">
<H4 class="css_Überschrift4" >
4.A.1.2 Using RXA-17 in vaccine messages
</H4>
<p>
Use in RXA-17-substance manufacturer name to identify the manufacturer or distributor of the particular vaccine administered.  The codes listed are used by immunization registries in the U.S.  Entries will be added as needed to accommodate international requirements.  Refer to chapter 2C Imported Table 0227 - manufacturers of Vaccines in Chapter 2C, Code Tables, for valid values.  If using an MVX, Manufacturer, code, the coding system component (RXA-17.3) should be valued as "MVX", not as "HL70227."
</p>
<a id="Heading300">
<H2 class="css_Überschrift2" >
4.A VACCINATION MESSAGE EXAMPLES 
</H2>
<a id="Heading301">
<H3 class="css_Überschrift3" >
4.A.1 VXQ - query for vaccination record
</H3>
<p>
Attention:  The original mode query, including QRD and QRF segments were retained for backward compatibility only as of v 2.4 and withdrawn as of v 2.7. The reader is therefore referred to Chapter 5, section 5.4, for the current query/response message structure.
</p>
<a id="Heading302">
<H3 class="css_Überschrift3" >
4.A.2 VXX - response to vaccination query with multiple PID matches
</H3>
<p>
Attention:  The original mode query, including QRD and QRF segments were retained for backward compatibility only as of v 2.4 and withdrawn as of v 2.7. The reader is therefore referred to Chapter 5, section 5.4, for the current query/response message structure.
</p>
<a id="Heading303">
<H3 class="css_Überschrift3" >
4.A.3 VXR - vaccination record response
</H3>
<p>
Attention:  The original mode query, including QRD and QRF segments were retained for backward compatibility only as of v 2.4 and withdrawn as of v 2.7. The reader is therefore referred to Chapter 5, section 5.4, for the current query/response message structure.
</p>
<a id="Heading304">
<H3 class="css_Überschrift3" >
4.A.4 VXU - unsolicited vaccination record update
</H3>
<p>
MSH|^~\&||AZVACREC||GAVACREC|200605221606||VXU^V04^VXU_V04|...&lt;cr&gt;
</p>
<p>
PID|...&lt;cr&gt;
</p>
<p>
NK1|...&lt;cr&gt;
</p>
<p>
NK1|...&lt;cr&gt;
</p>
<p>
PV1|...&lt;cr&gt;
</p>
<p>
PV2|...&lt;cr&gt;
</p>
<p>
IN1|...&lt;cr&gt;
</p>
<p>
IN2|||||||NUCLEAR^NANCY^D|909686637A|...&lt;cr&gt;
</p>
<p>
ORC|...&lt;cr&gt;
</p>
<p>
RXA|0|1|20060901115500|20060901115500|03^MMR^CVX|.5|MG^^ISO+|    222557777^KIDDER^KAREN^K^^DR|^^^ CHILD HEALTHCARE CLINIC^^^^^1044 Healthcare Drive^^METROPOLIS^AZ||||W23487909876456|20061125|MSD^Merck \T\ Co., Inc.^MVX|...&lt;cr&gt;
</p>
<p>
RXR|IM^INTRAMUSCULAR^HL70162|LG^LEFT GLUTEUS MEDIUS^HL70163|...&lt;cr&gt;
</p>
<p>
OBX|1|NM|1000.3^TEMP.RECTAL^AS4||102.9|DEGF^^ANSI+|||||F|||20060901153000|...&lt;cr&gt;
</p>
<p>
NTE|||PATIENT DEVELOPED HIGH FEVER APPROX 3 HRS AFTER VACCINE INJECTION. PROBABLE ADVERSE REACTION|...&lt;cr&gt;
</p>
<p>
This message shows an unsolicited update of a vaccination record.  The message type is VXU-Unsolicited Vaccination Record Update, with event code V04 (unsolicited vaccination record update).  This example is given to show possible uses for some of the optional segments in the message.
</p>
<a id="Heading305">
<H3 class="css_Überschrift3" >
4.A.5 Query acknowledgment with no records found
</H3>
<p>
Attention:  The original mode query, including QRD and QRF segments were retained for backward compatibility only as of v 2.4 and withdrawn as of v 2.7. The reader is therefore referred to Chapter 5, section 5.4, for the current query/response message structure.
</p>
<p>
</p>
<p>
</p>
<p>
</p>
</BODY>
</HTML>
